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Chapter 1 
 
 
 
1. Summary 
Hyperammonemia (HA) is defined as an elevated ammonia concentration in the blood, 
which is caused by an impairment of liver function and the resulting inadequate ammonia 
detoxification. The increased ammonia concentrations in the brain exert toxic effects on 
neural cells and is an important factor in different encephalopathies, such as hypoxia, 
hypoglycemia, ischemia, and the hepatic encephalopathy (HE). Despite of intensive 
investigations on the role and importance of ammonia in cerebral metabolism, the exact 
molecular mechanism could not be yet clarified. Three main hypotheses exist:  I) Disturbance 
in cerebral energy metabolism. II) Abnormality in neurotransmission. III) Alteration of the 
cellular volume. In all cases, the metabolic interaction between astrocytes and neurons 
(metabolic trafficking) play an important role. In this context, the glutamine-glutamate cycle 
represent one of the most important metabolic cycles in the brain. This cycle plays not only a 
special role for glutamatergic neurotransmission but also for the removal of excess ammonia. 
Since glutamine and ammonia are essential components of this cycle, the effects of 
extracellular ammonia and glutamine, which serve as both carbon- and nitrogen-source for the 
synthesis of TCA cycle intermediates and amino acids, on cerebral metabolism were 
investigated. For this purpose, apart form multinuclear NMR spectroscopy, molecular 
biological methods, e.g. Western Blotting, RT-PCR, and immunohistochemistry were used. 
Special attention was paid to the glucose- and energy-metabolism in neural cells, e.g. in 
astrocytes and neurons. 
 
To investigate the effect of extracellular ammonia on neural metabolism, primary cultures 
of astrocytes and neurons were incubated for 24 hours in media containing pathophisiological 
concentrations of ammonia (5 mM). The metabolic alterations were determined by labelled 
[1-13C]glucose using NMR spectroscopy. 
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The data of the present study clearly show that ammonia causes an increased glucose 
metabolism by stimulation of glycolytic- and TCA cycle-activity in cultured astrocytes. This 
was also observed in neurons, but to a much lesser extent. This shows the effective role of 
astrocytes for ammonia detoxification processes, as reflected by an elevated synthesis of 
amino acids, e.g. of glutamine, glutamate, aspartate, and alanine.  
 
According to the fact that astrocytes selectively contain the anaplerotic enzyme pyruvate 
carboxylase (PC), they synthesize glutamate predominantly via PC-activity. Neurons, on the 
other hand, possess no PC-activity. An interesting result of the present study was that 
extracellular glutamine enters the neuronal TCA cycle. Furthermore, it could be shown that 
glutamine was utilized as an anaplerotic substrate by providing oxaloacetate to condense with 
acetyl-CoA to citrate. In addition, the nitrogen from glutamate was transferred to oxaloacetate 
and pyruvate by aminotransferase. This indicates to alternative ammonia detoxification 
processes in neurons, compared to glutamine synthesis in astrocytes. 
 
The results of the present study confirm the higher susceptibility of the energy-status in 
astrocytes to ammonia. This was determined from the decreased high energy phosphates 
using 31P-NMR spectroscopy. However, the exact reasons for this effect are not yet clear. 
 
The synthesized glutamine in astrocytes represents not only the most important 
detoxification product of ammonia. As organic osmolyte, it plays also a significant role in cell 
volume regulation, and could be responsible for the swelling of astrocytes and consequently 
brain edema in acute HA. In this context, the results show that long-term treatment of 
astrocytes with excess ammonia results in elevated synthesis and accumulation of intracellular 
glutamine, while other organic osmolytes, such as myo-inositol (myo-Ins) and hypotaurine 
(HTau), significantly decrease. 
 
To study the effect of extracellular glutamine on neural metabolism, primary astrocytes 
and neurons were incubated for 24 hours in a glutamine-containing medium. The metabolic 
alterations were determined by labelled [1-13C]glucose using multinuclear NMR 
spectroscopy. 
The data of the present study show that deprivation of extracellular glutamine leads to a 
disturbance in the neuronal TCA cycle, demonstrating a crucial role of glutamine on the 
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normal, physiological metabolism in neurons was further confirmed. Furthermore, the results 
prove that the glutamine-glutamate cycle is not stochiometric, and that extracellular glutamine 
enters the TCA cycle. This finding may be of high importance with regard to the regulation of 
the glutamine-glutamate cycle. Interestingly, while the energy-status of astrocytes after 24 
hours glutamine-deprivation decreases significantly, primary neurons show an improved 
energy-status. This effect could not be elucidated in this study. However, this important 
finding points to the value of further investigations in this field.  
 
Using Western blot analysis, it was shown that both ammonia and extracellular glutamine 
cause a remarkably increase of glutamine synthetase (GS) expression in astrocytes. This 
finding indicates to an important role of GS in the elimination of ammonia and the regulation 
of the glutamine-glutamate cycle. Furthermore, based on these data, we could determine that 
ammonia, in contrast to glutamine, causes a significant decrease of glial fibrillary acidic 
protein (GFAP) expression in astrocytes. The decreased GFAP expression after ammonia 
treatment might be implicated in cellular volume regulation, since GFAP determine the 
viscoelasticity of the cells. 
 
The metabolic pathways of glutamine were determined using uniformly labelled [U-13C5] 
glutamine and multinuclear NMR spectroscopy. Thus, it was clearly assessed that glutamine 
predominantly enters the TCA cycle to be catabolized. This confirms that extracellular 
glutamine is used as an important energy substrate for neurons. Furthermore, the results of the 
present study show that glutamine can be substitute for glucose as an energy source for the 
neurons. An interesting result was that pyruvate recycling takes place not only in astrocytes, 
but also in neurons under hypoglycemia. This might be of high importance in situations, in 
which the supply of pyruvate is limited. 
 
Not only ammonia but also manganese accumulates in certain brain regions, e.g. LGP and 
FC, in patients with chronic HA. Since manganese is an important co-Factor for several 
metalloproteins, the effect of manganese on GS expression and lactate dehydrogenase 
isoenzyme (LDH-1), which is responsible for conversion of lactate to pyruvate, was 
investigated. For this purpose, Sprague-Dawley rats were injected intraperitoneally with 
MnCl2 (5 mg/kg/day) for 4 days. After perfusion of rates, the LGP and FC were isolated and 
analyzed using Western Blotting, RT-PCR, and immunohistochemistry. 
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The results of the present study show that manganese accumulation in globus pallidus 
(LGP) leads to increased expression of GS in LGP, while no alterations in the GS expression 
could be observed in FC. The increased GS expression might cause an elevated glutamine 
synthesis. Furthermore, the results show that manganese exert an inhibitory effect on the 
LDH-1 expression. This is an important finding because a decrease of LDH-1 indicates to a 
lower consumption of lactate in the brain, which may lead to elevated lactate in the LGP. For 
example, the accumulation of lactate may cause lactacidosis in the brain, which may represent 
one factor contributing to disordered neural energy metabolism. 
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Kapitel 1 
 
 
1.  Zusammenfassung 
 
Hyperammonämie (HA) wird als eine erhöhte Ammonium-Konzentration im Blut 
bezeichnet, die durch Beeinträchtigung(en) in der Leberfunktion, und infolgedessen 
unzureichender Ammonium-Entgiftung, hervorgerufen wird. Die erhöhte Ammonium-
Konzentration im Gehirn übt toxische Effekte auf neurale Zellen aus und wird als ein 
wichtiger Faktor für die Entwicklung von verschiedenen Enzephalopathien wie Hypoxia, 
Hypoglykämie, Ischämie, und vor allem der Hepatischen Enzephalopathie betrachtet. Trotz 
jahrzehntelanger intensiver Forschung über die Rolle des Ammoniums für den zerebralen 
Metabolismus konnten bis heute die genauen molekularen Mechanismen noch nicht eindeutig 
aufgeklärt werden. Drei Hypothesen sind vorrangig: I) Störungen im zerebralen Energie-
Metabolismus. II) Abnormalität in der Neurotransmission III) Veränderungen des zellulären 
Volumens. In allen Fällen spielen die metabolischen Wechselwirkungen zwischen Astrozyten 
und Neuronen, die durch verschiedene Zyklen vermittelt werden, eine effiziente Rolle. Der 
Glutamin-Glutamat-Zyklus stellt in diesem Zusammenhang einen der wichtigsten 
metabolischen Zyklen im Gehirn dar. Dieser Zyklus spielt nicht nur eine besondere Rolle für 
die glutamaterge Neurotransmission, sondern auch für die Beseitigung überschüssigen 
Ammoniums. Da Glutamin und Ammonium essentielle Komponenten dieses Zyklus sind, 
sollten im Rahmen dieser Arbeit die Effekte von extrazellulärem Ammonium und Glutamin, 
die als sowohl Kohlenstoff- als auch Stickstoff-Quelle für die Synthese von TCA-Zyklus-
Intermediaten und anderen Aminosäuren dienen, auf den zerebralen zellulären Metabolismus 
untersucht werden. Hierbei wurden neben der multinuklearen NMR-Spektroskopie 
molekularbiologische Methoden wie Western Blotting, RT-PCR, und Immunohistochemie 
eingesetzt. Die Untersuchung des Glukose- und Energie-Metabolismus standen dabei im 
Vordergrund.  
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Um die Effekte von extrazellulärem Ammonium auf den neuralen Metabolismus zu 
untersuchen, wurden pathophysiologische Konzentrationen von Ammonium (5 mM) in 
primären Kulturen von Astrozyten und Neuronen für 24 Stunden eingesetzt. Die 
metabolischen Änderungen wurden zunächst durch markierte [1-13C]Glukose mit Hilfe der 
NMR-Spektroskopie festgestellt.  
 
Die Daten der vorliegenden Arbeit zeigen eindeutig, dass Ammonium einen erhöhten 
Glukose-Metabolismus durch Stimulierung der Glykolyse- und TCA-Zyklus-Aktivität in 
Astrozyten verursacht. Dieses wurde auch in den Neuronen beobachtet, jedoch in weitaus 
geringerem Ausmaß. Dieses reflektiert die effektive Rolle der Astrozyten für Ammonium-
Entgiftungsprozesse, was sich in einer stark erhöhten Synthese von Aminosäuren wie 
Glutamin, Glutamat, Aspartat, und Alanin widerspiegelte. 
 
Astrozyten, die das anaplerotische Enzyme Pyruvat Carboxylase (PC) enthalten, 
synthetisieren Glutamat vorwiegend über PC Aktivität. Neuronen hingegen weisen keine PC 
Aktivität auf. Ein interessantes Ergebnis der vorliegenden Arbeit war, dass extrazelluläres 
Glutamin in den neuronalen TCA-Zyklus tritt. Weiterhin konnte festgestellt werden, dass 
Glutamin als anaplerotisches Substrat verwendet wurde, indem es Oxaloacetat zur weiteren 
Kondensation mit Acetyl-CoA nachliefert. Darüber hinaus wird der Stickstoff vom Glutamat 
auf Oxaloacetat und Pyruvat mit Hilfe von Aminotransferasen übertragen. Dieses deutet auf 
alternative Ammonium-Entgiftungsprozesse in Neuronen hin, die nicht wie die Astrozyten, 
Glutamin synthetisieren können. 
 
Darüber hinaus bestätigen die Ergebnisse die höhere Anfälligkeit des Energiestatus in 
Astrozyten gegenüber Ammonium. Dies wurde aus der Abnahme der energiereichen 
Phosphate mit Hilfe der 31P-NMR-Spektroskopie ermittelt. Die genauen Ursachen konnten 
jedoch noch nicht aufgeklärt werden. 
 
Es muss jedoch erwähnt werden, dass das in den Astrozyten synthetisierte Glutamin nicht 
nur das wichtigste Entgiftungsproduckt von Ammonium darstellt. Es spielt außerdem als ein 
wichtiger Osmolyt, eine entscheidende Rolle in der Zellvolumenregulation, und könnte eine 
Schwellung der Astrozyten und nachfolgend die beobachteten Gehirn-Ödeme in der akuten 
HA verursachen. In diesem Zusammenhang zeigen die Ergebnisse, dass die Behandlung der 
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Astrozyten mit Ammonium zur Akkumulation des intrazellulären Glutamins führt, während 
andere organische Osmolyte wie myo-Inositol und Hypotaurin stark abnehmen. 
 
Um den Effekt von extrazellulärem Glutamin auf den neuralen Metabolismus zu 
untersuchen, wurden Astrozyten und Neuronen mit einem Glutamin-freien Medium für 24 
Stunden inkubiert. Die metabolischen Veränderungen wurden durch [1-13C]Glukose mit Hilfe 
der multinuklearen NMR-Spektroskopie ermittelt.  
 
Die Ergebnisse zeigen, dass der Entzug von extrazellulärem Glutamin zu einer 
wesentlichen Beeinträchtigung des mitochondrialen TCA-Zyklus in Neuronen führt. Somit 
wurde die kritische Rolle des Glutamins für den normalen, physiologischen, Metabolismus 
der Neuronen nachgewiesen. Darüber hinaus bestätigen diese Ergebnisse, dass der Glutamin-
Glutamat-Zyklus nicht stöchiometrisch abläuft, und dass extrazelluläres Glutamin 
überwiegend in den neuronalen TCA-Zyklus eingeschleust und dort metabolisiert wird. 
Dieser Befund könnte eine wichtige Rolle für die Regulation des Glutamin-Glutamat-Zyklus 
spielen. Interessanterweise, während der Energie-Status der Astrozyten nach 24 Stunden 
Glutamin-Entzug stark abnimmt, zeigen die Neuronen einen verbesserten Energie-Status. Die 
Ursachen für diesen Effekt konnten anhand der erhaltenen Daten nicht genau aufgeklärt 
werden und benötigen weitere Experimente.  
 
Mit Hilfe der Western Blot Analyse konnte festgestellt werden, dass sowohl Ammonium 
als auch extrazelluläres Glutamin einen bemerkenswerten Anstieg der Glutamin Synthetase 
(GS)-Expression in Astrozyten verursachen. Dieser Befund deutet auf eine wichtige Rolle der 
GS in der Eliminierung von Ammonium. Desweiteren konnte gezeigt werden, dass 
Ammonium, im Gegensatz zu Glutamin, eine starke Abnahme der glial fibrillary acidic 
protein (GFAP)-Expression in Astrozyten verursacht. GFAP ist ein spezifischer Marker für 
Astrozyten, das für Form, Beweglichkeit und Modulation der Astrozyten verantwortlich ist. 
Die Abnahme der GFAP-Expression nach Ammonium-Behandlung könnte von großer 
Bedeutung für die zelluläre Volumenregulation sein, da GFAP die Viskoelastizität der Zellen 
bestimmt. 
 
Die Stoffwechselwege des Glutamins wurden in weiteren Experimenten mit Hilfe von [U-
13C5]Glutamin ermittelt. Es wurde festgestellt, dass Glutamin überwiegend in den TCA-
Zyklus eintritt und dort katabolisiert wird. Es wurde weiterhin bestätigt, dass extrazelluläres 
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Glutamin ein wichtiges Energie-Substrat besonders für die Neuronen darstellt. Darüber hinaus 
zeigen die Ergebnisse, dass extrazelluläres Glutamin die Glukose als eine wichtige Energie-
Quelle für die Neuronen ersetzen kann. Anhand der erhaltenen Ergebnisse konnten außerdem 
gezeigt werden, dass “pyruvate Recycling” nicht nur in Astrozyten, sondern auch in Neuronen 
stattfindet. Dies könnte von großer Bedeutung sein, besonders in Situationen, in denen die 
Breitstellung von Pyruvat begrenzt ist, wie z.B. unter Hypoglykämie.  
 
Nicht nur Ammonium, sondern auch Mangan akkumuliert in bestimmten Gehirnregionen, 
z.B. im Lateral Globus Pallidus (LGP) und Frontal Cortex (FC), in Patienten mit chronischer 
HA. Da Mangan ein wichtiger Co-Faktor für verschiedene Metalloproteine ist, sollte im 
Rahmen dieser Arbeit der Effekt von Mangan auf die Expression von GS und das Laktat 
Dehydrogenase Isoenzym (LDH-1), das für die Umsetzung von Laktat zu Pyruvat 
verantwortlich ist, untersucht werden. Für diese Fragestellung wurden Ratten mit MnCl2 (5 
mg/kg/Tag) für 4 Tage injiziert. Nach der Perfusion wurden LGP und FC isoliert, und mit 
Hilfe von Western Blotting, RT-PCR und Immunohistochemie analysiert. 
 
Die erhaltenen Daten zeigen, dass Mangan-Akkumulation im LGP zu einer erhöhten 
Expression von GS führt, während keine Änderung der GS-Expression im FC beobachtet 
wurde. Die erhöhte GS-Expression könnte eine erhöhte Glutamin-Synthese verursachen und 
somit in der Pathogenese der Mangan-Neurotoxizität involviert sein. Darüber hinaus zeigen 
die Ergebnisse, dass Mangan einen “inhibitorischen“ Effekt auf die LDH-1 Expression im 
LGP ausüben kann. Dies kann von großer Bedeutung sein, denn eine Abnahme von LDH-1 
bedeutet weniger Verbrauch von Laktat im Gehirn und kann daher zu einer Laktat-
Akkumulation im LGP führen. Die erhöhte Laktat-Konzentration im Gehirn könnte zur 
Laktatazidose, die als ein wichtiger Faktor für die Beeinträchtigung des neuralen Energie-
Metabolismus betrachtet wird, führen. 
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Chapter 2 
 
 
 
 
2  Introduction 
 
 
2.1 Nervous System 
 
The Nervous System is the information acquisition, storage and analyzing center, and 
control system of the body. Its main function is to collect information from the external and 
internal environments, to analyze this information, and to initiate appropriate responses to 
maintain the viability of the organism. For a thorough understanding of the normal functions 
of the nervous system and how the system is affected by pathological conditions, i.e. injury, 
disease, drugs, etc., it is essential to understand the basic backgrounds of the anatomy, 
biochemistry, and physiology of the nervous system. This chapter mainly concentrates on the 
metabolic fundamentals of the brain, in particular with regard to neurotransmitter metabolism, 
metabolic trafficking between neurons and astrocytes, and their metabolic behaviour under 
pathological conditions such as hyperammonemia (HA), hypoglycemia, and manganism. 
 
 
2.1.1  Brain cells 
 
The brain is made up of various neural cells, including nerve cells (neurons) and neuroglia 
(glial cells). Neurons generate, transmit, and store information. The number of neurons in the 
human brain is estimated to be about 100 billion. The other neural cells, named glial cells, are 
by far more numerous than neurons (approx. 10 fold). Glial cells exhibit a wide range of 
different functions, which will be mentioned later in this chapter. 
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2.1.1.1  Neurons 
 
A neuron consists of a cell body (soma) with branching dendrites (signal receivers) and a 
projection called axon, which conducts the nerve signal (Fig. 2.1.1). At the other end of the 
axon, the axon terminals transmit the electrical signal across a synapse (the gap between the 
axon terminal and the receiving cell).  
 
Figure 2.1.1: Structure of a neuron 
 
 
 
 
 
 
 
 
 
 
Schematic presentation of the neuron structure. It consists of a cell body, dendrites, axons, and axon terminals. 
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The axon, a long extension of a nerve cell, takes informations away from the neuronal cell, 
whereas dendrites import information to the neuronal cell. Myelin coats and insulates the 
axon, to increase the transmission speed along the axon. The soma contains the neuronal 
nucleus with DNA and typical nuclear organelles. Neurons are interconnected by synapses. A 
typical neuron possesses about 1,000 to 10,000 synapses, which enables them to communicate 
with 1,000-10,000 other neurons or receptor cells (muscle cells, glands, etc.). There are 
different types of neurons with regard to their morphology (shape and size), functions, and 
released neurotransmitters, which are localized in different parts of the brain. For example, 
GABAergic- and glutamatergic neurons are localized in the cerebrum and the cerebellum, 
respectively. 
 
 
2.1.1.2  Glial cells 
 
In addition to neurons, the nervous system is populated with a category of cells that 
support the functions of neurons in various ways. These cells are called glial cells. Glia is a 
Greek term meaning “glue”. There are about 10 times more glial cells (approx. 1000 billion) 
compared to neurons in the brain. However, since they are approximately one-tenth the size of 
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neurons, glial cells takes up an equal space of the brain. The various glial cells actively 
participate in several processes crucial to brain function and neuronal activity, such as 
provision of energy, nutrients and neurotransmitter precursors to neurons, uptake and 
recycling of neurotransmitters, scavenging of free radicals, digestion of parts of dead neural 
cells, or providing insulation and physical support for neurons. Table 2.1.1 represents the 
different types of glial cells including astroglia (astrocytes), oligodendroglia 
(oligodendrocytes), microglia, satellite sells, and schwann’s cells, with their corresponding 
functions. 
 
Table 2.1.1: Type of glial cells and their functions 
Name  of Glial Cells Function(s) 
 
Astrocyte 
(astroglia) 
Star-shaped cells that provide manifold supports for neurons:  
1)  Clean up brain "debris". 
2)  Transport nutrients to neurons. 
3)  Hold neurons in place. 
4)  Digest parts of dead neurons. 
5)  Regulate content of extracellular space. 
Oligodendroglia Provide the insulation (myelin) to neurons in the central nervous system. 
Microglia Part of immune system like monocytes. 
Satellite cells Physical support to neurons in the peripheral nervous system. 
Schwann’s cells Provide the insulation (myelin) to neurons in the peripheral nervous system. 
 
 
 
2.1.2 Neuronal Signalling  
 
 
2.1.2.1 Neurotransmission and neurotransmitters 
 
The communication between neuronal cells is mediated by nerve impulses. A nerve 
impulse consists of a wave of transient membrane depolarization known as an action 
potential. Neurons electrically transmit these signals along their extended lengths as travelling 
waves of ionic currents. Nerve impulses are chemically transmitted across most synapses by 
the release of neurotransmitters. This process is triggered by an increase in cytosolic Ca2+ 
concentration resulting from the arriving action potential’s opening of voltage-gated  
Ca2+ channels. The released neurotransmitter from presynaptic neuron diffuses across the 
synaptic cleft, where it binds to its specific receptor on the postsynaptic neuron, and induces 
the electrical response of the postsynaptic neurons (Fig. 2.1.2). 
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The released neurotransmitters are removed from the synaptic cleft either by specific 
enzymes, which degrade the released neurotransmitter or by specific transport proteins 
located in neuronal and glial plasma membranes. For example, Acetylcholine is rapidly 
degraded through the action of acetylcholinesterase, and glutamate is taken up by the 
glutamate transporter GLT-1 localized in astrocytes and by GLAST in both neurons and 
astrocytes (Rothstein et al., 1994; Kondo et al., 1995).  
 
The nervous system has developed a large number of neurotransmitter (about 50 
neurotransmitters are known and characterized) in order to facilitate internal communication 
and signal transmission within the brain (Patrik et al., 2000). Neurotransmitters may have 
either an excitatory or an inhibitory effect. The latter stimulate the opening of anion (Cl-) 
channels, thereby causing the postsynaptic membrane to become hyperpolarized so that it 
must be more highly depolarized than otherwise to trigger an outgoing action potential. For 
example, γ-aminobutyric acid (GABA) and glycine are known as inhibitory neurotransmitters, 
while glutamate and aspartate are the most important excitatory neurotransmitters (Krnjevic, 
1970; Shank et al., 1979; Fonnum et al., 1984; Orrego and Villanueva, 1993).  
 
 
2.1.2.2  The Glutamine-glutamate cycle  
 
The metabolism of the neurotransmitters glutamate and GABA is linked to a substrate cycle 
between neurons and astrocytes involving ammonia, glutamine, glutamate, and GABA, which 
has been recognized as the so-called “glutamine-glutamate cycle” for more than 30 years 
(Van den Berg, 1972; Benjamin and Quastel 1975; Shank and Aprison, 1981). In this cycle, 
extracellular glutamate is rapidly taken up by astrocytes via glutamate transporters (Fig. 
2.1.2), converted into glutamine through the astrocytic enzyme glutamine synthetase (GS). 
The astrocytic glutamine is released and can be reimported by neurons where it can be 
deaminated to glutamate via the action of the neuronal enzyme phosphate-activated 
glutaminase (PAG) (Kvamme et al., 1988; Bradford et al., 1978) to close the glutamine-
glutamate cycle. In addition, glutamate can be metabolized to the neurotransmitter GABA in 
neurons or converted into α-ketoglutarate, which may subsequently enter the tricabroxylic 
acid cycle (TCA cycle = Krebs cycle) and is finally metabolized to CO2 and H2O. It is well 
known that the glutamine-glutamate cycle plays an important role in the carbon and nitrogen 
homeostasis, the ammonia detoxification processes and glial-neuronal metabolic trafficking. 
Therefore, any disorder in the glutamine-glutamate cycle caused by pathologic conditions 
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may result in different pattern of brain disorders. Hence, it is necessary and expedient to 
obtain more information on the metabolism of the substrates involved in the glutamine-
glutamate cycle, e.g. of ammonia, glutamine, and glutamate. 
 
Figure 2.1.2: The glutamine-glutamate cycle in the brain 
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Schematic representation of the glutamine-glutamate cycle between astrocytes and neurons and glutamatergic 
neurotransmission. Glutamate, released by presynaptic neurons (1), is taken up by astrocytes (2) and converted 
into glutamine by GS (3). Glutamine is released, taken up by neurons (4), and converted into glutamate by PAG 
(5). Glutamate is also a precursor for GABA (6). AMPA; a-amino-3-hydoxy-5-methyl-4-isoxazol-4-propionic 
acid, GLAST; glutamate-aspartate transporter, Glc; glucose, Glu; glutamate, Gln; glutamine, GABA; γ-
aminobutyric acid, GS; glutamine synthetase, NMDA; N-methyl-D-aspartate, PAG; phosphate activated 
glutaminase, Pyr; pyruvate. 
 
 
2.1.3 Brain Energy metabolism 
 
 
2.1.3.1  Introduction 
 
The energy state of cells is reflected by the concentration of high energy phosphates such 
as nucleoside di-and triphosphates (NDP’s, NTP’s), in particular ADP and ATP (adenosine 
di- and triphosphate), and phosphocreatine (PCr). Glucose is the obligatory energy substrate 
for brain, which is almost entirely oxidized to CO2 and H2O. The first part of glucose 
metabolism is glycolysis resulting in the synthesis of pyruvate and production of 2 mol 
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ATP/mol of glucose. Pyruvate can be converted into lactate, which regenerates nicotinamide 
adenine dinucleotide (NAD+), which is required for the maintenance of glycolysis. 
Alternatively, pyruvate can enter the TCA cycle and produces 30 mol of ATP/mol of glucose 
via mitochondrial oxidative phosphorylation. Any disorder in these physiological processes, 
(i.e. glycolysis, the TCA cycle, and oxidative phosphorylation) may cause disturbance in 
energy metabolism and result in damage of neural cells and/or in neurotransmitter 
dysfunction. These disorders can be caused by a variety of agents, such as ammonia, 
manganese, and excitotoxic elevated extracellular glutamate concentrations. Previous studies 
have shown that cells with dysfunctions in their energy metabolism caused by 
hypoxia/ischemia, hypoglycemia, and in Hepatic Encephalopathy (HE) are more susceptible 
to excitotoxic injury or death, i.e. even slight elevations of extracellular concentration of 
glutamate are toxic to energy-deficient cells (Novelli et al., 1988). This also means that a 
deprivation of energy substrates in brain, such as glucose, but also any disturbance in the 
energy producing processes, may result in brain dysfunction (Magistretti et al., 1993; 
Magistretti and Pellerin, 1999a). In the present study, we investigated the energy metabolism 
of astrocytes, neurons, and co-cultures under each pathological condition as 
hyperammonemia, glutamine-deprivation, and hypoglycemia. 
 
 
2.1.3.2 Astrocytic and neuronal role in energy metabolism 
 
Brain energy metabolism is often considered to reflect predominantly, if not exclusively, 
neuronal energy metabolism and to be dependent almost exclusively on the provision of 
glucose. However, to date, ambiguity still exists regarding cellular glucose utilization (Dienel 
and Hertz, 2001; Magistretti and Pellerin, 1999a). Predominant neuronal oxidative 
metabolism does not necessarily imply that the majority of glucose is taken up and 
metabolized by neurons. Evidence has been provided that astrocytes could be the primary site 
of glucose uptake during neuronal activity (Tsacopoulos and Magistretti, 1996). Also the 
neuroanatomical features of the brain imply that glucose has to pass through astrocytic “end-
feed”, which are interposed between the surface of blood vessels and neuronal processes (Fig. 
2.1.3a).  
In 1994 Magistretti and colleagues proposed a mechanism, whereby lactate is 
glycolytically synthesized in astrocytes and serves as energy substrate for neurons (Pellerin 
and Magistretti, 1994). According to this hypothesis, not more that 5% of the ATP is 
produced in glial cells while the rest would be generated from astrocyte-derived lactate in 
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neurons. These values correspond to the relative energy production under the assumption that 
approximately 95% of glucose is taken up and metabolized by neurons (Pellerin and 
Magistretti, 1994 and 2003; Tsacopoulos and Magistretti, 1996) (Fig. 2.1.3b). However, 
controversy still exits about the relative contribution of astrocytic lactate and neuronal glucose 
metabolism to fuel the energy demand of neurons. 
 
Figure 2.1.3a: Anatomical coupling between astrocytes, neurons and blood brain barrier 
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The “end-feet” of astrocytes form part of the blood-brain-barrier (BBB) together with the capillary endothelium. 
The other processes of astrocytes extend to the neurons. Glucose crosses the blood-brain barrier through the 
endothelial cells and may enter both astrocytes and neurons through the extracellular space. 
 
 
 
Figure 2.1.3b: Glucose utilization by neurons and astrocytes 
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Classical brain energy budget (A): neurons take up more than 95% of total glucose while astrocytes take up only 
5%. New brain economy with lactate exchange (B): both neurons and astrocytes take up approximately the same 
value of glucose. The glycolytically synthesized lactate is transferred to neurons and metabolized through the 
neuronal TCA cycle for energy production. 
 
 
Chapter 2: Introduction    24   
 
 
2.1.3.3  Na+/K+-ATPase and its role in cellular energy metabolism 
 
Most of brain cell’s energy consumption is used in the cytosol for active transport of ions 
to sustain and restore the membrane potentials (Bradford, 1967). On the other hand, cellular 
uptake and release processes are coupled to the activity of the Na+/K+-ATPase (Quastel, 
1970), which is also involved in several physiological functions such as regulation of cell 
volume, cell differentiation, and in the homeostasis of sodium, potassium, and calcium ions in 
the nervous system (Stahl and Harris, 1986; Albers et al., 1994). In particular, a close 
relationship between the Na+/K+-ATPase activity and neurotransmitter release has led to the 
suggestion that this enzyme plays a role in neurotransmitter release (Vizi, 1972).  
 
Figure 2.1.3.3: Neurotransmission and Na+/K+-ATPase. 
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Model of coupling synaptic activity with glucose utilization. The action of glutamate at glutamatergic synapses is 
terminated by an efficient glutamate uptake system located in astrocytes (1). Glutamate is co-transported with 
Na+ resulting in an increase in the intracellular concentration of Na+, which leads to the activation of the Na+-
K-ATPase (2a). Glutamate is converted to glutamine by glutamine synthetase (2b). Activation of the Na+-K+-
ATPase triggers aerobic glycolysis (3). Lactate produced by stimulation of glycolysis after glutamate uptake, is 
released from astrocytes (4). α-KG, α-ketoglutarate; BBB, blood-brain barrier; Cit, citrate; G, G-protein; Glu, 
glutamate; Gln, glutamine; Glc, glucose; GS, glutamine synthetase; Mal, malate; Lac, lactate; LDH, lactate 
dehydrogenase. 
 
Previous studies have shown that the uptake of glutamate into astrocytes is Na+-dependent 
(Kimelberg, et al., 1989) and triggers a cascade of molecular events involving the Na+/K+-
ATPase leading to uptake and consumption of glucose via glycolysis as well as the 
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consumption of energy via the sodium pump (Pellerin and Magistretti, 1994 and 1997) (Fig. 
2.1.3.3). The uptake of one molecule glutamate by astrocytes extrudes 3 Na+ against 2 K+ 
leading to uptake of one molecule glucose into astrocytes and production of 2 molecules ATP 
via glycolysis. One ATP molecule fuels one turn of the sodium pump, while the other 
provides the energy needed to convert glutamate into glutamine by glutamine synthetase (GS) 
(Pellerin and Magistretti, 1999a). 
 
 
2.1.3.4   Glucose and alternative energy substrates for the brain 
 
Although glucose is suggested to be the main substrate for brain energy metabolism, other 
substrates can substitute glucose to produce energy in the brain. In particular, during 
ontogenetic development, fasting and diabetes, and in a variety of pathological conditions, 
ketone bodies, free fatty acids or glycerol, and some amino acids can be alternative fuels for 
energy production (Hawkins et al., 1971; Edmond, 1992). The pioneering work of McIlwain 
(1955) on brain slices has shown that lactate can be an adequate energy substrate for the brain 
tissue. Over the years, several studies using different approaches have confirmed that lactate 
is efficiently oxidized by brain cells in vitro (Pellerin et al., 1998; Waagepetersen et al., 1998; 
Bouzier et al., 2000; Kitano et al., 2002). The capability of the brain to use several substrates 
apart from glucose allows for compensation for deficits in one substrate by an increased 
utilization of others.  However, it must be noted that the availability of most blood-borne 
substances other than glucose is limited by the ability to cross the blood-brain barrier, and the 
exact mechanisms by which neurons or glial cells select their fuels under different 
physiological or pathological conditions is still not well clarified.  
 
 
2.2  Ammonia and hyperammonemia (HA) 
 
2.2.1  Overview 
 
Ammonia gas is extremely well soluble in water, forming an alkaline solution called 
ammonium hydroxide. In aqueous solution, NH3 is in equilibrium with the ammonium ion 
(NH4+). 
 
NH3 + H+    NH4+ 
Ka  
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The pKa of ammonia in blood is 9.1–9.2 at 37°C (Bromberg et al., 1960). Investigations of 
Cooper and Plum (1987) have shown that ammonia enters the brain from the blood by 
diffusion of the non-ionized form (NH3) rather than by a transport system for the protonated 
form (NH4+). The ammonia concentrations in the CSF are to some degree constant and low (∼ 
3 µM) (Ferraro and Hare, 1984). In contrast, the arterial concentration of ammonia shows 
sizeable variations (50 – 500 µM) (Cooper and Plum, 1987).  
In living organism, ammonia is an important nitrogen substrate in several reactions, and 
plays an important role in nitrogen homeostasis of cells. Moreover, it is product as well as 
precursor of various important nitrogen containing metabolites such as amino acids, which in 
turn are the smallest subunits of proteins. However, an elevated concentration of ammonia in 
the brain is generally accepted to exert neurotoxic effects (Duffy and Plum, 1982; 
Butterworth, 1991), leading to functional disorders in the CNS, which could be involved in a 
variety of metabolic encephalopathies including hypoxia (Siesjö, and Nilson, 1971), 
hypoglycemia (Tews et al., 1965), cerebral ischemia (Thron and Heimann, 1985), and Hepatic 
Encephalopathy (HE) (Walker and Schenker, 1970; Schenker et al., 1974).  
 
Figure 2.2.1: Ammonia detoxification processes 
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The ammonia detoxification pathway via glutamine synthetase (GS) occur in astrocytes. Glutamate 
dehydrogenase (GDH), alanine aminotransferase (ALAT), and aspartate amino transferase (AAT), however, are 
present in both astrocytes and neurons. 
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To avoid the neurotoxic effects of ammonia, its concentration must be maintained at low 
levels. In general, the liver detoxifies ammonia in the organism by a series of enzymatic 
reactions summarized in the urea cycle (urea formation) or by glutamine synthesis via GS. 
Since the brain lacks the urea cycle, the clearance of ammonia must be performed by other 
ammonia detoxifying processes (Fig. 2.2.1).  
Astrocytes are the main target to remove an excess of ammonia through the conversion of 
glutamate into glutamine via GS (Butterworth et al., 1988). However, ammonia detoxification 
can occur also via other enzymatic reactions such as aminotransferase reactions (Fig. 2.2.1), 
which may play a particular role in conditions, when the capacity of GS for ammonia removal 
is limited.  
 
 
2.2.2  Ammonia intoxication  
 
Although ammonia is believed to be an important cause of cerebral dysfunctions like 
Hepatic Encephalopathy (HE) and other diseases with hyperammonemia, the exact molecular 
mechanism, by which ammonia exerts its toxic effect, are not yet known. Extensive studies 
using animal models and patients with liver failure have shown that elevated ammonia 
concentrations cause a variety of cerebral dysfunctions. Three main hypotheses exist: i). 
impaired brain energy-metabolism, ii) disturbed neurotransmitter-metabolism and iii) 
disordered cellular volume regulation.  
 
 
2.2.3  Hyperammonemia and brain energy metabolism 
 
An early hypothesis proposed to explain the pathogenesis of HE was the disorder in neural 
energy metabolism induced by elevated ammonia concentrations. Accumulated evidence 
suggests that a direct interference of ammonia at several points in cerebral energy 
metabolism, including glycolysis, TCA-cycle, and the electron transport chain, could lead to 
energy depletion. For example, ammonia has been suggested to compromise mitochondrial 
energy metabolism by interfering with α-ketoglutarate dehydrogenase, a rate-limiting enzyme 
of the TCA-cycle, (Bessman and Bessman, 1955) and to a lesser extent with pyruvate 
dehydrogenase (PDH) leading to a slower TCA cycle turnover, a lower production of 
reductive equivalents, e.g. NADH and FADH2, and the subsequent energy depletion (Hindfelt 
and Siesjö, 1971; Cooper and Lai, 1987; Lai and Cooper, 1991). On the other hand, the 
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synthesis of glutamate from glutamine and ammonia via GS consumes ATP. Moreover, an 
excess of ammonia stimulates the Na+/K+-ATPase resulting in energy consumption 
(Sadasivudu et al., 1979; Albrecht et al., 1985; Ratnakumari et al., 1995; Monfort et al., 
2002). One further mechanism, which has been proposed to mediate ammonia-induced brain 
energy failure, is NMDA-receptor activation, a phenomenon, which has long been suggested 
to contribute to neuronal disorder in HA (Kosenko et al., 1994; Felipo and Butterworth, 
2002). It is interesting, that GS activity and glutamine content in the brain are modulated by 
NMDA receptors and nitric oxide (Kosenko et al., 2003). Additionally, recent studies 
suggested the possibility that ammonia induces the mitochondrial permeability transition 
(MPT) in astrocytes, which is associated with mitochondrial dysfunction. Altered 
mitochondrial metabolism appears to be an important mechanism responsible for the cerebral 
abnormalities associated with hyperammonemic states (Rao and Norenberg, 2001).  
 
 
2.2.4  Hyperammonemia and cellular volume (brain edema) 
 
The toxic effects of HA may be mediated by the subsequent ammonia metabolism rather 
than by ammonia itself (Hawkins et al., 1991, 1993), i.e. mediated by glutamine as a main 
product of ammonia detoxification (Cooper et al., 1985; Norenberg and Bender, 1994; 
Butterworth et al., 1988). The involvement of glutamine in the pathogenesis of HE has been 
suggested in a number of investigations, in which an increase of glutamine has been reported 
in different brain regions of patients with HE as well as after induction of HA in rat brain 
(Williams et al., 1972; Gjedde et al., 1978; Miyazaki et al., 2003). In this context, Hourani et 
al. (1971) found that glutamine concentrations in the CSF correlate reasonably well with the 
clinical grade of HE. Since glutamine is the major ammonia detoxification product as well as 
an essential part of the neuronal-astrocytic interaction via the glutamate-glutamine cycle, any 
alteration of its concentrations may affect the normal metabolic function of astrocytes and 
neurons as observed in HA and HE (Yudkoff et al., 1989; Butterworth, 1993). Moreover, a 
number of investigations have shown that glutamine accumulation affects the osmotic 
equilibrium causing astrocytes swelling and consequently leads to brain edema during HA in 
patients with HE (Watanabe et al., 1992; Lockhart-Wood, 1996; Rovira et al., 2002) and 
experimental models (Takahashi et al., 1991; Blei et al., 1994; Albrecht, 2003). However, the 
question whether the increase of glutamine or ammonia itself results the development of HE 
remains still unclear.  
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2.3 Manganese neurotoxicity (manganism) 
 
2.3.1 Introduction 
 
Manganese is available in a number of physical and chemical forms in the earth’s crust, in 
the atmosphere, and in water. Manganese has been found as Mn2+, Mn3+, and Mn4+ in both 
animals and humans (Archibald and Tyree, 1987). The main rout of manganese absorption is 
the gastrointestinal tract, but absorption also occurs via the lung (Aschner et al., 1991). 
Manganese is concentrated mainly in the liver, skeleton, pancreas, and brain. It is an essential 
element for humans and animals (Cotzias, 1966; Underwood, 1981), as it is involved in the 
metabolism of proteins, lipids and carbohydrates, and serves as a cofactor of enzymes such as 
decarboxylases, hydrolases and kinases (Wedler, 1993). Moreover, manganese is required for 
the normal physiological function of many metalloprotein enzymes such as GS (Wedler and 
Toms, 1986), mitochondrial superoxide dismutase (SOD) (Stallings et al., 1991), and 
phosphoenolpyruvate carboxykinase (PEPCK) (Bentle and Lardy, 1976). In most human and 
animal tissues, manganese concentrations are less than 1 µg/g wet weight (Sumino et al., 
1975), i.e. manganese concentrations in the human brain are approximately 0.25 µg/g wet 
weight (Markesbery et al., 1984). Higher concentrations of manganese can be neurotoxic. The 
central nervous system, in particular, the basal ganglia, is an important target in manganese 
neurotoxicity termed as manganism, a disorder resulting in neurological symptoms similar to 
that of Parkinson's disease (Huang et al., 1989). Indicators of manganism are neuropsychiatric 
symptomatology and extrapyramidal dysfunction, such as hypokinesia (abnormally decreased 
mobility and motor function or activity), fatigue, weakness, tremors, muscle stiffness, 
coordination problems, cramps, impotence, as well as many other Parkinson-like symptoms 
(Mena et al., 1967). Manganism has been observed amongst miners and industrial workers 
throughout the world, and agricultural workers that have been exposed to manganese. 
Moreover, recent studies have shown that manganese content is significantly increased in 
different brain regions, e.g. frontal cortex (FC), palladium, putamen, and caudate of cirrhotic 
patients (Rose et al., 1999). 
 
 
2.3.2 Manganism and astrocytic pathogenesis 
 
Recent evidences suggest that astrocytes are a site of early dysfunction and damage in 
manganism, since chronic exposure to manganese leads to selective dopaminergic 
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dysfunction and neuronal loss, accompanied by gliosis in basal ganglia structures together 
with characteristic astrocytic abnormalities known as Alzheimer type II astrocytosis 
(Pentschew et al., 1963; Olanow et al., 1996). Under these conditions, astrocytes exhibit 
typically enlarged pale nuclei, margination of chromatin and, often, prominent nucleoli. 
Astrocytes possess a high affinity, high capacity, specific transport system for manganese 
(Aschner et al., 1999) facilitating its uptake, and sequestration in mitochondria leading to a 
disruption of oxidative phosphorylation (Brouillet et al., 1993; Cano et al., 1996). In addition, 
manganese causes a number of other functional changes in astrocytes including an 
impairment of glutamate transport (Erikson and Aschner, 2002), alterations of the glycolytic 
enzyme glyceraldehyde-3-phosphate dehydrogenase (Hazell et al., 1999ab), production of 
nitric oxide (Spranger et al., 1998; Liu and Lin-Shiau, 1998), and increased number of 
binding sites for the "peripheral-type" benzodiazepine receptor PTBRs (Hazell et al., 1999a, 
2003); a class of receptor predominantly localized in mitochondria of astrocytes, which are 
involved in oxidative metabolism, mitochondrial proliferation, and neurosteroid synthesis. 
Such effects may lead to compromised energy metabolism, resulting in altered cellular 
morphology, production of reactive oxygen species, and increased extracellular glutamate 
concentration. These consequences may result in impaired astrocytic-neuronal interactions 
and play a major role in the pathophysiology of manganese neurotoxicity.  
 
 
2.3.3  Manganism and cerebral energy metabolism 
 
Results obtained from human patients show that the neurotoxicity of manganese at the 
cellular level affects both astrocytic and neuronal integrity, but leads to localized neuronal 
vulnerability and in some cases to neuronal loss (Olanow et al., 1996; Eriksson et al., 1987). 
However, the mechanisms of manganese neurotoxicity remain still unclear. In this context, it 
is hypothesized that manganese leads to disorder of energy metabolism because of its 
accumulation in mitochondria (Wedler and Toms, 1986) and subsequently to mitochondrial 
derangement. Since mitochondrial function is tightly coupled to cellular energy production, 
disordered brain energy metabolism may be a central feature of manganese neurotoxicity.  
Gavin et al. (1992, 1999) demonstrated a direct interference of manganese with oxidative 
phosphorylation, most likely by binding to the F1-ATPase and to the NADH dehydrogenase 
complex. In addition, results of other investigators point to an indirect secondary excitotoxic 
process of manganese mediated by NMDA receptor activation (Brouillet et al., 1993; Cano et 
al., 1996). 
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Based upon recent observations, the disorder of brain energy metabolism may also be due 
to an interference of manganese with TCA cycle-related enzymes, such as aconitase, leading 
to impairment of oxidative metabolism. As Zheng et al. (1998) reported, the alteration of 
brain aconitase activity after manganese exposure may lead to the disruption of mitochondrial 
energy production and cellular Fe metabolism in the brain. The investigations by Zwingmann 
et al. (2003) using 13C-NMR spectroscopy confirmed a selective impairment of neuronal 
oxidative metabolism of glucose in manganese-treated cultured cells.  
 
 
2.3.4 Manganism and synaptic neurotransmission 
 
A low portion of manganese is bound to manganese metalloproteins, especially glutamine 
synthetase (GS) in astrocytes, while a small portion of manganese exists in the synaptic 
vesicles of glutamatergic neurons. Thus, manganese is coupled dynamically to the 
electrophysiological activity of the neurons. Several groups have demonstrated that 
manganese influences synaptic neurotransmission at high doses (~mM) (Takeda, 2003). 
Narita et al. (1990) suggest that Mn2+ can enter nerve terminals through the voltage-dependent 
Ca2+ channel during action potentials in frog motor nerve enhancing the release of 
neurotransmitters. Drapeau and Nachshen (1984) also demonstrate that Mn2+ permeates 
presynaptic voltage-dependent Ca2+ channels and induces dopamine release from depolarized 
nerve terminals. Manganese also activates glutamate-gated cation channels, e.g. via the N-
methyl-D-aspartate (NMDA) receptor, which contributes to neuronal transmission (Brouillet 
et al., 1994). Moreover, recent investigations have shown that manganese exposure to 
astrocytes decreases glutamate uptake due to decreased astrocytic glutamate transporter 
GLAST mRNA causing abnormal glutamate neurotransmission and neurotoxicity (Hazell and 
Norenberg, 1997; Erikson and Aschner, 2002). Taken together, these results suggest that 
manganese could modulate the release of glutamate and other neurotransmitter(s) from 
neuronal terminals and consequently influence the levels of neurotransmitters in synapses. 
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2.2 Aims of the study 
 
The central aim of this study was to investigate the effect of exogenous nitrogen sources, 
i.e. of ammonia and glutamine, on cellular energy metabolism and the cellular carbon- and 
nitrogen-homeostasis in the glutamine-glutamate cycle. For this purpose, primary cell 
cultures, i.e. cortical astroytes and neurons, were incubated with [1-13C]glucose in 
combination with ammonium chloride and/or unlabelled glutamine. Multinuclear (1H-, 31P-, 
and 13C)-NMR spectroscopy was applied to determine metabolite concentrations, the energy 
state, and the de novo synthesis of glycolytic- and TCA-cycle related metabolites.  
 
To obtain further information on the metabolic pathways of glutamine in neural cells and 
the competition between glucose and glutamine as precursor for neuronal glutamate and/or as 
an energy substrate for neural cells, individual primary cell cultures and a combination of 
both celltypes, i.e. astrocytes + neurons (cocultures) were used. [U-13C5]glutamine was used 
as labelled substrate in the presence or absence of extracellular unlabelled glucose.  
 
A central question was further the implication of ammonia- and glutamine-induced 
alterations in the expression of astrocytic proteins, i.e. of GS and GFAP. For this purpose, 
primary astrocytes were incubated with 5 mM NH4Cl in the presence or absence of 
extracellular glutamine. GS and GFAP expressions were determined by Western blot analysis. 
 
Since manganese is accumulated in basal ganglia of cirrhotic patients and can influence 
synaptic neurotransmission, another aim of this study was to investigate the effect of 
manganese on the distribution and expression of the astrocytic metalloprotein GS and neural 
LDH-1 in different brain regions, e.g. in frontal cortex (FC) and lateral globus pallidus (LGP). 
For this aim, the rats were injected intraperitoneally with MnCl2 (50 mg/kg/day) for 4 days, 
and isolated brain regions were analyzed using immunohistochemistry, Western blotting, and 
RT-PCR. 
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Chapter 3 
 
 
 
 
3 Results and Discussion 
 
 
 
 
3.1   Effect of hyperammonemia on glial and neuronal 
metabolism 
 
3.1.1    Introduction 
 
Hyperammonemia (HA) is characterized by an elevated ammonia concentration within the 
blood (> 0.5 mM). This may lead to cerebral dysfunction, coma and death. An elevated 
plasma ammonia concentration can be caused by a dysfunction of liver, which is the primary 
organ for maintaining physiological blood ammonia levels by ammonia detoxification mainly 
by urea- or glutamine formation. An elevated concentration of ammonia in the brain 
accompanies certain brain disorders such as Hepatic Encephalopathy (HE) (Hindfelt et al., 
1977; Butterworth et al., 1987; Cooper and Plum, 1987), hypoxia (Siesjö and Nilson, 197) 
hypoglycemia (Tews et al., 1965), and ischemia (Thron and Heimann, 1985). The first studies 
on HA began a century ago by Pavlov and co-workers (Hahn et al., 1893). The major 
pathologic signs of HA are reflected by astrocytic dysfunctions (Norenberg, 1987), such as 
cell swelling (Norenberg et al., 1991; Norenberg and Bender, 1994) and consequently brain 
edema (Watanabe et al., 1987; Ganz et al., 1989). Nevertheless, the molecular mechanisms 
involved in HE and ammonia toxicity have not been clarified. The main ammonia 
detoxification process in the brain is the conversion of glutamate to glutamine by glutamine 
synthetase (GS) (Lockwood et al., 1979; Cooper et al., 1985; Butterworth et al., 1988), which 
is localized predominantly in astrocytes (Norenberg and Martinez-Hernandez, 1979). 
However, there are other pathways for ammonia removal in both astrocytes and neurons, 
which may play an important role for the removal of excess ammonia. It is, therefore, 
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reasonable to obtain more information on other ammonia detoxification processes in both 
astrocytes and neurons. The present study investigated primary cortical astrocytes as well as 
cortical neurons (GABAergic neurons) as an in vitro model. We have investigated in 
particular two parameters: 1) Amino acid metabolism, i.e. alterations in the concentrations 
and the de novo synthesis of glutamate, glutamine, aspartate, and alanine. 2) Energy 
metabolism via glycolytic and tricarboxylic acid (TCA)-cycle. After incubation of the cells 
with pathologically ammonia concentrations (5 mM), perchloric acid (PCA) extracts were 
performed (see chapter 4, page, 90) and subsequently analyzed by multinuclear NMR 
spectroscopy (page 107). 
 
 
3.1.2  Glucose and energy metabolism in cortical astrocytes and    
neurons 
 
3.1.2.1  Alterations of amino acids (glutamate, glutamine) 
 
Based on previous investigations, cerebral glutamine concentrations increase considerably, 
while intracellular glutamate, the major excitatory neurotransmitter, decreases in HA due to 
liver failure (de Graaf et al., 1991). In addition, cerebrospinal fluid and brain glutamine are 
found to be significantly elevated in cirrhotic patients with encephalopathy and in rats 
following portacaval anastomosis (Dejong et al., 1992 and 1993; Cordoba et al., 1996). This 
could be due to an up-regulation of GS activity or GS expression in astrocytes leading to an 
increased conversion of glutamate to glutamine, and/or by an inhibition of glutamine 
hydrolysis to glutamate by neuronal phosphate-activated glutaminase (PAG).  
The data of this study show that the 13C-label from [1-13C]glucose, whether ammonia was 
presented or not, was found mainly in neuronal glutamate (Fig. 3.1.1), while in astrocytes the 
13C-enrichment was higher in glutamine compared to glutamate (Tab. 3.1.1 and Fig. 3.1.2). 
This is in accordance with the localization of the glutamine-synthesizing or -degrading 
enzymes, i.e. GS in astrocytes, and PAG in neurons. 
 The results also show that 24 hours exposure of neurons and astrocytes to 5 mM NH4Cl 
resulted in an increased Gln/Glu ratio (absolute concentration) to 151% and 141% of control 
(P<0.001), respectively (Tab.  3.1.2). In addition to modified glucose metabolism, this may be 
partly due to an increased glutamine uptake and/or an inhibited conversion of glutamine to 
glutamate via  PAG and/or a stimulated conversion of glutamate to glutamine via GS. 
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Table 3.1.1: 13C-label incorporation from [1-13C]glucose into amino acids  
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1.2.2  : Concentrations of metabolites (nmol/mg protein) 
 
 
 
metabolites astrocytes neurons 
 (control) 5 mM NH4Cl (control) 5 mM NH4Cl 
Gln C2 10.04 ± 0.19 15.54 ± 0.60...#*** 0.49 ± 0.27     0.73 ± 0.17...ns 
Gln C3   7.48 ± 0.77 10.20 ± 0.61...#** 0.59 ± 0.34     0.77 ± 0.26...ns 
Gln C4   9.08 ± 1.27 12.48 ± 0.56...#*** 0.73 ± 0.26     1.08 ± 0.53...ns 
Glu C2   6.35 ± 0.88 9.25 ± 0.80...#*** 8.36 ± 1.10 14.58 ± 0.94...#*** 
Glu C3   3.01 ± 0.18 3.96 ± 0.29...#** 8.57 ± 1.34 15.38 ± 1.13...#*** 
Glu C4   8.57 ± 0.61 10.76 ± 0.54...#**  16.45 ± 0.92 39.43 ± 3.37...#*** 
GABA C2 nd nd 2.62 ± 0.40   4.99 ± 0.66...#*** 
Asp C2   0.97 ± 0.23 1.79 ± 0.33...#*** 1.97 ± 0.26     2.73 ± 0.30...#* 
Asp C3   2.06 ± 0.44   2.58 ± 0.40...#* 2.94 ± 0.27 3.48 ± 0.49...#** 
Ala C3   4.81 ± 0.73 11.63 ± 1.32...#*** 6.76 ± 0.72 18.94 ± 1.01...#*** 
 
The percentage 13C-enrichments in specific carbon position of individual metabolites were calculated by 
integration of the respective signals in 13C-NMR spectra obtained from cell extracts after 24 h incubation of 
neurons and actrocytes with media containing 6 mM [1-13C]glucose under control conditions or treatment 
with 5 mM NH4Cl. The values are given as nmol/mg protein and represent means ± SD of five individual 
experiments (#, significantly different from controls; ***P<0.001, **P<0.01, *P<0.05; ANOVA; ns, not 
significant; nd, not detectable).  
 
Table 3.1.2: Absolute concentrations of metabolites 
 
 
 
 
 
 
 
 
 
 
metabolites astrocytes neurons 
 (control) 5 mM NH4Cl (control) 5 mM NH4Cl 
Gln  144.80 ± 5.75 225.83 ± 6.31...#**   97.30 ± 8.70 178.40 ± 5.80...#*** 
Glu 74.68 ± 4.93   82.25 ± 5.27...#** 115.70 ± 6.39 140.70 ± 4.49...#*** 
Asp 12.55 ± 1.66 14.43 ± 1.42...ns   27.30 ± 4.36 34.56 ± 2.02...#*** 
Ala 34.05 ± 7.43 49.37 ± 1.98...#***   54.90 ± 6.80 83.20 ± 5.45...#***  
Lac 172.60 ± 12.61 277.30 ± 28.72...#*** 124.10 ± 21.30 142.40 ± 13.73...ns 
 
The total amounts of metabolites were calculated by integration of the respective signals in 1H NMR spectra 
obtained from cell extracts after 24 h incubation of actrocytes and neurons with media containing 6 mM [1-
13C]glucose under control conditions or treatment with 5 mM NH Cl. The values are given as nmol/mg protein 
and represent means ± SD of five individual experiments (#, significantly different from controls; 
4
***P<0.001, 
**P<0.01; ANOVA ns, not significant).  
 
In astrocytes, the increased Gln/Glu ratios are possibly due to an increased de novo synthesis 
of glutamine via GS. Consistent with the lack of GS in neurons, these cells show no 
significant alterations in de novo synthesis of Gln C2 and Gln C4 after ammonia treatment, 
while total intracellular glutamine concentrations increased to 183% of control (P<0.001). 
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Figure 3.1.1: 13C-NMR spectra of neurons  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative 13C-NMR spectra of neurons (PCA-extracts). Neurons were incubated for 24 hours with BME 
containing 2 mM glutamine (control) and 5 mM NH4Cl with 6 mM [1-13C]glucose. Peak assignments: Ala, 
alanine; Asp, aspartate; Gln, glutamine; Glu, glutamate; GLT, glutathione; Lac, lactate; Pro, proline. 
 
 
3.1.2.2  13C-isotopomer pattern in glutamate and glutamine (PC and PDH) 
 
The percentage 13C-enrichments in individual carbons, i.e. in the C2-, C3-, and C4-
positions of glutamate and glutamine (Tab. 3.1.1), depend on the relative fluxes through TCA 
cylce-releated enzymes. Pyruvate dehydrogenase (PDH), transforming [1-13C]glucose into [2-
13C]acetyl-CoA and hence into the TCA-cycle intermediate [4-13C]α-ketoglutarate, is active 
in both neurons and astrocytes and plays a major role in the regulation of glucose oxidation 
and mitochondrial energy production in the brain. The predominance of [4-13C]glutamate 
under both experimental conditions shows that PDH is very active in our cultured neurons 
(Fig. 3.1.1). It is generally believed that only in astrocytes, [1-13C]glucose can be transformed 
also to [2-13C]α-ketoglutarate via pyruvate carboxylase (PC), the main anaplerotic enzyme in 
the brain (Shank et al., 1985).  
An exact quantification of the relative contribution of the anaplerotic pathway is difficult, 
since the label of glutamate at C-2 may arise also during the second PDH turn. This has to be 
particularly considered in our study using a long incubation time with [1-13C]glucose (24 
hours). Consistent with the localization of GS in astrocytes, only minor label incorporation 
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was detected in neuronal glutamine (% 13C-enrichment of Gln C2: 0.49 ± 0.10 and of Gln C4: 
0.73 ± 0.16) compared to astrocytic glutamine (% 13C-enrichment of Gln C2: 10.04 ± 0.19 
and of Gln C4: 9.08 ± 1.27). To obtain more information about the relative 13C-turnover in the 
TCA-cycle through PC or PDH, we calculated the ratio of Glu C2/Glu C4 and Gln C2/Gln 
C4. As the results show, the exposure of neurons and astrocytes to ammonia for 24 hours 
resulted in a decreased and increased Glu C2/Glu C4 ratio to 72% and 116% of controls 
(P<0.01), respectively. The increased Glu C2/Glu C4 ratio in astrocytes may indicate an 
elevated PC activity compared to PDH, while neurons show an increased turnover via the first 
PDH turn under hyperammonemic conditions. 
 
Figure 3.1.2: 13C-NMR spectra of astrocytes  
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Representative 13C-NMR spectra of astrocytes (PCA-extracts). Astrocytes were incubated for 24 hours with 
DMEM containing 2 mM glutamine (control) and 5 mM NH4Cl with 6 mM [1-13C]glucose. Peak assignments: 
Ala, alanine; Asp, aspartate; Gln, glutamine; Glu, glutamate; Htau, hypotaurine; Lac, lactate; Tau, taurine. 
 
 
3.1.2.3 Alterations of the amino acids aspartate and alanine 
 
The exposure of ammonia to astrocytes and neurons for 24 hours resulted in minor 
increases in aspartate concentrations to 115% and 126% of controls (ns and P<0.05), 
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respectively, while alanine increased to 145% and 151% of controls (P<0.001), repectively, 
(Fig. 3.1.3.A). These results suggest that ammonia detoxification via alanine aminotransferase 
(ALAT, EC 2.6.1.1) is much more efficient compared to aspartate transferase (AAT, EC 
2.6.1.2) in both cell types.  
 
Figure 3.1.3: Alterations of aspartate and alanine concentrations and synthesis 
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Absolute intracellular concentrations (A) and %13C enrichments (B) (% of controls) of aspartate and alanine 
after 24 hours ammonia exposure to astrocytes and neurons. 
 
 
This suggestion was confirmed by the determination of de novo synthesis of aspartate and 
alanine derived from [1-13C]glucose (Fig. 3.1.3.B). As the data show, 24 hours ammonia 
exposure to astrocytes showed no significant alterations in [3-13C]aspartate but a remarkable 
increase in [3-13C]alanine to 242% of control (P<0.001). In neurons, both [3-13C]aspartate and 
[3-13C]alanine increased to 138% and 280% of controls (P<0.001), respectively (Fig. 3.1.3.B). 
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These results indicate a predominant neuronal ammonia detoxification processes via ALAT. 
This seems to be meaningful, since the detoxification of ammonia in astrocytes is mediated 
mainly by GS (Cooper et al., 1985; Butterworth et al., 1988). Therefore, neurons, which lack 
GS, may utilize alternative pathway(s) in order to detoxify excess intracellular ammonia. This 
finding may also indicate a stimulating effect of ammonia on glycolysis and TCA-cycle 
turnover, because the synthesis of aspartate and alanine requires the provision of oxaloacetate 
and pyruvate, respectively. In contrast to neurons, after 24 hours ammonium exposure, 
astrocytes show much higher % 13C enrichment in [2-13C]aspartate compared to [3-
13C]aspartate. This may be due to a higher equilibration rate between oxaloacetate and 
fumarate under HA. 
 
Figure 3.1.4: Lactate (pyruvate)-alanine-cycle and glutamine-glutamate cycle 
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Schematic representation of the metabolic coupling of neurons with astrocytes via the alanine-lactate-shuttle 
and the glutamine-glutamate cycle. In this cycle, alanine is released from neurons, taken up by astrocytes, 
converted to pyruvate by ALAT, and subsequently oxidized to lactate by lactate dehydrogenase (LDH). 
Astrocytic lactate is released and taken up by neurons. The neuronal LDH-1 isoenzyme is able to converte 
lactate to pyruvate which is transaminated to alanine by ALAT. The exchange of alanine and lactate between 
astrocytes and neurons seems to be a supplementary pathway to transport ammonia from neurons to astrocytes. 
 
 
A higher increase of alanine synthesis in neurons compared to astrocytes under 
hyperammonemic conditions may be of high importance for the intracellular nitrogen transfer 
from neurons to astrocytes. In this regard, previous studies in our laboratory showed that 
alanine may serve as a carrier of ammonia nitrogen between neurons and astrocytes 
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(Zwingmann et al., 2000). Moreover, Westergaard et al. (1993) and Waagepetersen et al. 
(2000) showed that alanine is tranformed to lactate in astrocytes, which accumulated into both 
cortical neurons and cerebellar granule neurons. The released carbon skeleton of alanine in 
form of lactate by astrocytes constitutes a way of transferring nitrogen from neurons to 
astrocytes, thereby supporting ammonia detoxification in neurons. This metabolic relation 
between neurons and astrocytes is associated with a cycle known as the lactate(pyruvate)-
alanine-cycle (Fig. 3.1.4), which may account for the nitrogen exchange required in the 
glutamine-glutamate cycle. 
 
 
3.1.2.4 Effect of ammonia on lactate synthesis 
 
The 13C-enrichments and the absolute concentrations of intracellular lactate in astrocytes and 
neurons under control and hyperammonemic (5 mM NH4Cl, 24 hours) conditions are given in 
Table 3.1.3. As the data show, astrocytes contain much more lactate compared to neurons 
under both control and hyperammonemic conditions. In addition, the de novo synthesis of [3-
13C]lactate after 24 hours ammonia exposure to primary astrocytes was elevated to 164% of 
control (P<0.001), while in neurons no significant alterations occured. This is consistent with 
the finding that astrocytes have higher glycolytic activity compared to neurons, which can be 
upregulated under pathological conditions, e.g. under HA for anaerobic generation of ATP 
(Marrif and Juurlink, 1999). 
 
Table 3.1.3: Percentage 13C-enrichments and absolute concentrations of intracellular 
lactate 
 
 
 
 
 
 
 
 
metabolite astrocytes neurons 
 (control) 5 mM NH4Cl (control) 5 mM NH4Cl 
Lac nmol/mgprotein    206 ± 14      296 ± 14 #*** 124 ± 21     140 ± 37...ns 
Lac C3 17.91 ±  2.38   29.49 ± 5.35 #***   7.90 ± 1.88    9.09 ± 1.45...ns 
 
The absolute concentrations and percentage 13C-enrichment of lactate were calculated by dividing the areas of 
the 1H-13C-peaks to the total area (1H-13C + 1H-12C) in 1H-NMR spectra of PCA extracts of neurons and 
actrocytes after incubation with a medium containing 6 mM [1-13C]glucose and 5 mM NH4Cl for 24 hours. The 
values represent means ± SD of five individual experiments (#, significantly different from controls; 
***P<0.001; ANOV; ns, not significant). 
 
Ratnakumari and Murthy (1993) have shown that the activities of cytosolic enzymes involved 
in glycolysis except for hexokinase were elevated in the brain of hyperammonemic rats. The 
accumulation of lactate under hyperammonemic conditions may cause lactaic acidosis in the 
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brain, which may represent an important factor contributing to disordered neural energy 
metabolism. On the other hand, the high amount of newly synthesized lactate in astrocytes 
may serve as an energy substrate for oxidative metabolism in neurons (Philis et al., 1999; Qu 
et al., 2000; Bouzier et al., 2000; Medina and Tabernero, 2005). Therefore, changes in lactate 
synthesis might also be implicated in the pathogenesis of HA by a modification in metabolic 
trafficking between astrocytes and neurons via the lactate(pyruvate)-alanine-cycle. 
 
 
3.1.2.5  Effect of ammonemia on the cellular energy status 
 
The energy state of brain cells is reflected by the concentrations of high energy phosphates 
such as nucleoside di- and triphosphates (NDP´s, NTP´s), in particular ADP and ATP 
(adenosine di- and triphosphate), and phosphocreatine (PCr). These substances can be 
quantified from 31P-NMR spectra of PCA extracts from astrocytes and neurons (Tab. 3.1.4; 
Fig. 3.1.5 and .6).  
 
Table 3.1.4: Effect of HA on high-energy phosphates  
 
 
 
 
 
 
 
metabolite astrocytes neurons 
 (control) 5 mM NH4Cl (control) 5 mM NH4Cl 
NTP/NDP    6.57 ± 1.84  1.63 ± 0.12...#***   5.52 ± 0.39  3.43 ± 0.23 ...#*** 
PCr/Cr    1.51 ± 0.16  0.68 ± 0.05...#***   0.70 ± 0.03  0.41 ± 0.03... #*** 
PCr/NTP    0.83 ± 0.15  0.35 ± 0.02...#***    0.41 ± 0.03  0.25 ± 0.03... #***
The concentrations of high-energy phosphates were calculated by integration of the respective signals in 31P-
NMR spectra and 1H-NMR spectra after 24 h incubation of astrocytes and neurons with media containing 6 mM 
[1-13C]glucose and 2 mM glutamine in the absence or presence of 5 mM ammonium chloride. Values are given 
as ratios and represent means ± SD of five individual experiments. (#, significantly different from controls; 
***P<0.001; ANOVA). 
 
 
As can be seen from the data, high energy phosphates are more concentrated in astrocytes 
than in neurons under control conditions (Fig. 3.1.5), which might be attributed to higher 
energy production and/or lower energy consumption in astrocytes compared to neurons. 
Moreover, the ratio of astrocytic PCr/NTP is about twice as high as neurons. The results of 
the present study confirm previous findings from our laboratory (Zwingmann et al., 1998) that 
exposure of ammonia to astrocytes resulted in a decrease in the cellular energy level. In 
particular, NTP/NDP and PCr/Cr ratios decreased to 25% and 45% compared to controls 
(P<0.001), respectively. Similarly, long term treatment (24 hours) of neurons with 5 mM 
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NH4Cl decreased NTP/NDP and PCr/Cr ratios to 62% and 61% compared to controls 
(P<0.001), respectively (Fig. 3.1.5). Since cellular energy production in the brain depends 
almost exclusively on mitochondrial oxidation of glucose in the TCA-cycle, a stimulation of 
PDH-mediated entry of glucose into the TCA-cycle should be reflected by an increased 
production of NTP. However, the results of the present study show that exogenous ammonia 
seriously deteriorates the cellular energy state of both cell types. Therefore, it can be 
concluded that changes in the cellular energy state are unrelated to the changes in 
mitochondrial energy metabolism, i.e. the ammonia-induced decrease of ATP might be more 
likely due to a stimulation of energy-consuming processes. 
 
Figure 3.1.5: Alterations in the concentrations of high energy phosphates  
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The absolute concentrations of  high energy phosphates were calculated from 1H- and 31P-NMR spectra 
obtained from cell extracts after 24 h incubation of astrocytes and neurons with media containing 6 mM [1-
13C]glucose under control conditions (2 mM glutamine) or treatment with 5 mM NH4Cl. The values are given as 
nmol/mg protein and represent means ± SD of five individual experiments.  
 
 
In addition, the results of the present study show that the energy state of astrocytes was 
considerably more affected than that of neurons after long-term exposure (24 hours) to 
ammonia. Considering the involvement of astrocytes in ammonia-induced pathological 
alterations, changes in the astrocytic energy state might be implicated in hyperammonemic 
brain dysfunction. However, this possibility has to be studied in detail.  
The mechanism of how ammonia might impair mitochondrial energy state is not yet clear. 
Several direct effects of ammonia have been proposed. In addition to the early study by 
Bessman and Bessmann (1955) that suggested that ammonia might induce a loss of α-
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ketoglutarate and NADH by reductive amination to glutamate, direct mechanisms include an 
ammonia-induced inhibition of α-ketoglutarate dehydrogenase (α-KGDH) (Lai and Cooper, 
1986), a rate-limiting enzyme of the TCA-cycle, a decreased transfer of reduced equivalents 
(NADH) from the cytoplasm to the mitochondrion via the malate-aspartate-shuttle (Hindfeld 
et al., 1977), a stimulation of the Na+/K+-ATPase (Sadasivudu et al., 1979) or NMDA 
receptor activation (Felipo et al., 1998; Monfort et al., 2002). 
 
 
Figure 3.1.6: 31P-NMR spectra of astrocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative 31P-NMR spectra of astrocytes (PCA-extracts). Astrocytes were incubated for 24 hours with 
DMEM containing 2 mM glutamine (control) and 5 mM NH4Cl with 6 mM [1-13C]glucose. Peak assignments: 
NTP, nucleoside triphosphate; NDP nucleoside diphosphate; PCr, phosphocreatine; pi, inorganic phosphate; 
(G)PE, (glycero)-phosphoethanolamine; (G)PC, (glycero)-phosphocholine. 
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In addition to high energy phosphates, 31P-NMR spectra show precursors and catabolites of 
phospholipids such as phosphomonoester and phosphodiester (Fig. 3.1.6). Long-term 
ammonia exposure to astrocytes reduced the concentration of phosphocholine and 
phosphoethanolamine to 45% and 60% of controls (P<0.001), respectively, while neurons did 
not show any significant alteration of these substances (results not shown). This matches well 
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with previous studies in our laboratory on glioma cells and primary astrocytes (Zwingmann et 
al., 1998). The cellular functions of these phosphomonoesters are manifold, and the reason for 
their decrease can be only speculated. For example, since phosphocholine and 
phosphoethanolamine are important components of cellular lipid membranes, their changes 
might be related to ammonia-induced cell swelling and cellular volume regulation. 
 
 
3.1.2.6 Alterations of intracellular osmolytes 
 
Many important intracellular metabolites participating in cellular volume regulation, 
termed as organic osmolytes, are detected in 1H-NMR spectra of extracts from astrocytes and 
neurons (Fig. 3.1.7). In neurons, glycine (Gly), taurine (Tau), and choline-containing 
compounds (Cho), and in astrocytes myo-inositol (myo-Ins), hypotaurine (HTau), and taurine 
(Tau) can be detected.  
 
Figure 3.1.7: 1H-NMR spectra of astrocytes and neurons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative 1H-NMR spectra of neutralized PCA extracts obtained from astrocytes (A) and neurons (B) after 
24 hours incubation in medium containing 6 mM [1-13C]glucose and 2 mM glutamine (control). Peak 
assignments: Ala, alanine; Asp, aspartate; (P)Cho, (phospho)-choline-containing compounds; Cr, creatine; 
GABA, γ-aminobutyric acid; Gln, glutamine; Glu, glutamate; Glx, Gln+Glu; Gly, glycine; HTau, hypotaurine; 
Ile, isoleucine; Lac, lactate; Leu, leucine; myo-Ins, myo-inositol; PCr, phosphocreatine; Suc, succinate; Tau, 
taurine; Val, valine. 
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As the data show, exposure of astrocytes to 5 mM NH4Cl for 24 hours resulted in a 
considerable decrease of myo-Ins and HTau to 37% and 66% of controls (P<0.01), 
respectively. In contrast, neurons show an increase of Gly, Tau and choline-containing 
compounds to 131% (P<0.001), 113% (P<0.05) and 145% (P<0.01) of controls, respectively 
(Fig. 3.1.8). Myo-Ins and HTau have been shown to be important and specific organic 
osmolytes in astrocytes (Brand et al., 1993). In addition, astrocytes showed an increase of Tau 
levels after NH4Cl treatment. These results are consistent with experimental HA (Kreis et al., 
1991; Häussinger et al., 1994) and ammonium-treated astrocytes (Norenberg et al., 1994; 
Zwingmann et al., 1998; Isaacks et al., 1999), demonstrating that both short-term (3-6h) and 
long-term (24h-10 days) ammonium treatment results in a decrease of myo-Ins in astrocytes. 
The enhancement of intracellular glutamine, an osmotically active compound, was reported to 
account for brain edema development during HE (Blei et al., 1994; Cordoba et al., 1996). 
Since a decrease of myo-Ins might be partly due to compensate for an increased intracellular 
osmolarity due to glutamine accumulation, the present results further support the hypothesis 
of glutamine-induced disturbance in astrocytic volume regulation under hyperammonemic 
conditions (Norenberg et al., 1994; Blei et al., 1994). 
 
Figure 3.1.8: Concentrations of organic osmolytes in astrocytes and neurons 
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Concentrations (nmol/mg protein) of organic osmolytes in astrocytes and neurons (PCA extracts) incubated for 
24 hours with 6 mM [1-13C]glucose in the presence of 2 mM glutamine (control) or 5 mM NH4Cl. The values are 
given as nmol/mg protein and represent means ± SD of five individual experiments.  
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Among the osmotically active molecules, HTau, the “reduced form“ of Tau, which is 
localized in astrocytes (Brand et al., 1992) has been found to be decreased in ammonia-treated 
astrocytes (Zwingmann et al., 1998). Nevertheless, the lack of a correlation between changes 
in the sum of organic osmolytes including glutamine in encephalopathy and brain edema 
(observed using 1H-NMR spectroscopy in brain tissue of the hepatic devascularized rat 
(Zwingmann et al., 2004)) suggests that the decrease of brain HTau and myo-Ins may not 
adequately compensate for the increased intracellular osmolarity by glutamine accumulation, 
which may lead subsequently to cell swelling (Zwingmann et al., 2004). In contrast to 
astrocytes, neurons show an increase of organic osmolytes such as Gly and choline. However, 
a role for these changes in ammonia-treated neurons is not known.  
 
 
3.1.3  Analysis of astrocytic GS and GFAP protein expression 
 
3.1.3.1 Effect of ammonia on GS expression 
 
The results of the present study using NMR spectroscopy show that astrocytes exhibit 
increased synthesis of glutamine after 24 hours exposure of 5 mM NH4Cl. In order to obtain 
more information on the GS protein expression, we performed Western blot analysis (see 
chapter 4, page 97).  
 
24 hours ammonia exposure to astrocytes resulted in a significant increase in the GS 
protein expression to 190% of control (P<0.001) (Fig. 3.1.9). This matches well with our 
results obtained by NMR spectroscopy showing a high de novo synthesis of glutamine under 
hyperammonemic conditions, which may be due to an increase of GS activity or/and a high 
GS expression. However, the results obtained with experimental models of HA indicate that 
GS activity was significantly reduced in the brain (Girard et al., 1993). Therefore, increased 
expression of GS protein in astrocytes may be responsible for a high synthesis of glutamine. 
Indeed, GS plays an important role in the ammonia detoxification under hyperammonemic 
conditions. On the other hand, the increased GS expression and subsequently elevated 
glutamine synthesis may be implicated in the pathogenesis of HA due to a modified 
glutamine-glutamate cycle by yet unknown mechanism(s). 
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Fig. 3.1.9: Effect of ammonia on astrocytic GS expression 
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Cultures of astrocytes were incubated for 24 hours with 2 mM glutamine in the absence (control) (A, lanes 1-5) 
or presence of 5 mM NH4Cl (B, lanes 6-10). β-actin was used as a control for the loading. Schematic 
representation of the data is shown in panel (C). The values represent means ± SD of five individual experiments 
(#, significantly different from controls; ***P<0.001; ANOVA). 
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3.1.3.2 Effect of ammonia on GFAP expression 
 
Although we have no direct evidence for morphological changes under hyperammonemic 
conditions, an important question is if an excess of ammonia may have an effect on cell 
structure and proliferation in astrocytes. Glial fibrillary acid protein (GFAP) is a 50 KDa 
intracytoplasmic filamentous protein that constitutes the major component of intermediate 
filaments in differentiated astrocytes of the CNS. Among other functions, GFAP modulates 
astrocyte motility and shape by providing structural stability to astrocytic processes (Eng et 
al., 1971 and 2000). GFAP represents the most specific astrocytic marker under normal and 
pathological conditions, and antisera to GFAP are routinely used to identify astrocytes in 
tissue sections or thier purity in cell cultures (Norenberg 1977; Suarez et al., 1996; Sobel et 
al., 1981). An alteration in GFAP expression might give important information about 
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structural or morphological changes in astrocytes under HA (Neary et al., 1994). In the 
present study, the GFAP protein was quantified by Western blot analysis. The results show 
that after 24 hours ammonia exposure to astrocytes GFAP expression significantly decreased 
to 64% compared to control values (P<0.01) (Fig. 3.1.10).  
 
Fig. 3.1.10: Effect of ammonia on astrocytic GFAP protein expression 
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Cultures of astrocytes were incubated for 24 hours with 2 mM glutamine in the absence (control) (A) or 
presence of 5 mM NH4Cl (B). β-actin was used as a control for the loading. 
 
The reduced GFAP content may be due to an inhibition of its expression at the mRNA 
level and/or due to a high degradation of this enzyme under hyperammonemic conditions. In 
this context, previous studies have demonstrated that exposure of primary astrocytes to 
millimolar ammonia concentrations (1-5 mM) led to a destabilization of GFAP mRNA and 
loss of GFAP protein expression (Neary et al., 1994; Haghighat et al., 2000). Cornet et al. 
(1993) showed that the cytoskeletal network, of which GFAP is a key component, is 
implicated in cell volume regulation. Furthermore, exposure of cultured astrocytes, obtained 
from neonatal rat cortices, to ammonia results in cell swelling and concomitant loss of GFAP 
expression (Norenberg et al., 1990, 1991). A reasonable explanation for this effect is that 
GFAP may alter cellular viscoelastic properties, thereby allowing for the development of 
swelling in astrocytes. This suggestion is consistent with recent studies concerning the role of 
the cytoskeletal network in cell swelling and regulatory volume decrease (RVD) (Cornet et 
al., 1993). However, the question of whether the decrease of GFAP implicated in astrocytic 
cell swelling in HA is yet unclear, and needs further investigations. 
The ammonia-induced decrease of GFAP, on the other hand, might be associated with 
changes in astrocytic proliferation, since GFAP is increased in hypertrophy and proliferation 
of astrocytes (astrogliosis) (Neary et al., 1994). Chronic hyperammonemic states resulting 
from chronic liver failure are associated with a characteristic alteration in astrocytic 
Chapter 3: Results and Discussion  49  
morphology known as Alzheimer type II astrocytosis in which astrocytes manifest a large, 
swollen, prominent nucleus, margination of their chromatin pattern and glycogen deposition 
(Norenberg, 1977; Horita et al., 1981). Sobel et al. (1981) reported that the Alzheimer type II 
change was associated with a loss of expression of GFAP in cerebral gray matter in chronic 
liver failure. 
  
3.1.4 Summary 
 
The effect of long-term (24 hours) ammonia exposure to astrocytes and neurons on glucose 
and energy metabolism, ammonia detoxcification, as well as on GS and GFAP protein 
expression is schematically summarized in Figure 3.1.11. The data of the present study clearly 
indicate that an excess of extracellular ammonia causes increased glucose metabolism via 
glycolysis and TCA-cycle activity in both astrocytes and neurons. In addition, our results 
confirmed the deleterious effect of ammonia on the energy state in both astrocytes and 
neurons. The increase of GS protein expression, a key enzyme involved in the glutamate-
glutamine cycle, and decreased GFAP as a major component of the glial filament network, 
may be involved in the astrocytic pathology under hyperammonemic conditions. In particular, 
increased GS expression and glutamine synthesis might lead to a disruption of the normal 
physiological neuron-glial metabolic trafficking.  
 
Fig. 3.1.11: Introduction about the relative alterations of enzymatic pathways, energy state, 
and molecular parameters in astrocytes and neurons  
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3.2.     Impact of extracellular glutamine on glial and 
neuronal glucose metabolism 
 
3.2.1  Introduction 
 
It is well known that glucose is the main substrate for brain energy metabolism (Sokoloff, 
1977, 1992; Gjedde and Marrett, 2001; Gjedde et al., 2002). In addition, the high rate of 
glucose consumption during neuronal signalling, measured in the in vivo brain, has been 
suggested to be directly coupled to cerebral activity (Attwell and Laughlin, 2001). However, 
previous studies have shown that other substrates may also serve as a fuel for brain cells 
(Edmond, 1992; Hawkins, 1996). In particular glutamine has been suggested to serve as an 
energy substrate for brain cells (Bradford et al., 1978; Hassel et al., 1995 and 2002; Zielke et 
al., 1998). One argument for the role of glutamine as an energy source for the brain is the 
relative higher in vitro rate of glutamine oxidation compared to that of glucose (Tildon and 
Roeder, 1984). Glutamine is present in higher concentrations in the blood (0.6-0.8 mM) and 
in the extracellular fluid (0.3-0.5 mM) (Kanamori and Ross, 2004) and studies by Schwerin et 
al. (1950) as well as Oldendorf (1971, 1981) have demonstrated that there is a net uptake of 
this amino acid by the brain. Furthermore, glutamine is the main detoxification product of 
ammonia in the brain and it is documented that glutamine as a main precursor for glutamate 
synthesis plays an important role in the metabolic trafficking between astrocytes and neurons 
via the glutamine-glutamate cycle (Van den Berg and Garfinkel, 1971; Shank and Aprison, 
1981, 1988; Berl and Clarke, 1983).  
 
Nevertheless, the impact of glutamine on cerebral glucose metabolism and its relative use 
as cellular energy substrate has not yet been clarified. We designed this study to obtain more 
information about the effect of extracellular glutamine on glucose and energy metabolism in 
astrocytic and neuronal cell cultures. Moreover, we studied the impact of exogenous 
glutamine on two astrocytic key proteins, namely GS and GFAP. The de novo synthesis of 
metabolites derived from [1-13C]glucose metabolism and the alterations of intracellular 
metabolite concentrations were measured by 13C- and 1H- NMR spectroscopy. Cellular energy 
levels were analyzed using 31P-NMR spectroscopy. GS and GFAP expressions were measured 
by Western blotting. Astrocytes and neurons were incubated in glutamine-containing (control) 
or glutamine-free medium for 24 hours. [1-13C]glucose was used as the labelled substrate for 
both cell types. 
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3.2.2   Effect of glutamine on glucose- and energy metabolism in 
cultured primary astrocytes and neurons 
 
 
3.2.2.1  Alterations of TCA-cycle-related amino acids  
 
The absolute concentrations of amino acids, lactate, and the TCA-cycle intermediate 
succinate were calculated from 1H-NMR spectra obtained from astrocytic and neuronal cell 
extracts (Tab. 3.2.1). In both astrocytes and neurons, deprivation of glutamine from the 
incubation media for 24 hours significantly decreased the concentrations of intracellular 
amino acids. However, the decrease of TCA-cycle-related amino acids was much higher in 
neuronal than in astrocytic cell cultures. This pattern might reflect impaired oxidative glucose 
metabolism especially in neuron cultures in the absence of exogenous glutamine. However, it 
is also reasonable to assume that decreased amino acid concentrations in these cells are due to 
the lack of glutamine as a substrate. Therefore, in subsequent experiments we investigated if 
neuronal metabolism is more dependent on extracellular glutamine than that of primary 
astrocytes.  
 
Table 3.2.1: Absolute concentrations of amino acids, lactate, and succinate 
 
 
 
 
 
 
 
 
 
metabolites astrocytes neurons 
 (control) without glutamine (control) without glutamine 
glutamine 144.80 ± 5.75   32.41 ± 2.67    #*** 97.30 ± 8.70   14.54 ± 1.12   #***
glutamate  45.30 ± 3.75   28.39 ± 2.90    #*** 115.70 ± 16.02   61.30 ± 2.82   #***
aspartate 12.55 ± 2.62     7.91 ± 1.36    #** 27.30 ± 4.36     6.02 ± 1.50   #***
alanine 34.05 ± 2.78   36.59 ± 2.14    ns 54.90 ± 6.80   33.12 ± 2.56   #***
lactate 172.60 ± 12.61 197.23 ± 17.90  ns 124.10 ± 15.30 157.94 ± 9.23   #**
succinate 23.53 ± 2.53   20.70 ± 3.13    ns 13.30 ± 1.96     8.96 ± 2.23   #*
 
The absolute concentrations of metabolites were calculated by integration of the respective signals in 1H-NMR 
spectra of cell extracts after 24 h incubation of astrocytes and neurons with media containing 6 mM [1-
13C]glucose under control conditions (2 mM glutamine) or in the absence of extracellular glutamine. The 
values are given as nmol/mg protein and represent means ± SD of five individual experiments (#, significantly 
different from controls; ***P<0.001, **P<0.01, *P<0.05; ANOVA; ns, not significant). 
The relative de novo synthesis of a metabolite derived from [1-13C]glucose is reflected by 
its 13C-enrichment, which was calculated from 1H- and 13C-NMR spectra as described in the 
experimental part (see chapter 4, page 113). Figure 3.2.1 shows representative 13C-NMR 
spectra of neuron extracts. The percentage 13C-enrichments in TCA-cycle-related amino acids 
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and lactate of both astrocytes and neurons are given in Figure 3.2.2. As these data show, the 
incubation of both astrocytes and neurons for 24 hours in glutamine-free media led to a 
considerable decrease in de novo synthesis of the amino acids glutamate, glutamine, alanine, 
and aspartate from [1-13C]glucose, which is discussed in detail below.  
 
Figure 3.2.1: 13C-NMR spectra of neurons 
(A) 
(B) 
Representative 13C-NMR spectra of neurons (PCA extracts). Neurons were incubated for 24 hours with BME 
containing 6 mM [1-13C]glucose in the presence of 2 mM glutamine (control; A) or in the absence of 
extracellular glutamine (B). Peak assignments: Ala, alanine; Asp, aspartate; GABA, γ-aminobutyric acid; Glu, 
glutamate; Lac, lactate; Pro, proline. 
 
 
In cultured astrocytes, the absence of extracellular glutamine decreased the de novo 
synthesis of [2-13C]glutamate and [4-13C]glutamate to 74% and 38% of control (P<0.001), 
respectively. These isotopomers reflect the flux of carbon from glucose through the 
anaplerotic (PC) and the oxidative (PDH) pathway, respectively, which are both active in 
astrocytes (for the description of the pathways see chapter 4, page 115). Although both 
pathways were impaired in glutamine-free media, the inhibition of flux through PDH is 
clearly dominant as also evident from the increased Glu C2/Glu C4 ratio to 194% of control 
(P<0.001). In addition, after deprivation of extracellular glutamine from astrocyte cultures, 
the de novo synthesis of [2-13C]glutamine and [4-13C]glutamine decreased to 61% (P<0.01) 
and 23% (P<0.001) of control, respectively. The higher decrease of glutamine- compared to 
glutamate-synthesis might indicate to a relative higher inhibition of GS compared to the TCA-
cycle flux after glutamine deprivation. 
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In primary neurons, the decrease in glutamate synthesis from [1-13C]glucose after 
incubation in glutamine-deprived medium was even much higher compared to that observed 
in astrocytes (Fig. 3.2.2). Although neurons lack PC activity, both [2-13C]glutamate and [4-
13C]glutamate decreased to 14% and 9% of controls (P<0.001), respectively. However, the 
13C-label in C-2 of glutamate can arise also via the second PDH-mediated carbon entry into 
the TCA-cycle turn (see chapter 4, page, 120). The lack of PC activity in neurons, which 
provides oxaloacetate to condense with acetyl-CoA, might be responsible for a much higher 
decrease in flux through PDH in neurons compared to astrocytes after exposure to a 
glutamine-free medium.  
 
Fig. 3.2.2: Changes in the percentage 13C-enrichment in amino acids and lactate induced 
by glutamine-deprivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0
50
100
150
200
250
C2 C3 C4
Glu
C2 C3 C4
Gln
Ala
C3
Lac
C3
%
13
C
-e
nr
ic
hm
en
ts
%
 o
f c
on
tr
ol
astrocytes
neurons
25
75
125
175
225
The percentage 13C-enrichments in specific carbon position of amino acids and lactate were calculated by 
integration of the respective signals in 13C-NMR spectra of cell extracts after 24 h incubation of astrocytes and 
neurons with media containing 6 mM [1-13C]glucose under control conditions (2 mM glutamine) or in the 
absence of extracellular glutamine. The values represent means ± SD of five individual experiments. 
 
This strongly indicates that under normal conditions (glutamine-containing medium), the 
neurons use this amino acid as a substrate for the TCA-cycle. Previous studies have also 
shown that neurons contain phosphate activated glutaminase (PAG, EC 3.5.1.2) (Weiler et al., 
1979).  
In contrast to astrocytes, the detected glutamine signals in 13C-NMR spectra correspond to 
natural abundance 13C of glutamine in neurons. These cells exhibit also no significant 
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alterations of glutamine de novo synthesis after deprivation of extracellular glutamine. This is 
in agreement with previous observations that GS is localized in astrocytes but not in neurons 
(Norenberg and Martinez-Hernandez, 1979). Rather, as evidenced by the present data, 
neurons are dependent on (astrocytically released) glutamine not only for the synthesis of 
neurotransmitters, but also for the replenishment of TCA-cycle intermediates to maintain their 
TCA-cycle activity. 
The first step of cellular glutamine metabolism depends on the activity of phosphate 
activated glutaminase (PAG), which catalyzes the conversion of glutamine to glutamate by 
deamination (chapter 4, page 122). PAG has also been found in astrocytes, but its activity is 
very low compared to that in neurons (Hogstad et al., 1988). As stated above, extracellular 
glutamine seems to be more efficiently metabolized by neurons than by astrocytes. Indeed, 
the conversion of glutamine to glutamate might be in part responsible for the higher neuronal 
content of glutamate after incubation in glutamine-containing medium. However, the relative 
de novo synthesis of glutamate from [1-13C]glucose was much higher after incubation with [1-
13C]glucose in glutamine-containing medium, resulting in a 8-fold increase in the total 
amount of 13C-labelled glutamate in neurons. This means that carbons from glucose, and not 
from glutamine, were recovered in glutamate, since conversion of unlabelled glutamine to 
glutamate would lead to decreased percentage 13C-enrichment in glutamate. The second step 
in glutamine metabolism is the conversion of glutamate to α-ketoglutarate, an intermediate of 
the TCA-cycle, via glutamate dehydrogenase (GDH, EC 1.4.1.3). 
The observation of increased conversion of glucose to glutamate in the presence of 
glutamine is consistent with a previous observation in C6 glioma cells (Portais et al., 1996) 
and primary astrocytes (Martin et al., 1995), which was called to be an “isotopic-exchange 
process” between unlabelled glutamine and [1-13C]glucose. However, it has to be considered 
that glutamine represents both a carbon- and a nitrogen source. It is, therefore, reasonable to 
assume that ammonia, which is released from glutamine by the action of PAG, secondarily 
stimulates neuronal amino acid synthesis from glucose in order to detoxify ammonia. 
Therefore, in the present study, the effect of extracellular glutamine on neuronal metabolism 
was compared with the metabolic effects of extracellular ammonia. Consistent with the above 
assumption, exposure of neurons to 5 mM ammonia also increased neuronal glutamate stores 
as well as its de novo synthesis from [1-13C]glucose. An increased metabolic activity through 
the TCA-cycle contributing to neuronal glutamate synthesis was observed also previously in 
ammonia-exposed cultured granule cells (Chan et al., 2003). However, the present data show 
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that the stimulating effect of 5 mM ammonia on [1-13C]glucose metabolism was by far not as 
pronounced as observed using 2 mM glutamine. Furthermore, the stimulating effect of 
ammonia on neuronal amino acid synthesis from glucose was much higher in the presence of 
exogenous glutamine. Thus, the additive effects of ammonia and glutamine on neuronal 
glutamate synthesis through the TCA-cycle was synergistic.  
Astrocytes exhibited an increase in the percentage 13C-enrichment in glutamate 
isotopomers after incubation with [1-13C]glucose in glutamine-containing medium compared 
to incubation in glutamine-free medium, resulting in a 3-fold increase in the total amounts of 
13C-labelled glutamate. This indicates a stimulatory effect of exogenous glutamine on 
astrocytic amino acids synthesis, though not as effectively as was shown in neurons. This is 
reasonable, since astrocytes are capable of replenishing the TCA-cycle intermediates pool 
through the anaplerotic pathway by PC. In addition, the stimulating effect of ammonia on 
glucose metabolism and amino acid synthesis (through glycolysis and the TCA-cycle) in the 
absence of glutamine was much higher in astrocytes than in neurons. Thus, these results 
clearly confirm again that primary neurons are effective compared to astrocytes in using 
exogenous glutamine as a mitochondrial carbon substrate for the TCA-cycle. Furthermore, 
our results also explain, why in cortical slices a limitation in neuronal glutamine supply could 
not be adequately compensated by increased de novo synthesis of glutamate from glucose 
(Rae et al., 2003). Therefore, in conclusion, glutamine is not only a complementary fuel to 
glucose, but also functions as an anaplerotic substrate. 
 
 
3.2.2.2 Ammonia detoxification 
 
As stated above, GS is the most important pathway for ammonia detoxification in the brain 
(Cooper et al., 1987). However, there are other enzymes, e.g. alanine aminotransferase 
(ALAT, EC 2.6.1.2) and aspartate aminotransferase (AAT, EC 2.6.1.1), participating in the 
cerebral detoxification of ammonia. These enzymes are present in both astrocytes and neurons 
(Schmitt and Kugler, 1999; Mckenna et al., 2000). The above data showed that the 
deprivation of glutamine causes a considerable decrease in de novo synthesis of glutamine in 
astrocytes and glutamate in neurons (Fig 3.2.2). This may be due to an inhibition of astrocytic 
GS and neuronal GDH and/or an impairment of the TCA-cycle in both cell types. Moreover, 
the incorporation of [1-13C]glucose into [3-13C]aspartate via AAT and into [3-13C]alanine via 
ALAT in both astrocytes (not significant and 81%; P<0.05 of control, respectively) and 
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neurons (not detactable and 49%; P<0.001 of control, respectively) also decreased. These 
results indicate an inhibition of both AAT and ALAT under glutamine deprivation. Therefore, 
it can be concluded that the existence of glutamine is necessary for the activity of 
aminotransferases in both astrocytes and neurons. 
 
 
3.2.3 Effect of glutamine on lactate synthesis after glutamine-deprivation 
 
The percentage 13C-enrichment of lactate indicates an increased flux of [1-13C]glucose 
through glycolysis. Glutamine deprivation stimulated the lactate production from glucose to 
169% of control (P<0.01) in neuron cultures (Fig. 3.2.3).  
 
Figure 3.2.3: Alteration in the percentage 13C-enrichment of lactate 
 
 
 
 
 
 
 
 
 
The percentage 13C-enrichments in lactate were calculated from 1H-NMR spectra of cell extracts after 24 h 
incubation of astrocytes and neurons with media containing 6 mM [1-13C]glucose under control conditions (2 
mM glutamine) or in the absence of extracellular glutamine with or without 5 mM NH4Cl. The values represent 
means ± SD of five individual experiments. 
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If the deprivation of glutamine does not inhibit the release and/or consumption of lactate, 
the increased de novo synthesis of lactate may suggest a shift to glycolytic energy production 
in neurons. This may be due to compensation for the decreased energy production after 
inhibition of mitochondrial glucose oxidation. In particular, the synthesis of lactate provides 
NAD+ for the maintenance of glycolytic activity and cytosolic ATP production. In contrast, 
astrocytes show no significant alterations in the de novo synthesis of lactate in glutamine-free 
media. This observation further supports that the TCA-cycle activity, and therefore 
mitochondrial energy production, of astrocytes is less affected than that of neurons due to the 
absence of exogenous glutamine.  
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Interestingly, the exposure of astrocytes to 5 mM NH4Cl in the absence of exogenous 
glutamine resulted in an increased de novo synthesis of [3-13C]lactate to 156% of control 
(P<0.01), while neurons do not show a significant increase of [3-13C]lactate. In this context, it 
has been observed that ammonia stimulates certain enzymes of the glycolytic pathway and 
therefore enhances the rate of glycolysis in the brain (Ratnakumari and Murthy, 1993; 
Tsacopoulos et al., 1997). The results of the present study extend these data in demonstrating 
the stimulatory effect of ammonia on glycolysis and lactate synthesis selectively in astrocytes, 
but not in neurons.  
 
 
3.2.2.4  Effect of glutamine on the cellular energy status 
 
From 31P-NMR spectra of PCA extracts (Fig. 3.2.4), high-energy phosphates such as 
nucleoside di- and triphosphates (NDP’s, NTP’s), adenosine di- and triphosphate (ADP and 
ATP), and phosphocreatine (PCr) were calculated. The data showed that 24 hours glutamine 
deprivation from the astrocytic medium produced no obvious changes in NTP, while PCr 
concentrations decreased to 78% of control (P<0.01) (Table 3.2.2). In contrast, neurons show 
a remarkable increase of NTP and PCr to 143% (P<0.001) and 120% (P<0.05) of controls, 
respectively, when they were incubated in glutamine-free media. 
Since cellular energy production depends almost exclusively on mitochondrial oxidation of 
glucose in the TCA-cycle, a stimulation of PDH or PC-mediated entry of glucose into the 
TCA-cycle, which were stimulated by both ammonia and glutamine in both astrocytes and 
neurons, should be reflected by an increased production of ATP. However, using 31P-NMR-
spectroscopic analysis, we demonstrated that both ammonia and glutamine cause an 
impairment of cellular energy state of neurons, whereas in astrocytes only ammonia exhibits 
an inhibitory effect on their cellular energy status. Several mechanisms might be responsible 
for the observed decrease in the cellular energy state of ammonia-treated neurons and 
astrocytes as discussed in chapter 3.1 (page 42). However, 13C-isotopomer analysis of the 
glutamate isotopomers showed that changes in mitochondrial glucose oxidation did not 
account for cellular energy failure. The ammonia-induced decrease in ATP might be, at least 
in part, due to a stimulation of energy-consuming processes. The present results also show 
that exogenous glutamine significantly deteriorated the ammonia-induced ATP depletion, but 
only in neurons. However, the additive effects of ammonia and glutamine in stimulating 
mitochondrial glucose oxidation and TCA-cycle turnover concomitant with the depletion of 
neuronal energy stores further confirm that ammonia-induced changes in the cellular energy 
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state are unrelated to changes in neuronal mitochondrial energy metabolism. Considering 
strongly activated glucose oxidation in astrocytes and neurons, the decrease of ATP caused by 
ammonia and/or glutamine by other mechanism, therefore, would be even higher than 
indicated by the actually measured ATP levels in neurons. 
 
Table 3.2.2: Absolute high energy phosphate concentrations (nmol/mg protein) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
metabolite cortical astrocytes cortical neurons 
nmol/mg 
protein (control) without Gln 
without Gln 
+ NH4Cl (control) without Gln 
without Gln 
+ NH4Cl 
NTP  102.58 ± 8.60 90.59 ± 7.28..ns 48.11 ± 2.08...#*** 73.64 ± 2.84 105.72 ± 2.51..#***  81.02 ± 3.01...#* 
NDP    19.03 ± 3.07 23.46 ± 2.26..ns 35.08 ± 2.71...#*** 13.37 ± 0.79   14.38 ± 0.61..ns 16.35 ± 0.41...#*** 
PCr     83.50 ± 4.43 65.11 ± 4.38..#** 28.75 ± 2.02...#*** 29.46 ± 3.28   35.09 ± 2.06..#* 24.64 ± 2.08...#** 
Cr       53.85 ± 2.75 59.43 ± 2.02..#** 49.60 ± 3.68...#* 42.02 ± 3.62   39.46 ± 2.76..ns 27.07 ± 0.99...#*** 
(ratio)       
NTP/NDP    5..57 ± 1.84   3.90 ± 0.60..#**   1.38 ± 0.08...#***   5.52 ± 0.39    7.34 ± 0.41...#***   4.96 ± 0.35...ns 
PCr/Cr   1.51 ± 0.16   1.28 ± 0.18..#*   0.58 ± 0.09...#***   0.70 ± 0.03    0.89 ± 0.10..#**   0.68 ± 0.07 ..ns 
PCr/NTP    0.83 ± 0.15   0.72 ± 0.06..#*   0.60 ± 0.04...#** 0.41 ± 0.03    0.33 ± 0.03..ns   0.30 ± 0.02 ..#*** 
The concentrations of high-energy phosphates were calculated by integration of the respective signals in 31P-
NMR spectra and 1H-NMR spectra after 24 h incubation of astrocytes and neurons with medium containing 6 
mM [1-13C]glucose in the absence or presence of 2 mM glutamine (control) or 5 mM ammonium chloride. 
Values are given as nmol/mg protein (or metabolite ratios) and represent means ± SD of five individual 
experiments. (#, significantly different from controls; ***P<0.001, **P<0.01, *P<0.05; ANOVA; ns, not 
significant). 
 
Most of the cell‘s energy consumption is used in the cytosol for active transport of ions to 
sustain and restore membrane potential (Bradford and Rose, 1967). Cellular uptake processes 
are coupled to the activity of the Na+/K+-ATPase (Quastel, 1970), which might be directly 
activated by ammonium ions, leading to ATP consumption. This would be a reasonable 
explanation, since ammonia causes a depolarization of neuronal membranes (Rao and 
Murthy, 1991) and evidence is given that ammonia can substitute potassium in activating the 
sodium pump (Moser, 1987). In this regard, also the transport of considerable amounts of 
glutamine via sodium-dependent transport systems (Dolinska et al., 2004) may deteriorate 
neuronal ATP after ammonia-treatment in glutamine-containing medium. Aerobic glucose 
metabolism generally is able to provide the cytosol with sufficient energy to maintain these 
processes. However, neurons are unable to increase their glycolytic activity, even when 
mitochondrial respiratory function is inhibited (Walz and Mukerji 1988). This is also reflected 
by the present study demonstrating unchanged lactate de novo synthesis under 
hyperammonemic conditions. However, after omission of glutamine, lactate de novo synthesis 
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increased >1.5-fold after ammonia treatment. Thus, the relative attenuation of neuronal ATP 
stores in the absence of glutamine may partly be due to glycolytic ATP production.  
 
Figure 3.2.4: 31P-NMR spectra of cortical neurons 
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31P-NMR spectra of perchloric acid extracts of neurons  incubated for 24 hours with 6 mM [1-13C]glucose in the 
presence of 2 mM glutamine (A), and in the absence of extracellular glutamine (B). Peak assignments: NTP, 
nucleoside triphosphate; NDP nucleoside diphosphate; PCr, phosphocreatine; Pi , inorganic phosphate; (G)PE, 
(glycero)-phosphoethanolamine; (G)PC, (glycero)-phosphocholine. 
 
In contrast, astrocytes showed no significant alterations in their energy state after 
glutamine deprivation, while ammonium caused a considerable loss of high-energy 
phosphates. This is compatible with previous observations confirming high ammonia uptake 
by astrocytes, which can subsequently activate Na+/K+-ATPase (Sadasivudu et al., 1979; 
Ratnakumari et al., 1995; Kala et al., 2000), and thereby consume ATP.  
However, the question still remains, whether the much higher loss of neuronal ATP in the 
presence of exogenous glutamine is solely due to glutamine uptake processes. In light of 
unchanged ADP concentration, we believe that also other, yet unknown mechanism(s), are 
responsible for decreased ATP production in the absence of extracellular glutamine. Although 
ammonia is detoxified to neuronal amino acids, this might be not sufficient to compensate for 
the additional amounts of ammonia released from glutamine via glutaminase. Therefore, also 
a direct effect of ammonia on oxidative phosphorylation can not be excluded. Further studies 
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are needed to address this issue, e.g. how exogenous glutamine deteriorates ammonia-induced 
neuronal energy failure.  
 
3.2.2.5 Alterations of intracellular osmolytes 
 
The relative alterations of intracellular osmolytes calculated from 1H-NMR spectra of 
cultured astrocytes and neurons are given in Fig. 3.2.5. Deprivation of extracellular glutamine 
resulted in an increase of intracellular organic osmolyte concentrations of astrocytes, e.g. of 
myo-inositol (myo-Ins), taurine (Tau), hypotaurine (HTau), and choline to 235% (P<0.01), 
198% (P<0.001), 145% (P<0.001), and 175% (P<0.01) of controls, respectively. 
 
Figure 3.2.5: Alterations of intracellular osmolyte concentrations after glutamine-
deprivation 
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Alterations in the concentrations of organic osmolytes, calculated by integration of the respective signals in 1H 
NMR spectra of cell extracts after 24 h incubation of astrocytes and neurons with media containing 6 mM [1-
13C]glucose under control conditions (2 mM glutamine) or without extracellular glutamine. The values are given 
as nmol/mg protein and represent means ± SD of five individual experiments. 
 
In contrast, neurons show a marked decrease of glycine (Gly), taurine (Tau) and choline to 
78% (P<0.05), 42% (P<0.001), and 68% (P<0.001) of control, respectively. In previous 
studies of our laboratory, we could show that the accumulation of glutamine due to ammonia 
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detoxification by astrocytes was accompanied by the depletion of some organic osmolytes, 
such as myo-Ins, HTau, and Tau, which may be involved in the swelling of astrocytes 
(Zwingmann et al., 1998). The results of the present study show that the deprivation of 
glutamine resulted in an increase of organic osmolytes in astrocytes but not in neurons. One 
reasonable explanation for this observation is that the increased synthesis of these osmolytes 
compensates for the lack of intracellular glutamine, observed using glutamine-free medium, 
to maintain constant intracellular osmolarity.  
 
 
3.2.3  Analysis of astrocytic GS and GFAP expression 
 
3.2.3.1  Effect of glutamine on astrocytic GS expression 
 
As mentioned earlier in this chapter, the deprivation of extracellular glutamine from the 
medium of astrocytes resulted in a decrease in the de novo synthesis of glutamine, which 
suggests an inhibition of GS activity under this condition. However, the decrease of newly 
synthesized glutamine may be also due to a decrease in the expression of the GS protein. In 
order to obtain more information about GS at the molecular level after glutamine deprivation, 
we performed Western blot analysis (see chapter 4, page 97).  
As the results show, the deprivation of glutamine from the medium for 24 hours resulted in 
a significant decrease of GS protein expression to 25% of control (P<0.001) (Fig. 3.2.6). 
Nevertheless, it must be considered that the decrease of GS protein might also be due to GS 
degradation.  The half life of GS protein is relatively short (13-22 hours) (Suarez et al., 2002), 
and may be influenced after glutamine deprivation. This result further supports that the 
existence of extracellular glutamine is necessary for the ammonia detoxification via GS. 
 
Figure 3.2.6: Effect of glutamine on GS expression 
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Cultures of astrocytes were incubated for 24 hours with DMEM containing 6 mM glucose under control 
conditions (2 mM glutamine) (lanes 1-6) or without  extracellular glutamine (lanes 7-12). 
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24 hours exposure of cultured astrocytes to ammonia in the absence of extracellular 
glutamine (like glutamine-containing medium) also led to a similar increase of GS expression 
(to 132%; P<0.05 of control) (Fig. 3.2.6). This indicates that the stimulatory effect of 
ammonia on GS expression is not dependent on the presence of extracellular glutamine. 
 
 
Figure 3.2.7: Effect of glutamine deprivation and ammonia exposure on GS expression 
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Cultures of astrocytes were incubated for 24 hours with DMEM containing 6 mM glucose in the absence of 
extracellular glutamine and 5 mM NH4Cl (A). Schematic representation of the data is shown in panel (B). The 
values represent means ± SD of three individual experiments. 
 
 
3.2.3.2 Effect of glutamine on astrocytic GFAP expression 
 
The results obtained from Western blot analysis (Fig. 3.2.8) showed that the deprivation of 
extracellular glutamine for 24 hours resulted in a decrease of astrocytic GFAP expression to 
68% of control (P<0.01). A decrease of GFAP expression and concomitant cell swelling, 
observed also under hyperammonemic conditions, may be involved in the pathogenesis of 
brain edema (Norenberg et al., 1990, 1991). However, there is no direct evidence on 
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astrocytic cell swelling under glutamine deprivation until now. These results point to the 
importance of further investigations on this issue. 
Figure 3.2.8: Effect of glutamine deprivation on GFAP expression 
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Cultures of astrocytes were incubated for 24 hours with DMEM containing 6 mM glucose under control 
conditions (2 mM glutamine) or without extracellular glutamine. β-actin was used as control for the loading. 
 
 
3.2.4 Summary  
 
Altogether, these results revealed that the deprivation of extracellular glutamine resulted in 
an impairment of the TCA-cycle activity and mitochondrial dysfunction, and suggests a 
critical role of glutamine in normal physiological astrocytic and neuronal glucose metabolism. 
Moreover, it could be demonstrated that neurons depend more on extracellular glutamine than 
astrocytes to maintain the synthesis of TCA-cycle related amino acids under physiological 
conditions. These add further hints to our understanding of the regulation of the glutamine-
glutamate-cycle between astrocytes and neurons. In addition, we could show that glutamine is 
used as an anaplerotic substrate in neurons which lack PC. Moreover, glutamine and ammonia 
increase the GS expression of cultured astrocytes. This indicates a disordered homeostasis of 
the glutamine-glutamate-cycle between neurons and astrocytes under hyperammonemic 
states. In contrast to ammonia, glutamine causes an increased astrocytic GFAP expression, 
which may indicate a role of glutamine for the proliferation of astrocytes, and should be 
considered in addition to ammonia itself in the pathogenesis of HE. The present study also 
demonstrates that ammonia and glutamine additively affect the energy status of cultured 
neurons but not of astrocytes, which was not attributed to an impaired mitochondrial 
metabolic activity. 
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3.3 Metabolism of [1-13U5]glutamine in primary 
 astrocytes, neurons and cocultures of both 
 
3.3.1     Introduction 
 
Based upon the results presented in this chapter (3.1 and 3.2), it was demonstrated that 
exogenous glutamine plays a critical role in oxidative glucose metabolism in neural cells and 
its deprivation results in an impairment of the TCA-cycle turnover and consequently in 
mitochondrial dysfunction. Moreover, the metabolism of extracellular glutamine through the 
TCA-cycle was more efficient in neurons than in astrocytes. Furthermore, glutamine serves as 
an anaplerotic substrate in neurons to replenish the TCA-cycle intermediates.  
 
In the present study, we investigated the role of extracellular glutamine on energy 
metabolism in neural cell cultures, e.g. in astrocytes, neurons, and cocultures of both, in order 
to address further the question whether glutamine can substitute for glucose in energy 
metabolism of neural cells. Furthermore, in order to obtain more information on the specific 
metabolic pathways of glutamine via the TCA-cycle in astrocytes, neurons and cocultures of 
both cell types, and the relative contribution of these neural cells to cerebral energy 
metabolism, we have investigated the de novo synthesis of metabolites derived from [U-
13C5]glutamine under physiological conditions (2 mM glutamine and 6 mM glucose), under 
hypoglycemia (without glucose), and under hyperammonemic conditions (5 mM NH4Cl) 
using 1H- and 13C-NMR spectroscopy. In addition, the alterations of neural energy levels were 
determined using 31P-NMR spectroscopy. The cells were incubated for 24 hours with 0.5 mM 
[U-13C5]glutamine plus 1.5 mM unlabelled glutamine in the absence or presence of 6 mM 
unlabelled glucose and/or 5 mM NH4Cl.  
 
 
3.3.2 Metabolic pathways of [U-13C5]glutamine 
 
3.3.2.1   Analysis of the coupling pattern in metabolites of [U-13C5]glutamine 
metabolism 
 
Representative 13C-NMR spectra from PCA extracts of neurons under control, 
hyperammonemic, and hypoglycemic conditions are shown in Fig. 3.3.1. As can be seen from 
the spectra, the incubation of cells with [U-13C5]glutamine led to different coupling pattern of 
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detected isotopomers. The analysis of the coupling pattern of detected isotopomers revealed 
that the signal for the C3-position in glutamate exhibits a pseudo triplet (two doublets with 
equivalent coupling constant J2,3 = J3,4 = 34.5 Hz) and a doublet (J3,2 = 34.5 Hz) (Fig. 3.3.2). 
The doublet of Glu C3 can be attributed to different isotopomers, namely, [2,3-13C2]-, [3,4-
13C2]-, [1,2,3-13C3]- and or, [3,4,5-13C3]-glutamate. Nevertheless, the formation of [2,3-13C2]- 
or [3,4-13C2]-glutamate are not present in 13C-NMR spectra, since the former should give rise 
to a doublet in Glu C2 and the latter in Glu C4. 
 
Figure 3.3.1: 13C-NMR spectra of neurons  
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13C-NMR spectra from PCA extracts of cultured neurons incubated for 24 h in medium containing 0.5 mM [U-
13C5]glutamine plus 1.5 mM unlabelled glutamine in the presence of 6 mM glucose (A) or in the presence of 5 
mM NH4Cl and 6 mM glucose (B) or in the absence of glucose (C). Peak assignments:  GABA, γ-
aminobutyricacid; Gln, glutamine; Glu, glutamate; Asp, aspartate. 
 
Chapter 3: Results and Discussion  66  
If uniformly labelled oxaloacetate, derived from uniformly labelled glutamine, 
condensates with unlabelled acetyl-CoA, it will form labelled citrate which decarboxylates to 
[1,2,3-13C3]α-ketoglutarate. The following amination forms [1,2,3-13C3]glutamate (Fig. 3.3.3). 
Since Gln C2 and Glu C2 signals overlap considerably, the corresponding quantification of 
the amount in the C2-position would be inaccurate (Fig. 3.3.1).  
Further noteworthy information could be obtained by the analysis of the coupling pattern 
in the C4-position of glutamate: In addition to the doublets of doublets from uniformly 
labelled glutamate, an additional doublet was observed (Fig. 3.3.1). This isotopomer has only 
one 13C next to the label in the C-4 position to give a signal as doublet. It might be either C-3 
or C-5 of glutamate. However, from the coupling constant (J4,5 = 51.5 Hz), this 13C-label has 
to be at the carboxylic acid carbon position. 
The formation of [4,5-13C2]glutamate from uniformly labelled glutamine can only occur 
via pyruvate recycling (Fig. 3.3.4), which was described in the brain of adult rats in the early 
1990s (Cerdan et al., 1990; Künnecke et al., 1993). After entry of [U-13C6]glutamine into the 
TCA-cycle and formation of uniformly labelled malate and oxaloacetate, uniformly labelled 
pyruvate can be formed from oxaloacetate via the combination of phosphoenolpyruvate 
carboxykinase (PEPCK, EC 4.1.1.1.32) and pyruvate kinase (PK, EC 2.7.1.40) or from malate 
via malic enzyme (ME, EC 1.1.1.40). Then, the condensation of uniformly labelled acetyl-
CoA with unlabelled oxaloacetate, formed from unlabelled glutamine, results in the formation 
of [4,5-13C2]glutamate (Fig. 3.3.1 and 4). 
 
Figure 3.3.2: The coupling pattern of [3-13C]glutamate and [3-13C]glutamine 
 
 
 
 
 
 
 
 
 
 
Representative 13C-NMR spectrum of neurons incubated with 2 mM glutamine and 6 mM glucose for 24 hours 
(PCA extract). This is an expanded region from the spectrum in Figure 4.3.1, showing the C-3 position of 
glutamate and glutamine. Glu, glutamate; Gln, glutamine. 
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Because pyruvate is simultaneously being produced by these enzymes and consumed by 
the TCA-cycle, this pathway was considered as a futile cycle of glycolysis/gluconeogenesis in 
the liver and termed “pyruvate recycling” (Hue, 1981 and 1982).  
Labelled aspartate arise only if uniformly labelled glutamine enters the TCA-cycle. This 
occurs in two steps: by conversion of glutamine to glutamate via (PAG) and subsequent by 
deamination of glutamate to α-ketoglutarate via (GDH) (Fig. 3.3.3). The signals of Asp C2 
(52.89 ppm) and Asp C3 (37.41 ppm) show a doublet of doublet from uniformly labelled 
aspartate and in addition a doublet (J1,2 = 54,1 Hz and J3,4 = 50,8 Hz), derived from [1,2,3-
13C3]α-ketoglutarate after the first turn of the TCA-cycle (Fig.3.3.5). 
 
 
3.3.2.2   Alterations of glutamine-derived metabolites 
 
Typical 13C- and 1H-NMR spectra obtained from PCA extracts of astrocytes, neurons, and 
cocultures of both cell types under control conditions are represented in Figures 3.3.6 and 
3.3.7, respectively.  
 
Figure 3.3.3: Metabolic pathways of [U-13C5]glutamine 
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As the 13C-NMR spectra show, [U-13C5]glutamine was remarkably metabolized by 
cultured neurons and cocultures with label appearing in glutamate, glutamine and to a lesser 
extent in aspartate and γ-aminobutyric acid (GABA) under control conditions. In contrast, 
astrocytes show no labeling in aspartate and GABA under control conditions (Fig. 3.3.6). The 
appearance of the [1,2,3-13C3]glutamate isotopomer (1J2,3 = 34.5 Hz) in neurons and 
cocultures and of the [1,2,3-13C3]glutamine isotopomer (1J2,3 = 34.5 Hz) in astrocytes and 
cocultures under all experimental conditions confirmed the metabolism of glutamine through 
the TCA-cycle. The formation of these isotopomers can only occur, when uniformly labelled 
oxaloacetate, derived from extracellular [U-13C5]glutamine, condenses with unlabelled acetyl-
CoA. These results fits well with the findings presented in this chapter (3.1 and 3.2) showing 
that astrocytes and neurons are capable of taking up and metabolizing glutamine for the 
replenishment of TCA-cycle related amino acids such as aspartate and glutamate. 
 
 
The exposure of cortical neurons, astrocytes and cocultures to 5 mM NH4Cl for 24 hours 
resulted in an increase in the percentage 13C-enrichment in [1,2,3-13C3]glutamate to 124%, 
151%, and 173% of control (P<0.01), respectively (Fig. 3.3.8). Moreover, while astrocytes 
and cocultures showed an elevation of the [1,2,3-13C3]glutamine isotopomer to 133% and 
140% of controls (P<0.01), respectively, the neurons showed no detectable signals of this 
isotopomer, which is consistent with the presence of GS in astrocytes but absence in neurons 
(Norenberg and Martinez-Hernandenz, 1979). This may be due to ammonia detoxification by 
glutamate dehydrogenase (GDH) in both astrocytes and neurons, but by GS only in 
astrocytes. The enhanced formation of these glutamate and glutamine isotopomers 
demonstrates stimulation of GS and/or GDH and of glutamine catabolism through the TCA-
cycle under hyperammonemic conditions, which are consistent with our studies in chapter 
4.1.  
 
Interestingly, while the incubation of neurons and cocultures in glucose-free medium for 
24 hours resulted in a remarkable increase of [1,2,3-13C3]glutamate to 144% and 232% of 
control (P<0.001), respectively, no significant alterations of this isotopomer could be found in 
astrocytes. This suggests a much higher glutamine uptake and/or consumption in neurons and 
cocultures compared to astrocytes.  
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Figure 3.3.4: The formation of [4,5-13C2]glutamate via pyruvate recycling 
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Fig. 3.3.5: Coupling pattern in aspartate (C-2 and C-3 position) 
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Representative 13C-NMR spectra of neurons incubated with 2 mM glutamine and 6 mM glucose for 24 hours 
(PCA extracts). This is an expanded region from the 13C-NMR spectrum in Figure 3.3.1 showing the C-3 and C-
2 positions in aspartate (Asp). 
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Another conformation of the metabolism of uniformly labelled glutamine through the 
TCA-cycle was the appearance of [3-13C]aspartate in neurons and cocultures, but not in 
astrocytes under control conditions (Fig. 3.3.9). However, while glucose deprivation resulted 
in a marginal increase in this isotopomer in astrocytes, neurons and cocultures showed a 
significant increase in the [3-13C]aspartate isotopomer (Fig.3.3.9). In this regard, Bakken et al. 
(1998) have also reported that exposure of astrocytes for 2 hours to uniformly labelled 
glutamate resulted in an increase of the 13C-enrichment in aspartate when glucose was omitted 
from the medium. These results confirm again that the metabolism of extracellular glutamine 
through the TCA-cycle is more pronounced in neurons compared to astrocytes, in particular, 
if glucose supply is limited.  
 
Figure 3.3.6: 13C-NMR spectra of neurons, astrocytes, and cocultures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative 13C-NMR spectra of PCA extracts of neurons (A), astrocytes (B), and cocultures (C) incubated 
for 24 hours in media containing 0.5 mM [U-13C5]glutamine, 1.5 mM unlabelled glutamine and 6 mM unlabelled 
glucose. Peak assignments: Asp, aspartate; GABA; γ-aminobutyric acid; Gln, glutamine; Glu, glutamate. 
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Another interesting observation was the appearance of [4,5-13C2]glutamate isotopomer in 
neurons under hypoglycemic conditions (Fig. 3.3.10). Considering the biochemical pathways 
described above, this isotopomer of glutamate can arise only through the pyruvate recycling, 
proposed by Cerdan et al. (1990) to take place in neurons in the rat brain. However, some 
investigations in primary cell cultures do not support with this hypothesis and report that 
pyruvate recycling occurs in astrocytes only (Waagepetersen et al., 2002). The data of the 
present study show that this cycle is not active in neurons, whereas astrocytes and cocultures 
exhibit a minor turnover of this cycle under control conditions (Fig. 3.3.10). In addition, this 
result corresponds to in vitro studies in which it has been shown that the first part of pyruvate 
recycling, namely pyruvate formation from TCA-cycle intermediates, takes place in 
astrocytes (Sonnewald et al., 1996; Waagepetersen et al., 2002). 
 
Figure 3.3.7: 1H-NMR spectra of PCA extracts  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative 1H-NMR spectra of PCA extracts of neurons (A), astrocytes (B), and cocultures (C) incubated for 
24 hours in BME (neurons) or DMEM (cocultures and astrocytes) containing 0.5 mM [U-13C5]glutamine, 1.5 
mM unlabelled glutamine and 6 mM unlabelled glucose. Peak assignments: Ala, alanine; Lac, lactate; NAA, N-
acetyl-aspartate; GABA, γ-aminobutyric acid; Glu, glutamate; Gln, glutamine; Suc, succinate; PCr/Cr, 
(Phospho)creatine; Cho, choline; HTau, hypotaurine; Tau, taurine; Gly, glycine; myo-Ins, myo-inositol. 
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Figure 3.3.8: Concentrations of [1,2,3-13C3]glutamate  (PCA extracts) 
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The amounts of 13C (nmol/mg protein) in [1,2,3-13C3]glutamate were calculated from 1H and 13C-NMR spectra 
obtained from cell extracts after 24 h incubation of neurons, astrocytes, and cocultures with media containing 
0.5 mM [U-13C5]glutamine and 1.5 mM unlabelled glutamine in the presence (control) or absence of 6 mM [1-
13C]glucose and after treatment with 5 mM NH4Cl. The values represent means ± SD of three individual 
experiments.  
 
Figure 3.3.9: Concentrations of [3-13C]aspartate 
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The amounts of  [3-13C]aspartate (nmol/mg protein) were calculated from 1H and 13C-NMR spectra obtained 
from PCA extracts after 24 h incubation of neurons, astrocytes, and cocultures with media containing 0.5 mM 
[U-13C5]glutamine and 1.5 mM unlabelled glutamine in the presence (control) or absence of 6 mM [1-
13C]glucose and after treatment with 5 mM NH4Cl. The values represent means ± SD of three individual 
experiments.  
 
 
In contrast to hyperammonemia, which caused no significant alterations in the de novo 
synthesis of [4,5-13C2]glutamate in any of the neural cell cultures, hypoglycemia resulted in a 
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significantly increased de novo synthesis of this isotopomer in astrocytes and cocultures (to 
478% and 450% of control (P<0.001), respectively). Interestingly, we could show for the first 
time a remarkable de novo synthesis of neuronal [4,5-13C2]glutamate (to 580% of control, 
P<0.001) in the absence of exogenous glucose, demonstrating active pyruvate recycling in 
neurons under hypoglycemic conditions. The pyruvate recycling in neurons may be very 
important for their mitochondrial oxidative metabolism under conditions in which glucose 
availability and/or glycolytic activity are impaired. 
 
Figure 3.3.10: Concentrations of [4,5-13C2]glutamate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The amounts of [4,5-13C2]glutamate (nmol/mg protein) were calculated from 1H and 13C-NMR spectra obtained 
from PCA extracts of neurons, astrocytes, and cocultures after 24 h incubation with media containing 0.5 mM 
[U-13C5]glutamine and 1.5 mM unlabelled glutamine in the presence (control) or absence of 6 mM [1-
13C]glucose and after treatment with 5 mM NH4Cl. The values represent means ± SD of three individual 
experiments.  
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3.3.3  Energy status 
 
3.3.3.1  Alteration of the cellular energy status under hypoglycemia 
 
The absolute concentrations of high energy phosphates such as adenosine di- and 
triphosphate (ADP and ATP), and phosphocreatine (PCr), quantified from 31P-NMR spectra 
of PCA extracts from cultured neurons, astrocytes, and cocultures under control and 
hypoglycemic conditions, are presented in Figures 3.3.11 and 3.3.12.  
The data of the present study show that the deprivation of glucose from the neuronal 
medium for 24 hours does not cause any significant alterations of NTP. PCr decreased only to 
85% of control (P<0.01). In contrast, astrocytes and cocultures exhibit a considerably 
decrease in the levels of both NTP (to 63% and 82% of control; P<0.001, respectively) and 
PCr (to 17% and 24% of control; P<0.001, respectively) (Fig. 3.3.11). Under control 
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conditions, the PCr/NTP ratio was 2 times higher in astrocytes compared to neurons, whereas 
this value was reduced to 1.4 after glucose deprivation. This behaviour of astrocytes reflects 
the buffering of the NTP level at the expense of PCr, which does not occur to a significant 
degree in neurons.  
 
Figure 3.3.11: Effect of hypoglycemia on high-energy phosphates 
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The concentrations of high-energy phosphates were calculated by integration of the respective signals in 31P- 
and 1H-NMR spectra after 24 h incubation of neurons, astrocytes, and cocultures with media containing 0.5 mM 
[U-13C5]glutamine and 1.5 mM unlabelled glutamine in the presence (control) or absence of 6 mM [1-
13C]glucose. The values are given as % of controls and represent means ± SD of three individual experiments. 
 
 
A higher reduction in the energy status of astrocytes compared to neurons and cocultures 
under hypoglycemia may be partly due to more efficient glucose metabolism through 
glycolysis and subsequent lactate production in these cells under normoglycemic conditions. 
However, it has to be considered that the decreased energy status of the cells does not 
necessarily point to disturbed energy production via oxidative glucose metabolism (i.e. via 
glycolysis, and TCA-cycle). In particular, a decreased energy status can also occur by 
increased energy consumption under hypoglycemic conditions. Nevertheles, it was shown 
again that glutamine is an important energy substrate to replenish TCA-cycle intermediates. 
This was mainly observed in neurons, while the ability of glutamine to substitute for glucose 
was much less in astrocytes.  
 
 
3.3.4 Summary 
 
In conclusion, the results obtained using 13C-labelled glutamine further confirm that 
exogenous glutamine is not only a precursor for neurotransmitter glutamate, but also enters 
Chapter 3: Results and Discussion  75  
the TCA-cycle as mitochondrial energy substrate, a process which may have a much higher in 
vivo impact on brain energy metabolism under physiological and pathophysiological 
conditions than previously suggested. Most importantly, neuronal glucose metabolism 
strongly dependens on the supply of glutamine, whereas it is of minor importance for 
astrocytic glucose metabolism. In particular, neurons rely partly on astrocytic released 
glutamine for their mitochondrial energy metabolism. An interesting result was that pyruvate 
recycling takes place not only in astrocytes, but also in neurons under hypoglycemia. This 
might be of great importance in situations in which the supply of pyruvate is limited. 
 
Figure 3.3.12: 31P-NMR spectra of cortical neurons and astrocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31P-NMR spectra of perchloric acid extracts of neurons and astrocytes incubated for 24 hours with media 
containing 0.5 mM [U-13C5]glutamine and 1.5 mM unlabelled glutamine in the presence (control; A and C) or 
absence of 6 mM [1-13C]glucose (B and D). Peak assignments: NTP, nucleoside triphosphate; NDP nucleoside 
diphosphate; PCr, phosphocreatine. 
(ppm) 
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3.4    Immunohistochemical study on GS and LDH-1  
                   in lateral globus pallidus (LGP) 
 and frontal cortex (FC) after manganese treatment 
 
3.4.1   Introduction 
  
Previous studies using T1-weighted Magnetic Resonance Imaging (MRI) and neutron 
activation analysis have shown that an accumulation of manganese in the brain of cirrhotic 
patients occurs region-selectively with concentrations being highest in lateral globus pallidus 
(LGP) followed by putamen, caudate nucleus, and frontal cortex (FC) (Rose et al., 1999). In 
addition, direct measurements in LGP obtained at autopsy from cirrhotic patients who died of 
hepatic coma revealed 2- to 7-fold increases of manganese concentrations (Layrargues et al., 
1998). Similar increases of brain manganese were observed in experimental animals with HA 
due to chronic liver impairment after portal-systemic shunting (Rose et al., 1999). Recent 
studies using NMR spectroscopy have shown that sub-acute manganese exposure inhibited 
the astrocytic synthesis and release of glutamine (Zwingmann et al., 2003, 2004b). However, 
in the present study, we could show that manganese causes a significant increase in the 
expression of GS in astrocyte cultures (results not shown). Moreover, it was reported that 
manganese stimulates anaerobic glucose metabolism via glycolysis and lactate synthesis in 
astrocytes.  The synthesis and degradation of lactate is catalyzed by the action of lactate 
dehydrogenase (LDH, EC 1.1.1.27) isoenzyme. LDH exists in two distinct isoforms, namely 
LDH-1 and LDH-5. The formation of pyruvate from lactate is catalyzed by the LDH-1 
isoform localized in both neurons and astrocytes, while the LDH-5 isoform catalysing the 
formation of lactate from pyruvate localized mainly in astrocytes (Bittar et al., 1996). 
Previous studies reported a decreased glutamine- and an increased lactate synthesis after 
manganese treatment. One important question remains, whether manganese accumulation 
affects region-selectively on GS- and LDH-1 expressions. Therefore, the aim of this study 
was to obtain more information on the expression of GS and LDH-1 in the LGP and the FC, 
in which the highest and lowest amounts of manganese were reported (Rose et al., 1999). For 
the purposes of this study, the rats were injected with MnCl2 (50 mg/kg/day; i.p.) for 4 days. 
After isolation of both brain regions, e.g. the LGP and the FC, the protein- and mRNA 
expressions of GS and LDH-1 were analyzed using Western blotting and RT-PCR, 
respectively. The distributions of both enzymes were determined using immunohistochemical 
analysis. 
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3.4.2 Effect of manganese on GS in LGP and FC 
 
The brain sections were analyzed by immunohistochemical staining described in material 
and methods (page 103) for GS localized in astrocytes and for LDH-1 localized in both 
astrocytes and neurons. 
 
Figure 3.4.1: Immunohistochemical staining of GS protein in LGP and FC 
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Immunohistochemical staining of astrocytic glutamine synthetase (GS) protein. The rats were injected with 50 
mg/kg/day MnCl2 for 4 days. After perfusion with formaline, brains were cut using a Vibratome at 40 µM 
thickness (A; 1.25X objective). The sections were stained with diamine benzidine (DAB) after incubation with 
monoclonal primary and secondary antibodies of GS. Stained GS in astrocytes in frontal cortex of controls (B) 
or after treatment with MnCl2 (C), (B and C; 40X objective). Stained GS in astrocytes in lateral globus pallidus 
of controls (D) or after treatment with MnCl2 (E), (D and E; 40X objective). 
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As shown in Figure 3.4.1, GS shows astrocytic immunoreactivity in all sections. 
Manganese caused an increase in GS staining of astrocytes, particularly in LGP (Fig. 3.4.1 D 
and E). In contrast, the astrocytes of the FC (Fig. 3.4.1 B and C) show no obvious alterations 
in GS staining. The exact reason for this effect is not yet known, and it can only be 
speculated. However, it is suggested from these results that the increased GS staining in LGP 
is related to a prominent manganese accumulation in LGP compared to FC. This may be due 
to stimulated mRNA expression of GS and/or increased half life time of GS protein. 
 
 
3.4.3   Effect of manganese on LDH-1 in LGP and FC 
 
In the present study, brain sections show neural staining in LGP (Fig. 3.4.2 D and E) and 
axonal processes in the FC (Fig. 3.4.2 B and C). As can be seen from the pictures, manganese 
treatment caused a remarkably decrease of LDH-1 staining only in LGP. According to the 
size of the cells, it is obvious that both astrocytic (10 µm) and neuronal (16 µm) cells are 
stained.  
The decreased staining of LDH-1 in LGP after manganese treatment suggests a decreased 
amount of LDH-1 isoenzymes in this brain region. This may be due to an inhibitory effect 
ofmanganese on mRNA expression of this enzyme. For examination of this hypothesis, the 
expression of LDH-1 was investigated using Western blotting and RT-PCR. 
 
 
3.4.4 Summary 
 
Results of the present study show that manganese causes a significant increase in GS 
staining in astrocytes of the LGP. According to previous studies demonstrating a higher 
accumulation of manganese in LGP compared to FC (Krieger et al., 1995; Rose et al., 1999), 
the increased GS staining in LGP might be related to prominent manganese accumulation in 
LGP compared to FC. This may be due to stimulated mRNA expression of GS and/or 
increased half life of GS protein. 
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Figure 3.4.2.: Immunohistochemical staining of LDH-1 protein in LGP and FC 
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Immunohistochemical staining of the lactate dehydrogenase isoenzyme (LDH-1). The rats were injected with 50 
mg/kg/day MnCl2 for 4 days. After perfusion with formaline, brains were cut using Vibratome at 40 µM thickness 
(A; 1.25X objectives). The sections were stained with diamine benzidine (DAB) after incubation with monoclonal 
primary and secondary antibodies of LDH-1. Stained axonal processes in frontal cortex of controls (B) or after 
treatment with MnCl2 (C), (B and C; 40X objective). Stained cells in lateral globus pallidus of controls (D) or 
after treatment with MnCl2 (E). (D and E; 40X objective) 
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3.5 Western blot- and RT-PCR-analysis on the 
expressions of GS and LDH-1 in LGP and FC 
after manganese treatment 
 
3.5.1 Effect of manganese on GS expression in LGP and FC 
 
In order to assess the alterations of GS expression after manganese treatment, the effect of 
manganese on GS expression using Western blot analysis as well as on GS mRNA expression 
using RT-PCR in LGP and FC were analyzed (see chapter 4, page 107).  
 
Figure 3.5.1: Effect of manganese on GS expression in LGP and FC after manganese 
treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GS protein expression in LGP (A) and FC (B) of rat brains: The homogenates of both brain regions were probed 
by Western blotting with a monoclonal antibody against GS. Lanes 1-5: sham-operated controls, lanes 6-10: 
manganese (50 mg/kg/day MnCl2 was injected for 4 days). A schematic presentation of the data is shown in 
panel (C). The values represent means ± SD of five individual experiments. (#, significantly different from 
controls;* P < 0.05; ANOV; ns,  not significant). 
 
Consistent with immunohistochemical data, the results from Western blot analysis show an 
increase of GS protein in LGP (117% of control; P<0.01), while no significant alterations 
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were found in FC (104% of control; ns) (Fig. 3.5.1). This may be due to higher accumulation 
of manganese in the LGP compared to FC and a stimulatory effect of manganese on the 
expression of GS in this brain region. 
 
The data from RT-PCR analysis revealed a significant 135% increase (P<0.01) of GS mRNA 
in LGP (Fig. 3.5.2). The alteration of GS mRNA in FC was not significant (result not shown). 
These findings correspond well with the results obtained using Western blot analysis, 
indicating a stimulatory effect of manganese on GS mRNA expression in the brain region, in 
which the highest amount of manganese accumulate, e.g. in LGP exists. 
 
Figure 3.5.2: Expression of GS mRNA in lateral globus pallidus (LPG) 
 
 
 
 
 
 
 
 
 
Increased expression of GS mRNA in the lateral globus pallidus (LGP) of rats injected with 50 mg/kg/ day 
MnCl2   for 4 days. Total RNA was extracted from the LGP of rats under control conditions (lanes 9-14) or after 
managese treatment (lanes 3-8). GS was reverse-transcribed and amplified by PCR for 20 cycles. Lane 1: 
molecular weight standards (bp); lane 2: AMV reverse transcriptase was omitted (as a negative control) from 
the reaction mixture. 
 
 
3.5.2  Effect of manganese on LDH-1 expression in LGP and FC 
 
Results of previous NMR studies have shown that treatment of rats with 50 mg/kg/day 
MnCl2 for 4 days resulted in significantly increased de novo synthesis of lactate. This may 
lead to lactacidosis in the brain (Zwingmann et al., 2004b). The results in the present study 
using Western blot analysis add a new dimension to this issue, i.e. manganese exposure (4 
days; 50 mg/kg) resulted in a decrease of LDH-1 protein content in LGP (85%; P<0.05) while 
no significant alterations could be observed in FC (Fig. 3.5.3). This may be partly due to an 
inhibitory effect of manganese on LDH-1 expression in LGP. 
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Figure 3.5.3: Effect of manganese on LDH-1 expression in LGP and FC 
 
 
 
 
 
 
 
LDH-1 protein content in LGP (A) and FC (B) of brain rats: The homogenates of both brain regions were 
probed by Western blot analysis with a monoclonal antibody against LDH-1. Lanes 1-6: sham-operated 
controls, lanes 7-12: after treatment with manganese (50 mg/kg/day MnCl2   injection for 4 days). 
 
 
Hazell et al., (1999b) showed that manganese induced a stimulation of glycolysis in 
astrocytes at the level of the glycolytic enzyme glyceraldehyde-3-phosphate (GAPDH). On 
the other hand, the stimulated lactate production, observed in that study, may be responsible 
for the regeneration of NAD+ required for the maintenance of glycolysis under manganese 
treatment. Since LDH-1 is responsible for the consumption of lactate in the brain, an 
inhibition of LDH-1 expression after manganese treatment, observed in the present study, 
may also contribute to the accumulation of lactate in the brain, particularly in LGP. The 
accumulation of lactate, on the other hand, may result in lactaic acidosis of the brain, which 
may represent an important factor contributing to disordered neural energy metabolism. 
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3.5.3 Summary 
 
Taken together, the results from the present study, obtained with molecular biologic methods, 
demonstrate that manganese exerts a stimulating effect on GS mRNA expression and an 
inhibitory effect on LDH-1 expression in LGP, which may be due to a higher accumulation of 
manganese in this brain region. However, the exact mechanism(s) responsible for the 
increased GS expression and decreased LDH-1 expression are not yet known. These studies 
place high priority for further investigations on this issue. 
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3.6 Conclusion and perspectives 
 
In the first part of this study, the effects of ammonia and glutamine, which are essential 
components of the glutamine-glutamate cycle, were investigated on astrocytic and neuronal 
metabolic processes, i.e. on glucose- and energy metabolism as well as on ammonia 
detoxification processes. In the second part of this study, the effect of manganese on 
astrocytic and neuronal enzyme expressions, namely of the expression of glutamine 
synthetase (GS) and lactate dehydrogenase (LDH-1) was studied. 
 
The main findings of ammonia-induced alterations in astrocytic and neuronal cells are: 
¾ stimulation of glucose metabolism through glycolysis and the TCA-cycle. 
¾ stimulation of glutamate synthesis in both cell types. 
¾ stimulation of glutamine synthesis in astrocytes. 
¾ stimulation of aspartate and alanine synthesis in both cell types. 
¾ stimulation of astrocytic GS protein expression. 
¾ inhibition of astrocytic GFAP protein expression. 
¾ decrease of the energy-status in astrocytes, but not in neurons. 
 
 The main findings of glutamine-induced alterations in astrocytic and neuronal cells are: 
¾ stimulation of the TCA-cycle activity. 
¾ stimulation of glucose metabolism through glycolysis and the TCA-cycle. 
¾  stimulation of aminotransferases, e.g. alanine aminotransferase (ALAT) and aspartate 
aminotransferase (AAT).  
 
Ammonia as an important nitrogen source is required for various metabolic processes. 
However, high concentrations of ammonia are neurotoxic, and deteriorate the normal brain 
function. It is believed that hyperammonemia (HA) is an important cause of the cerebral 
dysfuntion in Hepatic Encephalopathy (HE) (Cooper and Plum, 1987). The first studies on 
HA began a century ago by Pavlov and co-workers (Hahn et al., 1893). Numerous studies 
using animal models (under hyperammonemic conditions) and patients with liver failure have 
been performed. Three main hypotheses exist: i) disturbed neurotransmitter metabolism, ii) 
impaired brain energy-metabolism, and iii) disordered cellular volume regulation. However, 
the exact pathophysiological effects of ammonia on cerebral metabolism and its molecular 
mechanism(s) are not yet well understood. In this chapter, the results of the present study will 
be discussed with regard to the three main hypotheses. 
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Since glucose metabolism is involved in the synthesis of glutamate, the main excitatory 
neurotransmitter, a stimulation of glucose metabolism, observed under hyperammonemic 
conditions, is potentially able to affect the glutamatergic neurotransmission. An increase of 
glutamate de novo synthesis and release as well as an inhibition of glutamate uptake after 
ammonia treatment will cause neurotoxic effect of glutamate due to a high extracellular 
glutamate concentration. The glutamate transporters, which are responsible for the uptake and 
release of glutamate, are involved in the glutamatergic neurotransmission. Therefore, it is 
reasonable to assume that ammonia-induced alterations of glutamate transporters might also 
be implicated in  the neurotoxicity of HA. In this context, extensive studies have been 
performed over the last decade. The investigations on the glutamate transporters in both 
cultured neurons and astrocytes demonstrated a significant suppression of the high affinity 
uptake of glutamate following exposure to ammonia (Chan et al., 2003). This might be a 
reason for the accumulation of extracellular glutamate, which might exert the neurotoxic 
effect on brain cells. However, the questions how and via which mechanism(s) increased 
extracellular glutamate may exert the neurotoxic effect on brain cells are not yet understood.  
Previous studies suggested that elevated extracellular glutamate due to acute ammonia 
toxicity is mediated by an activation of the NMDA receptor (Felipo et al., 1998), leading to a 
high intracellular Ca2+ concentration, which will subsequently initiate different intracellular 
events through the signal transduction pathways. Furthermore, the activation of the NMDA 
receptor may result in an activation of the Na+/K+-ATPase via the activation of calcineurin 
and protein kinase C (Monfort et al., 2002). The stimulation of the Na+/K+-ATPase causes 
increasing potassium uptake (Kala et al., 2000), which may affect signal transduction 
pathways and subsequently neuronal excitability in hyperammonemic syndromes.  
Although the results of this studies show a remarkable stimulation of glucose metabolism 
via glycolysis and the TCA-cycle in both cell types, the energy state is impaired in astrocytes. 
This might be due to a stimulation of energy consuming processes and/or an inhibition of 
oxidative phosphorylation under hyperammonemic conditions. However, the results obtained 
from in vitro and in vivo studies are controversial. This may be due to different experimental 
conditions. 
Another hypothesis concerns ammonia-induced cell swelling. The increased cell volume 
(cell swelling) of astrocytes is suggested to be an important factor in the pathogenesis of HE. 
The increased glutamine synthesis under hyperammonemic conditions might be responsible 
for the cell swelling and consequently brain edema. As the accumulation of intracellular 
glutamine, an organic osmolyte, will increase the intracellular osmolarity and subsequently 
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the uptake of water in the astrocytes. However, the mechanism(s) leading to brain swelling 
under hyperammonemic conditions seem to be far more complicated.  
 
The main findings of manganese induced alterations in astrocytic and neuronal cells are: 
¾ stimulation of astrocytic GS protein expression in lateral globus pallidus (LGP). 
¾ inhibition of neural LDH-1 expression in LGP. 
 
Manganese is an essential element and a co-factor or activator of key enzymes of cerebral 
metabolism. However, an accumulation of manganese, observed in different brain regions of 
cirrhotic patients (Pujol et al., 1993), is neurotoxic. Recent evidences suggest that astrocytes 
are a site of early dysfunction in manganism, since manganese accumulates primarily in 
astrocytes (Aschner et al., 1999). However, the results of this study demonstrate that 
manganese accumulates in both astrocytes and neurons as evident from changing in 
immunohistochemical staining of GS in astrocytes and of LDH-1 in both cell types after 
manganese treatment. Aschner et al. (1999) reported that the function of GS depends on the 
presence of manganese. In addition, GS accounts for approximately 80% of total manganese 
in brain (Erikson and Aschner, 2002). The results of this study demonstrate that manganese 
stimulates the expression of GS and inhibits the expression of LDH-1. The high expression of 
GS may result in an increased synthesis of glutamine from glutamate. This is an energy 
consuming process leading consequently to a decrease of ATP-levels. On the other hand, the 
inhibition of LDH-1, which is responsible for the conversion of lactate to pyruvate, may cause 
lactatic acidosis in the brain. Over the last decade, several investigations were performed on 
the effect of manganese on neural physiological processes. In this context, it has been 
reported that increased brain manganese levels induce oxidative stress, as well as alterations 
of neurotransmitter metabolism (Erikson and Aschner, 2002). One important mechanisms, in 
which manganese can produce oxidative stress in the brain, is the interference with 
mitochondrial respiration (Wedler and Toms, 1986). Since mitochondrial function is tightly 
coupled to cellular energy production, disordered brain energy metabolism may be a central 
feature of manganese neurotoxicity. Gavin et al. (1992, 1999) demonstrated a direct 
interference of manganese with oxidative phosphorylation, most likely by binding to the F1-
ATPase and to the NADH dehydrogenase complex. In addition, results of other investigators 
point to an indirect secondary excitotoxic process of manganese mediated by NMDA receptor 
activation (Brouillet et al., 1993; Cano et al., 1996). However, the mechanisms of manganese 
neurotoxicity still remain unclear.  In this regard, the results of the present study extend 
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previous investigations. In particular, the inhibition of LDH-1 might not only cause cerebral 
acidosis, but also metabolic impairments due to a decrease use of lactate as an energy 
substrate.  
 
Some important questions regarding HA and manganese remain, which must be studied in 
detail: 
Which molecular mechanism(s) are responsible for the neurotoxic effect of ammonia and 
manganese? How affects an accumulation of ammonia and manganese the mitochondrial 
function? How accumulates manganese under hyperammonemic conditions? Is there a 
relationship between the neurotoxic effect of HA and manganese accumulation? 
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Chapter 4 
 
 
 
4 Experimental Methods 
 
 
The NMR spectroscopic studies were carried out in the laboratory of Instrumentelle 
Analytik (Universität Bremen) under the supervision of Prof. Dr. Dieter Leibfritz. The 
molecular biological methods (Western blotting, immunohistochemistry and RT-PCR) were 
performed in the laboratory of Molecular Neurobiology (University of Montreal, Department 
of Medicine, Hospital Saint-Luc, Montreal, Quebec, Canada) under the supervision of Dr. 
Alan Hazell.  
 
 
4.1 Cell Culture 
 
4.1.1. Introduction 
 
Cell cultures are used as a model to investigate chemical and biological processes of cells 
in vitro. Using cell cultures, we are able to study individual cells and to differentiate between 
extra and intracellular metabolites in different cells of an organ, e.g. neuronal and glial cells in 
the brain. Moreover, cell culture provides a suitable model to obtain detailed insight into cell-
specific metabolism under physiological and pathological conditions. By varying the 
preparation methods and culture conditions, different cell types, i.e. neuronal and glial cells 
can be obtained (Booher and Sensenbrenner, 1972; McCarthy and de Vellis, 1980). The first 
neural culture system was developed by Harrison (1907). Since then, various cell cultures 
techniques have been developed in order to to study the characteristic features of neural cells 
(for example cell-type specific metabolism). These in vitro studies include the favoured use of 
primary cultures of astrocytes and neurons as well as cocultures of both cell types. 
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4.1.2 Primary cell cultures 
 
4.1.2.1  Introduction 
 
Definition. Primary cultures are obtained directly from the living animal and maintained in 
culture for at least 24 hours (Fedoroff, 1977). Primary cells can be obtained in high yield and 
high purity (>90%). Depending on the preparation technique, the area of the brain, and the 
developmental age of the animal, individual neural cells, e.g. neurons or astrocytes, can be 
cultivated.  
i) The preparation technique is an important factor to enrich individual cell types of the 
brain. For example, by varying the dissociation techniques and culture conditions (e.g. the 
surface of culture dishes, or the composition and serum content of the culture medium) 
different cell types (for example neurons, astrocytes, or oligodendrocytes) can be enriched 
(McCarthy and de Vellis, 1980; Richter-Landesberg and Heinrich, 1995; Heinrich et al., 
1999; Richter-Landesberg, 2000).  
ii) The area of the brain, from which astrocytes or neurons are isolated, plays a key role 
for the isolation and purification of different neural cell types. For example, GABAergic 
neurons are associated with neurons from the cerebral cortex, while glutamatergic neurons are 
obtained from the cerebellum.  
iii) The developmental age of the animal, at which astrozytes and neurons are isolated, is 
very important. For example, during ontogeny, the brain stem matures prior to the cerebellum, 
and neurons develop and become postmitotic (pertaining to the cells that stop dividing after 
reaching maturity) before glial cells proliferate. 
 
4.1.2.2 Preparation of cortical astrocytes 
  
Chemicals Materials 
DMEM (Dulbecco´s Modified Eagle Medium) Pipettes (2, 5, 100, 200, 1000 ml) 
FBS (fetal bovine serum) 10% Pasture pipettes 
Penicillin/streptomycine 1% Scissor 
Ethanol (70%, v/v) Curved forceps 
     Tweezers 
 Petri dishes (10 cm) 
 Centrifuge tubes (10 and 50 ml)  
 Laminar flow hood 
 Centrifuge 
 Vortex 
 Nylon filters (10 and 80 µm) 
 Incubator 
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Primary cortical astrocytes were obtained from 1-2-day old Wistar rats in two steps. 
 
1. MACRO DISSECTION: The rats were killed by decapitation with a scissor. The head 
skin was opened with the same scissor at the midline of the head across the ears and eyes, and 
cut from the base of the skull to the mid-eye area. Using curved forceps and applying slight 
pressure, the raised skull cap was removed. The cortex was taken out from the skull cavity by 
running the spatula underneath and along the length of the brain from the olfactory lobes to 
the beginning of the spinal cord (thickness ca. 2-3 mm). After the olfactory bulb, the superior 
colliculus, the cerebellum, and the brain stem were removed, the brain (cortex) was rapidly 
placed in sterile 10 mm dishes containing DMEM (10% FBS, 1% P/S) and splitted into two 
hemispheres. 
2. MICRO DISSECTION: The cerebral hemispheres in the petri dish were steadied with a 
forcep and separated by gently teasing along the midline fissure with the sharp edge of a 
second forcep. The meninges containing also the blood vessels were carefully peeled from the 
cortical lobes with fine forceps. The tissues were first cutted using a scissor and then placed 
into a 10 mL centrifuge tube containing 5 ml fresh DMEM (10% FBS, 1% P/S). The tissue 
was suspended gently with a 2 ml pipette (approximately 10 times), and then with a long, at 
the top slightly fused, Pasteur pipette (approximately 30 times). The cell suspension was 
centrifuged at 800 x g (2000 rpm) for 5 minutes, and then vortexed for 2 minutes. The 
suspension was again centrifuged at 800 x g (2000 rpm) for 5 minutes. The cells were filtered 
through a 80 µm Nylon filter and centrifuged at 800 x g (2000 rpm) for 5 minutes. The upper 
phase was removed and the pellet suspended first with 3 ml, and then 5 ml cold DMEM (10% 
FBS, 1% P/S). The fine suspended homogenates were filtered through a 10 µm Nylon filter 
on ice. An adequate amount of DMEM was added to the cells (one brain for two 10 mm petri 
dish with each 7 ml DMEM medium). The cultures were kept in an incubator with a 
humidified atmosphere of 10% CO2 in air at 37°C. After 24 hours, the medium was replaced 
by fresh DMEM (10% FBS, 1% P/S). The culture medium was replaced by fresh DMEM 
(10% FBS, 1% P/S) every 2-3 days. The primary cortical astrocytes were cultured for at least 
2-3 weeks until the cultures have become confluent. 
 
 
4.1.2.3  Preparation of cortical neurons (GABAergic neurons) 
 
Chemicals Materials 
BME (Basal Medium)                                            Pipettes (2, 5, 100, 200, 1000 ml) 
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FBS (fetal bovine serum) 10 and 0.5% Pasture pipettes 
Penicillin/streptomycine 1% Scissor 
Ethanol (70%, v/v) Small bent forceps 
Isoflurane or chloroform   Tweezers 
Poly-L-lysine Petri dishes (10 cm) 
 Centrifuge tubes (10 and 50 ml)  
 Laminar flow hood 
 Centrifuge 
 Vortex 
 Incubator 
 Flask (100 ml) 
 
 
The basic strategy for the preparation of primary neurons is to isolate them from the 
cerebrum at a developmental stage when large numbers of neurons have just entered their 
postmitotic stage of differentiation and only a few proliferative glial precursors are present 
(Richter-Landsberg, 1988). The embryonic age should be known accurately (i.e. use of time 
mated rats), and this should be the 17th embryonal day (E17). The small percentage of non-
neuronal cells is eliminated during the cultivation in a chemically-defined, low serum 
containing medium, which is different from the medium used for primary astrocytes. The 
preparation of neuronal cultures is somewhat similar to the astrocytes since both cell types are 
selected directly from cells present in the initial cell suspension and do not require an 
intermittent purification procedure. 
 
The pregnant rats (16-17 day) were anaesthetized in a glass chamber with chloroform or 
isoflurane for 2-3 minutes. When respiration ceased, the rat was placed back on a bench, and 
killed by cervical dislocation. The coat of the abdomen was sprayed with ethanol (70%, v/v), 
and carefully incised vertically with scissors to reveal abdominal contents, which was then 
extended bilaterally to flanks. In order to avoid contamination, the peritoneum was opened 
only by a second cut, after which the abdomen was exposed. The string of embryos was lifted 
up with forceps and the placental surfaces were removed from the mother and opened with a 
median cut. Both uterus lines containing the fetuses were transferred into sterile 10 cm culture 
dishes. The following preparation steps were performed under steril conditions under a 
laminar flow hood. The embryonic sac was opened at the dorsal side; the amniotic skin was 
dissected with a small, curved, and sharp scissor. The embryos were separated from the 
juniculus, and displaced in a new 10 cm petri dish. The embryo was putted on its side, and 
skin and skull of the dorsal part of the head were removed. Using small bent forceps, that 
Chapter 4: Experimental Methods  91  
have blunt tips, the brain was carefully pushed out of the skull by incision from the eye 
through the mouth up to the ventral mesencephalic flexure. The hemispheres were transferred 
into a 10 ml centrifuge tube containing 2 ml BME (10% FBS, 1% P/S). After that, a single 
cell suspension was prepared. The collective tissues of the embryonic brains from one 
pregnant rat were dissociated by mild trituration (10-20 times) with a long, fire-polished 
Pasteur pipette. The single cell suspension was filled up with further 4-5 ml BME (10% FBS, 
1% P/S) and centrifuged at 800 x g for 5 min. This cell wash procedure was repeated once, 
whereby the supernatant was discarded, the pellet resuspended in 2 ml BME (10% FBS, 1% 
P/S), and centrifuged at 800 x g for 5 min. The dissociated cells were resuspended in 1-2 ml 
medium and triturated again to optimize the dissociation. This cell suspension was transferred 
into a 100 ml flask and diluted with medium to the cell density considered for cultivation, i.e. 
5-6 ml medium for each brain. After 5 min, the non-dissociated tissue was precipitated at the 
bottom of the flask. The supernatant cell suspension (5-6 ml for each brain) was carefully 
plated into previous prepared 10 cm dishes (one dish for each brain). Before, the dishes were 
coated with poly-L-lysine (enhances cell attachment to plastic and glass surfaces), and filled 
to 10 ml BME (10% FBS, 1% P/S). 2-4 hours after plating of the cells in culture dishes, the 
BME (FBS 10%, 1% P/S) was replaced by BME containing 0.5% FBS, and 1% P/S. Half of 
the medium was changed after three days. The cells were incubated and extracted for the 
experiments after four days in culture (10-13 dishes/brains for each NMR experiment). The 
cultures were kept in an incubator with a humidified atmosphere of 10 % CO2 in air at 37 °C. 
 
 
4.1.2.4 Preparation of cocultures (cortical astrocytes and neurons) 
 
For the preparation of cocultures consistent of astrocytes and neurons, astrocytes were first 
prepared and cultivated in DMEM (10% FBS, 1% P/S) as described in 4.1.2.2. Thereafter, 
neuronal cells were added immediately after preparation as described in 4.1.2.3, and 
cocultures were cultivated for 4 days as described for neuronal cells in 10 cm culture dishes. 
In cocultures, the number of individual cells was determined previously (Brand et al., 1997). 
The ratio of astrocytes/neurons was found to be 4:6 at the end of the experimental incubation. 
 
 
4.1.2.5  Test for culture purity 
 
Microscopy: The cells were identified by the morphological characteristics and intercellular 
associations under a light microscope. 
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Western blot analysis: The procedures were performed in the labratory of Dr. Alan Hazell 
(Molecular Neurobiology; University of Montreal, Hospital Saint-Luc, Quebec, Montreal, 
Canada). Astroglial and neuronal cultures were investigated for purity by specific marker 
proteins and immunoblotting, i.e. by GFAP and GS immunoreactivity. 
NMR spectroscopy: In 1H-NMR spectra, the concentrations of cell specific marker 
molecules, such as myo-inositol (myo-Ins), and hypotaurine (HTau), which are predominantly 
observed in astrocytes, and taurine (Tau), γ-aminobutyric acid (GABA), and N-acetyl-L-
aspartate (NAA) as neuronal markers, revealed the uniformity of an individual cell 
population.  
 
 
4.2 Analytical methods  
 
4.2.1  Introduction 
 
In line of this Ph.D. thesis, different analytical methods were performed such as NMR 
spectroscopy, Western blotting, Immunohistochemistry, and RT-PCR. For NMR 
measurements, the cells were extracted with perchloric acid (PCA). For Western blotting, we 
carried out the protein extraction using Radio-Immunoprecipitation Assay (RIPA) and for 
RT-PCR the RNA extraction using the Trizol (TRI) Reagent. The determination of the protein 
content was performed using the Lowry-Method as well as the Biuret-Method. 
 
 
4.2.2 Incubation conditions 
 
A serum-free medium DMEM without glucose or glutamine was used. Bevor incubation, the 
DMEM with 1% P/S and 5% FBS was prepared with defined amounts of substrates, e.g. 
glucose, glutamine, unlabelled or labelled with 13C, and further supplements, such as 
ammonia. After a defined incubation period (24 hours), the incubation media were removed. 
The cells were extracted using different methods, e.g. PCA-, RIPA-, and TRI-extraction. 
 
 
4.2.3 Extraction methods 
 
4.2.3.1   Perchloric acid extraction (PCA) 
 
Chemicals Materials 
NaCl (150 mM) Pipettes (2, 5, 100, 200, 1000 ml) 
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Liquid nitrogen Pasture pipette 
PCA (perchloric acid, 0.9 M) Rubber scratch 
KOH (0.1, 2, 8 M)      Centrifuge  
dd H2O (re-distilled Water) pH-Meter E512  
 Hg/Hg2Cl2-pH-Electrode  
 Ultrasonic bath  
 
 
After experimental incubation, the medium was removed from the cells. The cells were 
washed twice with 5 ml ice-cold isotonic NaCl (150 mM = saline), frozen in liquid nitrogen 
and extracted with 1 ml ice-cold perchloric acid (PCA, 0.9 M) per culture dish. The dishes 
were washed with 1 ml re-distilled water. The collected cell materials were sonicated for 5 
minutes in ultrasonic bath. The cell suspension was centrifuged at 4000 rpm for 10 minutes. 
The supernatant was separated from the protein precipitate, kept on ice, and neutralized with 8 
M and 0.1 M KOH. The remaining pellets containing all acid insoluble components were 
resuspended in H2O, neutralized to pH = 7, lyophilized, and used for hydrolysis and 
quantification of proteins. The supernatant was collected from the KClO4 precipitate by 
centrifugation, and lyophilized after freezing in liquid nitrogen. The removal of all protein 
after the first centrifugation step is critical because a number of enzymes survive the acid 
treatment at this low temperature. 
 
 
4.2.3.2 Protein extraction using RIPA 
 
Chemicals Materials 
PBS (phosphate-buffered saline) Pipettes (2, 5, 100, 200, 1000 ml) 
For (1 lit) 10X PBS; Pasture pipette 
80g NaCl Rubber scratch 
2g KCl Centrifuge  
14.4g Na2HPO4 Homogenizer  
2.4g KH2PO4 Ultrasonicator 
Tris-solution (10 mM, pH 7.5) 
PIC (protease inhibitor cocktail, 500:1 in isopropanol) 
RIPA solution (1%, cold)  
SDS (sodiumdodecylsulfate, 1%)   
PMSF (phenylmethylsulfonylfluoride) protease inhibitor 100:1 in isopropanol 
 
 
STEP 1: 
After the incubation, the medium was removed and the cells were washed twice with 5 ml 
cold 2X PBS. Then the cells were scraped with 1 ml cold 2X PBS, collected in 2 ml 
eppendorf tubes and centrifuged at 5000 rpm for 45 minutes at 4°C. The supernatant was 
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discarded completely and the pellet was frozen at – 80°C for approximately 10-15 minutes or 
overnight. The cells were defrosted at room temperature and homogenized with 100 µ Tris-
solution. After 45 minutes centrifugation at 12000 rpm and 4°C, the supernatants were 
removed. The pellet was frozen and stored at – 80°C. 
 
STEP 2: 
The frozen cells were homogenized with 100 µl solution A (2 ml RIPA + 0.02 g SDS + 4 
µl PIC + 20 µl PMSF) and transferred into 2ml eppendorf cups on ice. After homogenization 
of the cells using a homogenizator, the cells were sonicated for 2-3 seconds. The cell material 
was centrifuged at 12000 rpm, 4°C, for 45 minutes. The supernatant was transferred in new 
eppendorf cups for western blot analysis and the pellet was removed. 
 
 
4.2.3.3 RNA extraction using TRI reagent 
 
Chemicals Materials 
Trizol reagent Pipettes (2, 5, 100, 200, 1000 ml) 
Chloroform Eppendorf cups (2 ml) 
Isopropanol Rubber scratch 
Ethanol  Vortex 
Depc water (diethyl pyrocarbonate + H2O) Centrifuge  
 
The RNA extraction necessitates a precise handwork since the samples can be easily 
contaminated or degenerated. Therefore, it must be considered that all steps of extraction 
must be performed under sterile conditions on ice at all times. The RNA extraction using TRI 
reagent is carried out in 5 steps. 
 
1. Homogenization: The medium was removed and the cells (from one 10 cm culture dish) 
were combined with 1.0 ml Trizol reagent. After the cells were scratched and collected 
into 2 ml eppendorf cups, they were homogenized by vortexing for approximately 10 
seconds until the samples were completely homogeneous (looks like strawberry 
milkshake). 
2. Phase separation: 200 µl chloroform was added to each sample (200µl/ml Trizol) and 
shaked vigorously. Afterwards, the samples were centrifuged for 30 minutes at 12000 rpm 
and 4°C. The colourless, upper, aqueous phase was transferred into new eppendorf tubes, 
combined with 500µl isopropanol and shaked by vortexing for approximately 10 seconds. 
For RNA precipitation, the samples were stored at – 80°C for 2-3 hours. 
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3. RNA precipitation/collection: The samples were left at room temperature for several 
minutes to allow them to melt, and centrifuged subsequently at 4°C and 12000 rpm for 30 
minutes to collect the RNA pellet. 
4. RNA washing: The supernatant was decanted and the RNA pellet was washed with 75% 
ethanol/depc water (1ml/sample). 
5. RNA solubilization: The RNA pellet was dried for approximately 10 minutes. Then, it 
was resuspended in 21 µl depc water. 1 µl of each sample was used for protein 
determination and the rest was stored at – 80°C for RT-PCR.  
 
 
4.2.4  Protein determination methods 
 
4.2.4.1 UV/VIS spectroscopy 
 
A protein in solution can be quantitatively assayed by several spectrophotometric methods. 
Most methods are based on binding of a chromophore to specific amino acids or bonds in the 
protein. The resulting color development can be detected at specific wavelengths of the 
visible light. The protein determinations are dependent on the sensitivity of the assay and the 
relationship between absorbance (A) and protein concentration (Beer-Lambert Law). A plot 
of (A) vs protein concentration will be linear over a limited range of protein concentration 
depending on the protein and method used. The standard curve, produced by measuring the 
absorbance of protein solutions of known concentrations, can be used to estimate the protein 
concentration of an unknown solution. Standard curves are generated using purified proteins. 
Bovine serum albumine (BSA) is usually used for this purpose. A linear equation is calculated 
from the absorbance values of 4-6 different concentrations of the protein standard and used to 
calculate the protein concentration from the absorbance of the unknown solution.  
 
 
4.2.4.2 Protein determination (Lowry-method) 
 
Chemicals Materials 
CuSO4 . 5 H2O Pipettes (20, 100, 200, 1000 µl) 
KNa-tartrate . 4 H2O Eppendorf cups (2 ml) 
Na2CO3 Vortex 
NaOH Centrifuge  
Folin-Ciocalteay reagent UV-VIS spectrometer 
BSA (bovine serum albumine)  
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The Lowry method is very sensitive, and low protein concentrations can be measured 
(Lowry et al., 1951). The principle of the Lowry method is the reactivity of the peptide 
nitrogen[s] with the copper [II] ions under alkaline conditions and the subsequent reduction of 
the Folin-Ciocalteay phosphomolybdic phosphotungstic acid to heteropolymolybdenum blue 
by the copper-catalyzed oxidation of aromatic acids. The major disadvantage of the Lowry 
method is the narrow pH range within which it is accurate. However, using very small 
volumes of the added samples (1-2 µl) the pH of the reaction mixture remains constant. 
Performance: 2 µl of each sample was transferred to a 2 ml eppendorf cup and mixed with 
23 µl re-distilled water, 125 µl solution A, and 1 ml solution B (see blow). The mixture was 
shaked thoroughly by vortexing for 10 seconds. At the same time, the standard curve was 
measured using BSA (bovin serum albumine) (0-200 µg; duplicate determination). Within 10 
minutes, a violet-coloured complex was formed, and its absorbance was measured at λ = 750 
nm using an UV-VIS spectrometer. 
Composition of solution A and B. The solution A consists of 1% CuSO4 x 5 H2O and 1% 
KNa-tartrate x 4 H2O and 2% Na2CO3 in 0.1 N NaOH (1:1:98 (v:v:v)). The solution B 
consists of a Folin-Ciocalteay reagent with re-distilled water 1:1. 
 
 
4.2.4.3   Protein determination (Biuret-method) 
 
Chemicals Materials 
NaOH Pipettes (20, 100, 200, 1000 µl) 
Sodium citrate (Na3C6H5O7 x 2 H2O) Eppendorf cups (2 ml) 
Na2CO3 x 10 H2O Vortex 
CuSO4 x 5 H2O Centrifuge  
BSA (bovine serum albumine) 96 multiwells 
 Multiplate-Reader 
 UV-VIS spectrometer 
 
The Biuret method is used to measure high concentrations of proteins in solution (Goa, 
1953). The assay has a range of 1-5 mg protein/ml. The principle of the Biuret-method is 
based on the reaction of Cu2+ in an alkaline solution with the carbonyl and amino groups of 
peptide linkages in proteins forming a violet-coloured copper-protein complex. The intensity 
of the colour produced is proportional to the protein concentration measured by an UV-VIS 
spectrometer at 540 nm. The Biuret-method was applied for protein determination in neural 
cells after the PCA extraction. 
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Performance: The protein pellet was suspended in 1-3 ml 6% NaOH. From each sample, 50, 
100 and 150 µl were transformed into Eppendorf cups and diluted to 500 µl with re-distilled 
water. 500 µl 6% NaOH was added and the samples were mixed thoroughly by vortexing. 
Afterwards, 250 µl Biuret-reagent was added to each sample and mixed again. Within 30 
minutes, a violet-coloured complex consisted of copper (II) ion and protein was formed and 
measured by its VIS-absorption at λ = 540 nm in 96 multiwells with a Multiplate-Reader. In 
order to determine the protein content, a standard curve using BSA (bovine serum albumine) 
was determined (0-2000 µg; duplicate determination). 
Composition of the Biuret-reagent: 9.85 g sodium citrate x 2 H2O and 13.5 g sodium 
carbonate x 10 H2O were resolved in 25 ml H2O and 135 mg copper (II) sulfate x 5 H2O in 5 
ml H2O resolved. Both solutions were combined and filled up to 50 ml with re-distilled water. 
 
 
4.2.5 Western blot analysis 
 
4.2.5.1 Introdution 
 
Western blotting is a method used to quantifiy specific macromolecules such as proteins in 
a complex mixture, e.g. in the protein fraction obtained from cell extracts. This method uses a 
high-quality antibody directed against a desired protein. The Western blotting is based on a 
three-step approach performed over 3 days: 1) separation of the proteins by gel 
electrophoresis, 2) transfer of the separated proteins to a membrane, and 3) identification and 
quantification of a specific protein using labelled antibodies. 
Gel electrophoresis is a method that separates macromolecules such as nucleic acids or 
proteins on the basis of their size, electric charge, and other physical properties. The term 
electrophoresis describes the migration of charged particle under the influence of an electric 
field. Electro refers to the energy of electricity. Phoresis, from the Greek verb phoros, means 
"to carry across." Thus, gel electrophoresis refers to the technique in which molecules are 
forced across a span of gel, motivated by an electrical current. Activated electrodes at each 
end of the gel provide the driving force. The molecule's physical properties determine how 
rapidly an electric field can move the molecule through a gelatinous medium. Many important 
biological molecules such as amino acids, peptides, proteins, nucleotides, and nucleic acids, 
posses ionisable groups and, therefore, depending on the pH, exist in solution as electrically 
charged species either as cations (+) or anions (-). Depending on the nature of the net charge, 
the charged particles will migrate either to the cathode or to the anode. Separation of 
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macromolecules depends upon two forces: charge and mass. The electrical current from one 
electrode repels the molecules while the other electrode simultaneously attracts the molecules. 
The frictional force of the gel material acts as a "molecular sieve," separating the molecules 
by size. Their rate of migration through the electric field depends on the strength of the field, 
size and shape of the molecules, relative hydrophobicity of the samples, and on the ionic 
strength and temperature of the buffer in which the molecules are moving. After staining, the 
separated macromolecules in each lane can be seen in a series of bands spread from one end 
of the gel to the other.  
The Polyacrylamide Gel Electrophoresis (PAGE) technique was developed by Raymond 
and Weintraub (1959). Polyacrylamide gels may be prepared to provide a wide variety of 
electrophoretic conditions. The pore size of the gel can be varied to produce different 
molecular sieving effects for the separation of proteins with different sizes. By controlling the 
percentage of polyacrylamide (from 3% to 30%), precise pore sizes can be obtained, usually 
from 5 to 2,000 KDa. This is the ideal range for gene sequencing, protein, polypeptide, and 
enzyme analysis. Polyacrylamide gels can be cast in a single percentage or with varying 
gradients. Gradient gels provide continuous decrease in pore size from the top to the bottom 
of the gel, resulting in thin bands. Because of this banding effect, detailed genetic and 
molecular analysis can be performed on gradient polyacrylamide gels. Polyacrylamide gels 
offer greater flexibility and more sharply defined banding than agarose gels.  
 
 
4.2.5.2 Recipes for Western blotting  
 
Materials  
SDS-PAGE reagents and apparatus 
Western transfer reagents and apparatus 
PVDF Membranes 
M paper 
Rocker or shaker 
Incubation containers 
Forceps  
X-Ray film  
Exposure cassette  
Developmental reagents and equipment 
Ponceau Stain (optional)  
Paper towels or wipes 
Specific primary antibody(ies) 
Loading buffer 
Washing buffer (TBS) 
Running buffer 
Transfer buffer 
 
 
 
Chemicals 
 
4% Stacking Gel: 
For two large stacking gels (30 ml);
18.3 ml H2O  
7.5 ml 0.5 M-Tris base (36.6 g Tris Base in 
480 ml H2O, pH 6.8 with HCl ) 
3.9 ml acrylamide 30%  
300 µl SDS 10%  
15 µl TEMED (add just bevor loading) 
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300 µl ammonium persulfate 10% (1.2 g 
ammoniumpersulfit + 12 ml H2O) 
 
15% Stacking Gel: 
For two large separating gels (70 ml); 
16.8 ml H2O  
17.5 ml 1.5 M-Tris base (109.2g Tris Base 
in 480 ml H2O, pH 8.8 with HCl ) 
35 ml acrylamide 30%  
700 µl SDS 10%  
35 µl TEMED (add just bevor loading) 
700 µl ammonium persulfate 10% (1.2 g 
ammoniumpersulfit + 12 ml H2O) 
 
RIPA Buffer: 
50 mM Tris-Cl , pH = 8.0 
150 mM NaCl 
0.1% SDS 
1% Triton X-100 
0.5% Sodium deoxycholate 
 
5X Running Buffer: 
For 4 Lit.;  
60.4 g Tris Base  
376 g glycine  
200 ml SDS (10%) 
Filter, sterilize and store at – 4°C 
 
Loading Buffer: 
50 µl DTT 2M (10%)   
450 µl Lammelli Buffer 
 
Transfer Buffer: 
For 4 Lit.; 
11.71 g  glycine 39 mM 
23.25 g Tris Base 48 mM 
14.8 ml SDS (10%) 
800 ml methanol  
 
10X PBS: 
For 1 Lit.; 
80 g NaCl 
2 g KCl 
14.4 g Na2HPO4
5.2 g KH2PO4
pH to 7.4 with NaOH  
 
TBS–Buffer: 
For 2 Lit.; 
20 ml 1M Tris pH 7.5 
40 ml 5M NaCl 
2 ml Tween 20  
 
 
 
4.2.5.3 Experimental procedures 
 
4.2.5.3.1 First day: loading and running the gel 
 
1. Setting up the gel plates: 
1. Place two long spacers (~14 cm) on the sides of two glass plates. 
2. Clamp the glass plates using binder clamps. 
3. Ensure that the joint of the bottom and side spacers is clamped. 
4. Place the both clamped glass plates into the plate holders (white racks). 
 
2. Preparing of the separating gel: 
1. Preparing the separating gel (15%), see recipes. 
2. Add TEMED just bevor loading. 
3. Fill the gel plates with 15% separating gel. The level is about 1 cm below the comb.  
4. Gently layer top with water or iso-butanol on top. 
5. Polymerization should occur within 30 min. 
 
3. Preparing of  the stacking gel: 
1. Prepare the stacking gel (4%), see recipes 
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2. Fill the gel plates up with 4% stacking gel. 
3. Place comb in slowly to avoid trapping bubbles. 
4. Polymerization should occur within 45 min. 
 
4. Setting up the plates: 
1. Take the clamped glass plates out of plates holder . 
2. Before taking out the comb, you may consider to mark the well positions. 
3. Take out comb by gently pulling straight out.  
4. Place the clamped glass plates into the gel box.  
 
5. Preparing of the running buffer: 
1. Prepare the running buffer, see recipes. 
2. Fill the running box with running buffer.  
3. Check the plates of leeking. 
 
6. Loading gel: 
1. Prepare the samples, see sample preparation. 
2. Load the gel (each well 20 µl) carefully. 
3. Insert point of the needle near the bottom of the well, slowly load sample. 
 
7. Running the gels 
1. The gels are running at 40-50 mV overnight at room temperature. 
 
 
4.2.5.3.2 Second day: Protein transfer from the SDS-Page to PVDF membranes: blotting 
 
1. Preparing of the PVDF membranes 
1. Cut a piece of PVDF-membrane matching the dimensions of the gel. 
2. Soak the PVDF membrane in methanol for approximately 3-5 minutes. 
3. Rinse the membrane well with dd H2O several times. 
 
2. Preparing of the SDS-PAGE 
1. Stop the running and put out the gel(s) from the apparatus. 
2. Remove top (smaller) plate carefully leaving the gel lying on the bottom (large plate). 
3. Cut and remove carefully the stacking gel portion(s). 
 
3. Assembling the sandwich(es) 
1. Open the sandwich (dark side to left, clear side to right). 
2. On the clear side, centre a sponge and then fit one 3M paper over it. 
3. Layer the first 3M paper with another one, add some transfer buffer. 
4. Carefully transfer the gel from the glass plate to the surface of the 3M paper. 
5. Add more transfer buffer. 
6. Smooth carefully out any bubbles with the side of a glas pipette. 
7. Layer the PVDF membrane to fit exactly over the gel. 
8. Layer another piece of 3M paper over the PVDF membrane. 
9. Add more transfer buffer and smooth out any bubbles again. 
10. Add final piece of 3M paper. 
11. Close the sandwich by folding the dark side over the layers of the 3M paper and the gel. 
12. Place the sandwich into the transfer machine with the dark side facing the red electrode. 
4. Transferring 
1. Fill the chamber with transfer buffer. 
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2. Make sure that the electrodes are submerged. 
3. Add a mixing bead in and set to stir at a moderate speed. 
4. Transfer overnight at 20 V. 
 
 
4.2.5.3.3 Third day: Probing 
 
1. Seting up the PVDF membrane 
1. Stop the transfer machine. 
2. Take the sandwiches out of the transfer machine. 
3. Put the sandwich on the dark side and open it. 
4. Take out the membrane carefully and put it on one 3M paper to dry it for 5 minutes. 
 
2. Immunoblotting 
1. Soak the PVDF membrane in methanol for approximately 3-5 minutes. 
2. Rinse the membrane twice with dd H2O to remove methanol and gel particles. 
(The membrane may be stained with Ponceau S to visualize protein bands, i.e., to examine 
protein loading before proceeding with the detection). 
3. Block the membrane by incubating for 1 hour at room temperature with dry milk 5% in 
TBST-buffer. 
4. Incubate the membrane for 2 hours at room temperature with agitation in the appropriate 
primary antibody diluted in freshly prepared blocking buffer, see dilution range of 
antibody (Tab. 4.1). 
5. Wash the membrane 5 times (3 - 5 minutes each) with washing buffer. 
6. Incubate the membrane for 1 hour at room temperature with agitation in the appropriate 
secondary antibody. 
7. Wash the membrane 5 times (3 - 5 minutes each) with washing buffer. 
 
3. Developing (chemiluminescent detection) 
1. Prepare LumiGLO™ Working Reagent prior to use by combining equal volumes of the    
Substrate Solution A and Solution B.  
2. Place an open Film Exposure Folder on a flat level surface.  
3. Transfer the membrane(s) from the washing buffer rinse to a fresh tray or dish.  
4. Add LumiGLO™ Working Reagent and incubate for 1 minute at room temperature. The 
membrane should be completely covered with the reagent. 
5. Remove the membrane(s) from the working reagent with forceps, remove excess reagent, 
and then gently touch the corner of the membrane to a paper towel or filter paper to 
remove the last drop.  
6.  Place the membrane(s) in the open film exposure folder, and then close the folder; make 
sure that there are no air bubbles between the membrane and the upper layer of the folder. 
7.  Place the folder in an appropriate X-Ray film exposure cassette. 
8. In a dark room, expose X-Ray film to the membrane(s). The exposure time may vary from 
a few seconds to a few minutes (or longer), depending upon the amount of antigen to be 
detected. 
9.  Develop the X-Ray film(s). 
10. After all desired films have been obtained; membranes may be stripped and reprobed, or 
stained with Ponceau S and/or dried as desired. 
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Table 4.1: Dilution range of utilized antibodies 
 
protein primary antibody secondary antibody 
GS 1:5000 1:10,000 
GFAP 1:2000 1:20,000 
LDH-1 1:5000 1:20,000 
β-actin    1:10,000 1:20,000 
 
 
4.2.5.4 Staining methods 
 
To confirm that the transfer of the proteins to the membrane occurred, a total protein stain 
such as Ponceau S is most commonly used. It is rapid, reversible, and does not interfere with 
subsequent immunodetection. In addition, staining the acrylamide gel after transfer confirms 
the complete migration of the proteins out of the gel. Beside Ponceau S, Coomassie Brilliant 
Blue R-250 is commonly used for the detection of proteins, and is sensitive in a range of 0.5 
to 25 µg of protein. Within this range, it also follows the Beer-Lambert law and thus can be 
quantitative as well as qualitative.  
 
4.2.5.4.1 Coomassie Brilliant Blue R-250:  
1.  Soak blott (after dd H2O rinse) in methanol.  
2.  Stain PVDF membrane with 0.1% Coomassie R-250 in 40% MeOH for no longer than 
ONE MINUTE - usually 15 to 20 seconds are sufficient. (Staining for longer periods of 
time will result in high background and will interfere with extraction and cleavage). 
3.  Destain with 50% methanol, several changes.  
4.  Rinse extensively with dd H2O.  
5.  Cut out the band of interest.  
 
4.2.5.4.2 Ponceau S:  
1. Rinse the PVDF membrane with methanol for 10 minutes. 
2. Wash the PVDF membrane with dd H2O three times. 
3.  Stain the PVDF membrane in 0.25% Ponceau S in 1% Acetic acid for 10 minutes (until 
protein bands are visible). 
4.  Rinse the membrane in dd H2O three times. 
5.  Dry PVDF membrane on 3M paper. 
 
4.2.6 Immunohistochemistry 
 
4.2.6.1 Introduction 
 
Immunohistochemistry is the localization of antigens (proteins) in tissue sections by the 
use of labelled antibodies as specific reagents through antigen-antibody interactions that are 
Chapter 4: Experimental Methods  103   
visualized by a marker such as fluorescent dye, enzymes, radioactive compounds or colloidal 
gold. 
Albert H. Coons and his colleagues (Coons et al. 1955) were the first to label antibodies 
with a fluorescent dye, and use it to identify antigens in tissue sections. With the expansion 
and development of immunohistochemistry technique, enzyme labels have been introduced 
such as peroxidase (Nakane and Pierce, 1967; Avrameas and Uriel, 1966) and alkaline 
phosphatase (Mason and Sammons, 1978). Colloidal gold (Faulk and Taylor, 1971) label has 
also been discovered and used to identify immunohistochemical reactions at both light and 
electron microscopy level. Other labels include radioactive elements, and the immunoreaction 
can be visualized by autoradiography. Because immunohistochemistry involves a specific 
antigen-antibody reaction, it has apparent advantages over traditionally used special enzyme 
staining techniques that identify only a limited number of proteins, enzymes and tissue 
structures. Therefore, immunohistochemistry has become a crucial technique and is widely 
used in many medical research laboratories as well as clinical diagnostics. There are 
numerous immunohistochemistry methods that may be used to localize antigens. The 
selection of a suitable method should be based on parameters such as the type of specimen 
under investigation and the degree of sensitivity required.  
Direct method: The direct method is a “one step staining method”, and involves a labelled 
antibody reacting directly with the antigen in tissue sections. This technique utilizes only one 
antibody and the procedure is fast. However, it is insensitive due to low signal amplification 
and is, therefore, rarely used after the indirect method has been developed. 
Indirect method: The indirect method involves the use of an unlabelled primary antibody 
(first layer) which reacts with the antigen in the tissue, and a labelled secondary antibody 
(second layer) which reacts with the primary antibody (Note: the secondary antibody must be 
directed against the IgG of the animal species in which the primary antibody has been raised). 
This method is more sensitive due to signal amplification through several secondary antibody 
reactions with different antigenic sites on the primary antibody. In addition, it has also 
economical advantages since one labelled second layer antibody can be used with several first 
layer antibodies to different antigens. The second layer antibody can be labelled with a 
fluorescent dye such as FITC, rhodamine or Texas Red, and this is called indirect 
immunofluorescence method. The second layer antibody may be labelled with an enzyme 
such as peroxidase, alkaline phosphatase or glucose oxidase, and this is called indirect 
immunoenzyme method.  
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Controls: Special controls must be run in order to test the protocols and for the specificity of 
the antibody being used. 
Negative control is to test for the specificity of the antibody. First, no staining must be shown 
after omission of the primary antibody or the replacement of the specific primary antibody by 
a normal serum (must be the same species as the primary antibody).  
 
Using immunohistochemistry, we studied the localization of two enzymes, i.e. glutamine 
synthetase (GS) and lactate dehydrogenase (LDH-1) in different regions of rat brains, in 
particular, the frontal cortex and the globus pallidus after intraperitoneally injection of 100µM 
MnCl2/day for 4 consecutive days as a sub-acute model of manganese neurotoxicity. 
 
 
4.2.6.2 Experimental procedures 
 
Chemicals Materials 
MnCl2 Pipettes (20, 100, 200, 1000 µl) 
Pentobarbital Centrifuge tube (50 ml) 
Phosphate buffered saline Vibratome  
Formaldehyde Forceps 
Ethanol Scissor 
H2O2 Syringe and needle 
1X PBS (0.1 M, pH 7.5)  
 
Sprague Dawley rats (150-200 g) were injected intraperitoneally with MnCl2 (50 
mg/kg/day) on 4 consecutive days. On day 5, the rats were anesthetized with pentobarbital 
(Somnotol®, 65 mg/kg) which was administered intraperitoneally. The animals were perfused 
through the heart (see “Perfusion” Fig. 4.2) with a solution of 0.1 M phosphate buffered saline 
(PBS, pH 7.5) followed by 10% formaldehyde in 0.1 M phosphate buffer (PBS, pH 7.5) 
(“formaline”). The rats were decapitated; brains were removed and placed in 10% 
paraformaldehyde. After 24 hours, the formaldehyde was replaced by 1X PBS, and stored at 
4°C. The brains of the animals were cutted sagittally in 40 µm slices with a vibratome. All 
sections were stored in borate buffered saline (pH 8.4) at 4°C for subsequent staining. 
Perfusion through the heart 
1. Aneasthetize rats by intraperitoneal somnotol injection (65 mg/kg). 
2. Place the rats on their backside on ice. 
3. Swab abdomen with 70 % ethanol. Cut horizon between abdomen and the chest; be 
carefully not to cut other organs. 
4. Open the chest chamber and fix it. 
5. Cut the diaphragm to expose the heart. 
6. Fix the heart with a forcep. 
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7. Insert carefully the needle into the left ventricle (see the pulse in syringe). 
8. Fix the needle with a long forcep. 
9. Cut the aorta. 
10. Inject 0.1 M phosphate buffered saline (PBS, pH 7.5) three times each 50 ml. 
11. Inject 10% formaldehyde (formaline phosphate) three times each 50 ml. 
12. Decapitate the rats and remove the brains. 
13. Put the brains into 10% formaldehyde and store them at 4°C. 
14. Replace the medium after 24 hours by 0.1 M phosphate buffered saline and store at 4°C. 
 
Figure 4.1: Perfusion through the heart 
 
 
 
 
 
 
 
 
 
 
Schematic representation of perfusion through the heart. The injection was carried out through the left venrticle, 
while the aorta is cut at the same time. 
 
 
 
 
Sections were placed in 24 multiwell plates and washed for 10 minutes at room 
temperature with phosphate buffered saline (1X PBS) and 0.3% hydrogen peroxide (H2O2) to 
oxidize the cellular peroxidase enzyme. Sections were then washed three times with 1X PBS 
for each 10 minutes to remove the excess of H2O2. Afterwards, the sections were incubated for 
20 minutes with a solution containing 1X PBS, 0.5 % Triton X100, and 5% donkey serum to 
block the sections. Subsequently, the sections were incubated for 24 hours at 4°C with the 
L e ft v e n tr ic le
R ig h t v e n tr ic le
A o rta
Right ventricle
Aorta
Lef v ntricle
Cutting site
4.2.6.3 Staining process 
Chemicals Materials 
0.3% H2O2 24 Multiwell plates 
1X PBS (0.1 M, pH 7.5) Microscope slides 
0.5 % Triton X100 Microscope cover glass 
5% donkey serum Shaker  
Primary antibodies (GS and LDH-1) Fine brush 
Secondary antibody (GS and LDH-1) Culture dishes 
3,3-diaminobenzidine (DAB) 0.05% Parafilm 
Nickelammoniumsulfate (NH4)2Ni(SO4)2  
Ethanol (75%, 95%, and 100%)  
Xyelene  
Permount solution (Touene Solution)  
ddH2O  
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primary antibody (1:500 for GS, and 1:250 for LDH-1), 5% donkey serum, 0.5% Triton X100 
in 1X PBS. Primary antibodies included the monoclonal antibody (directed against GS, and 
LDH-1). At the next day, sections were washed 3 times for 10 minutes in 1X PBS, and then 
transferred to a solution containing the secondary antibody (0.5% Triton X100 in 1X PBS) for 
1 hour at room temperature. For mouse monoclonal antibodies, a peroxidase-conjugated goat 
anti-mouse IgG was used at a dilution of 1:100 in PBS. The sections were then rinsed three 
times in fresh 1X PBS, Then, the specimens were incubated in a solution containing 0.05% of 
3,3- diaminobenzidine (DAB), 25 mg/ml nickel ammoniumsulfate and 0.03% of H2O2  in 1X 
PBS (pH 7.4) for approximately 5 minutes at room temperature until the staining was visible. 
Subsequently, the sections were rinsed three times with 1X PBS for 10 minutes. For 
permounting, the sections were putted onto microscope slides, washed three times with 
ddH2O, and rinsed with 75%, 95%, and 100% ethanol and subsequently with Xyelene for 45 
seconds. Afterwards, the slides were dried at room temperature for at least 5 minutes, droped 
with permount solution, and covered immediately with cover glass so that no bubbles 
appeared. 
 
 
4.2.7 Reverse transcription-polymerase chain reaction  
(RT-PCR) 
 
4.2.7.1 Introduction 
 
RT-PCR (reverse transcription-polymerase chain reaction) is the most sensitive technique 
for mRNA detection and for the quantitative analysis of gene expression. Compared to the 
two other commonly used techniques for quantifying mRNA levels, Northern blot analysis 
and RNase protection assay, RT-PCR can be used to quantify mRNA levels from much 
smaller samples. In fact, this technique is sensitive enough to enable quantification of RNA 
from a single cell. RT-PCR is more rapid and sensitive and can be more specific than northern 
blot analysis, but quantification can be difficult because many sources of variation exist, 
including template concentration and amplification efficiency. RT-PCR converts RNA into 
first strand cDNA, which is then used as a template for PCR. One approach to obtain 
quantitative RT-PCR results is a relative RT-PCR, which coamplifies the gene of interest with 
an internal control and quantifies the gene of interest relative to the internal control (Gause 
and Adamovicz, 1994). For the relative RT-PCR to be accurate, specific PCR conditions and 
an appropriate internal control must be determined. For quantification, the reaction must be 
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analyzed in the linear range of amplification before the products reach the PCR plateau for 
either the gene of interest or the internal control. Therefore, the number of starting target 
molecules and the amplification efficiency of both the target and the control must be 
comparable. 
 
A reliable internal control should show minimal changes, whereas a gene of interest may 
change greatly over the course of an experiment. Housekeeping genes are often selected 
because they encode proteins essential for cell viability and are therefore assumed to be 
expressed similarly in different cell types. However, the expressions of some commonly used 
internal controls, such as β-actin, glyceraldehyde-3-phosphate dehydrogenase, and 
cyclophilin, have been found to vary in different tissues and can be affected by experimental 
treatments (Stürzenbaum and Kille, 2001). In recent years, a number of methods have been 
developed that combine reverse transcription (RT) of mRNAs with polymerase chain reaction 
(PCR) to determine transcript concentrations. These methods avoid the need of large amounts 
of RNA and offer sensitive non-radioactive detection in small tissue samples (Siebert and 
Larrick, 1992). Quantitative (or competitive) RT-PCR (Q-RT-PCR), although offering the 
highest accuracy of these methods, requires the construction of an appropriate competitor 
template that should be included in the RT-reaction at several concentrations (Riedy et al., 
1995). Construction of such a competitor can be time consuming and the need for several RT-
reactions makes the procedure expensive. In contrast, semi-quantitative RT-PCR measures 
transcript levels are based on the band intensity of amplification products relative to an 
internal control (such as ubiquitin or β-actin) and do not require the synthesis of a competitor. 
However, to obtain accurate readings, the amplification reaction must be terminated before it 
reaches a plateau, thus requiring that several control reactions have to be run prior to the 
experiment.  
 
 
4.2.7.2 Experimental procedures 
 
Chemicals Materials 
DEPC-H2O (diethyl pyrocarbonate) 0.1% Pipettes (5, 10, 100, 200 µl) 
Acrylamide 30% Eppendorf cups (2 ml) 
10X TBE buffer Vibratome 
Acrylamide Gel 8% Running Box BIO-RAD (PROTEANR ) 
ΦX174-32P-labelled ladder Sandwiches; Sponges; Glass plate   
dNTP stock (10 mM) Micro Centrifuge 235C Fisher Scientific 
BSA Transfer membrane  
MgCl2 (1.5 mM) Membrane PVDF 
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Forward LDH-1 and GS Voltmeter BIO-RAD (PAC-3000) 
Reverse LDH-1 and GS Homogenizer Heidolph RZR 2051 
AMV (Reverse Transcriptase 25 U/µl) Glass putter 
RNAG (Rnase Inhibitor 40 U/µl)   
TAQ (DNA polymerase)  
Loading buffer  
 
After isolation and quantitative determination of the RNA using the TRI reagent (see RNA 
extraction), the procedures for RT-PCR were performed in 50 µl volumes as described below. 
 
4.2.7.2.1 Titration for GS, LDH-1 and β-actin: 
  
The quantity of the template total RNA and the optimal thermocycle number in the PCR 
were determined by titration of measured enzymes, i.e. GS, β-actin and LDH-1 as described 
below: 
Note: All buffers are thawed and placed on ice, all equipment, tubes and pippettes, must be 
DEPC treated and autoclaved. Use gloves! 
For 4 different cycles of each enzyme as following, 4 small eppendorf cups (2 ml) with 50 µl 
reagent were prepared. 
The suggested number of cycle for LDH: 18, 20, 22, 24 
The suggested number of cycle for β-actin: 16, 18, 20, 22 
The suggested number of cycle for GS: 16, 18, 20, 22 
1. Label the eppendorf tubes for LDH-1, β-actin and GS. 
2. Assemble the reaction mixtures (final volume = 50 µl) on ice, adding the components in 
the order shown below. Use the 2 µl pipette for volumes of less than 1 µl. Mix the 
components by pipetting up and down with each addition. 
3. Mix the following enzymes to the eppendorf tubes. 
4. Shake the reaction mixture on ice. 
5. Fill 50 µl in each eppendorf tubes (four tubes for 4 cycles). 
6. Layer the tubes with 3 drops of oil to avoid the evaporation. 
7. Transfer the tubes to the thermal cycler programmed to carry out the heating and cooling 
cycle steps. 
8. The whole sequence of cycles will take between 2 and 3 hours. Remove the tubes and 
store them at 4°C on ice. 
9. For analysis by acrylamide gel electrophoresis, insert carefully a pipette (100 µl) tip under 
the mineral oil and remove 49 µl of sample to a fresh, labelled tube.  
10. Add 3 µl loading buffer. Cap the tube, finger vortex and spin it down for 5 seconds. The 
samples will be analyzed under non-denaturing conditions, and there is no need to heat 
and cool the sample prior to loading. 
11. Add 1 µl ∅X-174-RF DNA marker, 16 µl 1X TBE buffer and 3 µl loading buffer in a 
new tube as marker for gel electrophoresis. 
12. Load 20 µl from each sample. 
13. Run the gels at 100 mV for 5-6 hours. 
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Table 4.2: Reagents for LDH, β-actin, and GS titration 
 
Reagents for LDH titration Volume 
T10X Reaction Buffer   20 µl 
1.5 mM MgCl2   16 µl 
dNTP mix    4 µl 
BSA   10 µl 
Forward LDH-1     8 µl 
Reverse LDH-1     8 µl 
Control RNA template      8 µl 
Depc.Water 126 µl 
Total Volume 200 µl 
Reagents for β-actin and GS titration Volume 
T10X Reaction Buffer   20 µl 
dNTP mix     4 µl 
BSA   10 µl 
Forward LDH-1     8 µl 
Reverse LDH-1     8 µl 
Control RNA template      8 µl 
Depc.Water 142 µl 
Total Volume 200 µl 
Enzyme (For LDH, β-actin,  and GS) Volume 
RNAG (Rnase Inhibitor 40 U/µl)   1 µl 
AMV (Reverse Transcriptase 25 U/µl)              1 µl 
TAQ (DNA polymerase)   6 µl 
 
PROGRAMM AAA: 
Step 1: 15 sec. 50°C (Reverse Transcription). 
Step 2: 3 sec. 95°C (Denaturation). 
Step 3: 30 sec. 95 °C (Denaturation). 
Step 4: 45 sec. 58-62°C (Annealing). 
Step 5: 1 min. 72°C (Elongation). 
Step 6: 75 sec. (return step 5 to 3). 
 
The forward and reverse primer sequences: 
(β-Actin, 347 bp); 
5´- CATCCCCCCAAAGTTCTAC-3´and 5´- CCAAAGCCTTCATACATC-3´  
(GS, 483 bp); 
5´- ACCTGACAAATGGCCCTAC-3´and 5´- ACCAAAAAATAACCCCCC-3´  
(LDH, 234 bp); 
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5´- ACTGCAAACTCCAAGCTG-3´and 5´- GCAACCACTTCCAATAAC-3´  
 
 
 
4.2.8  Nuclear magnetic resonance spectroscopy (NMR) 
 
4.2.8.1  Introduction 
 
Nuclear magnetic resonance spectroscopy (NMR) was independently developed by two 
groups, by Bloch at Stanford University (1946), and by Purcell at Harvard University (1946). 
The first NMR experiments have been developed in a new era in which NMR spectroscopy 
has become well established as a powerful tool for structure elucidation. In the 1970's, NMR 
was applied to living systems, including human, in 2 distinct approaches. One application was 
the production of images, called Magnetic Resonance Imaging (MRI), and other was the 
production of NMR spectra, called Magnetic Resonance Spectroscopy (MRS). Since NMR is, 
in contrast to commonly applied radioisotope techniques, non-invasive and non-destructive, it 
has increasingly been employed to obtain information about metabolic structures and 
dynamics of living cells and has also been applied to isolated cells, perfused organs, and 
intact organism.  
1H NMR is the most prevalent nucleus used for analysis in biochemical NMR 
investigations due to its high sensitivity compared to other nuclei such as 13C, 19F, 31P, and 
23Na, as well as due to the existence of a large number of metabolites detactable 
simultaneously without isotope enrichment. 13C is used for metabolic studies and is, in 
contrast to 14C, a stable, non-radioactive isotope. In spite of its low sensitivity compared to 1H 
nucleus and low natural abundant of 1.1%, 13C NMR has the particular advantage of 
elucidating the location of the label within the metabolites (specific 13C atoms within one 
molecule) and thereby to investigate different metabolic pathways such as glucose, TCA-
cycle, and lipid metabolism, as well as metabolite trafficking between different neural cells. 
31P NMR spectroscopy is a technique to determine the energy state of cells by detecting high 
energy phosphates such as adenosine triphosphate (ATP) and phosphocreatine (PCr). 
Moreover, by means of 31P NMR spectra, precursors and catabolic products of cell 
membranes and certain compounds related to membrane synthesis and degradation such as 
phospholipides can be detected. In an in vivo approach, it is also possible to determine the 
intracellular pH because the frequency (chemical shift) of inorganic phosphate (Pi) is pH 
dependent.  
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4.2.8.2  The principle of NMR spectroscopy 
 
The phenomenon of NMR is based on the fact that nuclei of certain elements (nuclei with 
an odd number of protons, neutrons, or both) possess an angular momentum called “nuclear 
spin” with a specific magnetic moment. In a linear magnetic field (B0), such nuclei can adopt 
one of the numbers of quantized orientations, each orientation corresponding to a particular 
energy (parallel to B0 low energy level, E1 and anti-parallel to B0 high energy level, E2) (Fig. 
4.2).  
The absorption of decisive energy (the energy quanta must correspond to the precession 
frequency of the nuclei about B0) results in transfer of the nuclei from E1 to E2, while 
relaxation processes cause transitions from the upper to the lower spin state (Fig. 4.2. I and 
II). The energy difference (∆E = E2 –E1), causing an altered energy state of spins, is 
irradiated to the nuclei by means of a radiofrequency pulse (RF) orthogonal to B0. The 
absorption of the resonance frequency is detected by the receiver as a free induction decay 
(FID) signal. This time dependent decaying signal can be converted by Fourier transformation 
(FT) into a frequency dependent function that represents the NMR spectrum (Fig. 4.3). 
 
Figure 4.2: Magnetic energy levels for nuclei with nuclear spin 1/2 
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A useful piece of information which may be derived from an NMR spectrum can be 
obtained from the relative intensity of the signals, which are directly proportional to the 
number of nucleus from which the signals arise. A second important parameter for the 
interpretation of NMR data is the fine structure of signals due to spin-spin-coupling. The local 
magnetic field around a nucleus is affected by the magnetic moment of a neighboring nucleus, 
which changes the energy states of the observed nucleus and changes the resonance 
frequency. This causes a line splitting of the resonance line of a nucleus depending upon 
number and type of neighboring nuclei.  
 
Figure 4.3: The conversion of the FID to an NMR spectrum by fourier transformation 
 
 
 
 
 
 
 
 
 
 
4.2.8.3 Multinuclear high-resolution NMR spectroscopy 
 
Chemicals     Materials 
Deuterium oxide (D2O)   Pipettes (100, 200, 1000 µl) 
Deuterium chloride (DCl)    Centrifuge tubes (10, 50 ml) 
NaOD      Centrifuge 
EDTA (ethylendiaminetetraacetate)  Vortex 
TSP (Trimethylsilyl-2,2,3,3,-d4-propionat) NMR tube  
Dioxan     pH-meter E512    
      Hg/Hg2Cl2-pH-electrode  
      Bruker NB 360-, WB 360- and DRX 600-NMR 
Spectrometer (Bruker)  
 
 
4.2.8.3.1 Sample preparation 
 
For NMR measurements, the lyophilized PCA extracts and media were dissolved in 400-
700 µl (600-1000 µl for media) deuterium oxide (D2O), centrifuged, and transferred into a 5 
mm NMR tube. The pH of the samples was adjusted at 6.9-7.1 with deuterium chloride (DCl) 
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and NaOD bevor NMR analysis to obtain reproduceable chemical shifts of metabolites, and to 
prevent glutamine carbamate formation in the media (Martin et al., 1993). After recording of 
1H and 13C-NMR spectra, 100 mM EDTA was added to the sample for complexation of 
divalent cations, the probe was adjusted to pH = 7, and high resolution 31P spectra were 
obtained.   
 
 
4.2.8.3.2 Analysis of 1H-, 13C-, and 31P-NMR spectra  
 
1H-NMR spectra were calibrated by the lactate resonance at 1.33 ppm as internal chemical 
shift reference. The signals in 13C-NMR spectra were referenced to the signal of the β-glucose 
carbon C1 at 96.8 ppm or to the C3 carbon of lactate at 21.3 ppm. As internal shift reference 
of phosphorous metabolites in 31P-NMR spectra, the resonance of phosphocreatine at –2.33 
ppm was used. Assignment of signals in 1H- and 13C-NMR spectra was based on the chemical 
shift values described in the literature (Willker et al., 1996a and b).  
 
 
4.2.8.3.3 Acquisition- and processing parameter of NMR spectra 
 
1H-NMR spectroscopy 
1H-NMR spectra were recorded on Bruker AVANCE WB-360, AVANCE NB-360 with 
8.4 Tesla, and DRX-600 with 13.1 Tesla, operating at frequencies of 360 MHz for WB and 
NB, and 600 MHz for 600-DRX. The NMR parameters are shown in Table 4.3. In addition to 
PCA extracts, lyophilized incubation media were recorded by 1H-NMR. Trimethylsilyl-
propionic-2,2,3,3-d4-acid (TSP) was used as external standard for absolute quantification of 
metabolites after recording of fully relaxed 1H-NMR spectra (repetition time of 15 sec).  
 
13C-NMR spectroscopy 
13C-NMR spectra were recorded on Bruker AVANCE WB-360, AVANCE NB-360 
spectrometers with 8.4 Tesla, and DRX-600 with 13.1 Tesla, operating at frequencies of 90.5 
Hz for WB and NB 360, and 150.9 Hz for DRX-600. The NMR parameters are shown in 
Table 4.4. In addition to the PCA extracts, lyophilized incubation media were recorded by 
13C-NMR.  
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Table 4.3: Parameter for recording of 1H-NMR spectra 
 WB/NB-360 DRX 600 
NMR probe head  5-mm HX-inverse 5-mm H,C,N-inverse 
Number of scans 200-600 200-600 
Flip angle 40° 40° 
Repetition time 15 sec 15 sec 
Spectral width 3,600 Hz 7,200 Hz 
Data size∗ 16 K 16 K 
apodisation GM GM 
∗ zero filing to 32 K 
GM gaussian multiplication (varied parameters) 
For 1H -NMR measurements of lipids the H2O signal was suppressed 
 
 
 
Table 4.4: Parameter for recording of 13C-NMR spectra 
 WB/NB- 360 DRX 600 
NMR probe head  5-mm 1H/13C dual 5-mm 1H/13C dual 
Number of scans 10,000-20,000 10,000-20,000 
Flip angle 27° 27° 
Repetition time 2.5 sec 2.5 sec 
Spectral width 20,800 Hz 47,600 Hz 
Data size∗ 32 K 16 K 
apodisation EM EM 
∗ zero filing to 64 K 
EM exponential multiplication (1-3 Hz) 
Composite pulse decoupling with WALTZ-16 
 
 
31P-NMR spectroscopy 
31P-NMR spectra were recorded on Bruker AVANCE WB-360 or AVANCE NB-360 
spectrometers, oparating at a frequency of 145.7 MHz. The NMR parameters are shown in 
Table 4.5. The metabolites in 31P-NMR spectra were quantified with reference to the 
phosphocreatine (PCr) concentration, which was calculated from 1H-NMR spectra. 
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Table 4.5: Parameter for recording of 31P-NMR spectra 
 
 WB/NB- 360 
NMR probe head  5-mm QNP 
Number of scans 10,000 
Flip angle 80° 
Repetition time 3.8 sec 
Spectral width 5,200 Hz 
Data size∗ 8 K 
apodisation EM 
∗ zero filing to 16 K 
EM exponential multiplication (1-2 Hz) 
 
 
4.2.8.4 Quantification of metabolites 
 
The pool size of metabolites have been determined from fully relaxed 1H-NMR spectra of 
extracts using trimethylsilylpropionic-2,2,3,3,-d4-acid (TSP) as an external standard. The 
absolute concentrations of each metabolite are expressed as nmol/mg protein which was 
calculated by equation 1. 
Integ. x [TSP] x Vs x 1000 
[metabolite]    =     —————————————  (1) 
   Hn x 100 x [prot.] 
 
Integ; Integral of corresponding Signals 
[TSP]; Concentration of trimethylsilylpropionic-2,2,3,3,-d4-acid  
Vs; Volume of dissolved sample in D2O (µl) 
[Prot.]; Protein concentration (mg) 
 
The 13C-enrichments in C-3 position of lactate were determined from 1H-NMR spectra by 
integration of peak areas of the [1H-12C] signal and both [1H-13C] satellite signals of the 
respective methyl groups (Fig. 4.4) (equation 2):  
 
area (1H-13C) x 100 
13C-enrichment    =     ————————————— (2) 
  area (1H-12C) + area (1H-13C) 
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The sum (area [1H-12C] + area [1H-13C]) is equivalent to the pool size of lactate, quantified 
form 1H-NMR spectra. The values were corrected for 1.1 % natural abundance 13C. 13C-
enrichments of each carbon in an individual metabolite other than lactate are derived from 
13C-NMR spectra from the peak area ratio of the 13C-labelled carbon/natural abundance 
carbon according to (Badar-Goffer and Bachelard, 1991) (equation 3): 
 
AMet – An.a. (Met) 
          EMet (%)   =    ————————   x   1.1  (3) 
                 An.a. (Met) 
 
where AMet represents the 13C carbon peak area of the metabolite of interest, and An.a. its 
corresponding natural abundance signal intensity; 1.1 is the percentage factor of the 13C-
isotope. The 13C signal intensities of the individual carbon positions were corrected for NOE 
(Nuclear Overhauser Enhancement) effects by comparison with a standard mixture of amino 
acids. The natural abundance of 13C, contributing to the total intensity (An.a. (Met)), was 
determined using the known 13C-enrichment and natural abundance of lactate by conversion 
of equation 2 and correction for the pool size (equation 4): 
 
                ALac • [Met] 
           An.a. (Met)   =   ———————  (4) 
               (ELac + 1) • [Lac] 
 
Where ALac represents the carbon peak area of lactate, [Lac] or [Met] the pool sizes of lactate 
and the metabolite of interest, respectively, and ELac the percentage 13C-enrichment in lactate. 
The absolute amount of 13C in a specified carbon position (given as nmol/mg protein) is the 
product of the pool size of a compound times the fractional 13C-enrichment. 13C-NMR spectra 
obtained after incubation of cells with unlabelled glucose were used to verify the calculation 
of natural abundance 13C-signal intensity.  
 
4.2.8.5    13C isotopomer analysis  
 
Using 13C- labelled substrates, such as [1-13C]glucose or [U-13C5]glutamine, the 
metabolites of glycolysis and the TCA-cycle are labelled in different carbon position 
depending on relative contribution of the enzymatic pathways. The incorporation of 13C 
substrates into different metabolites reflects the dynamics of cellular metabolism. 
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Figure 4.3: 13C satellites of alanine and lactate in 1H-NMR spectra 
 
 
 
 
 
 
 
 
 
The 1H-NMR spectra were expanded to show the methyl resonances of unlabelled lactate (Lac) and alanine 
(Ala), as well as their satellites arising from 13C-1H-coupling (J 0 128 Hz). The doublet downfield of lactate 
represents the methyl group of unlabelled threonine (Thr). 
 
 
                lactate
  [1H-13C]        [1H-12C]         [1H-13C]
                 alanine
  [1H-13C]          [1H-12C]         [1H-13C]
threonine
[1H-12C]
1.6 1.4 1.21.31.5 ppm
4.2.8.6 Metabolic pathways of [1-13C]glucose 
 
One of the most commonly used labelled substrates for 13C-NMR spectroscopy to study 
cellular dynamic processes in mitochondria and/or the cytosol of the brain is [1-13C]glucose. 
The metabolic fate of [1-13C]glucose is schematically presented in Figure 4.5. [1-13C]glucose 
leads to the formation of [3-13C]pyruvate as end product of glycolysis. [3-13C]pyruvate can be 
either reduced to [3-13C]lactate via lactate dehydrogenase (LDH) or be transaminated to [3-
13C]alanine via alanine amino-transferase (ALAT). Labelled pyruvate can enter the TCA-
cycle via three independent pathways; i) via the anaplerotic pathway, mediated by pyruvate 
carboxylase (PC) resulting in formation to [3-13C]oxaloacetate ii) via malic enzyme (ME) 
which produces malate. iii) via pyruvate dehydrogenase (PDH) which leads to the synthesis of 
acetyl CoA and is subsequently combined with oxaloacetate to form citrate. The entry of [3-
13C]pyruvate into the TCA-cycle via PC or ME results in the same 13C isotopomer pattern in 
TCA-cycle related metabolites of [3-13C]pyruvate. Therefore, in the following, only the 
metabolic fate of [3-13C]pyruvate via PC or PDH is explained. 
 
 
4.2.8.6.1 Metabolic pathway of [3-13C]pyruvate via PC (anaplerotic pathway) 
 
Anaplerotic (meaning "filling up" in Greek) pathways replenish the TCA-cycle 
intermediates that are drawn out to produce amino acids. The main reaction of this type is 
catalyzed by pyruvate carboxylase (PC), which produces oxaloacetate. 
 Pyruvate + CO2 + H2O + ATP Oxaloacetate + ADP + Pi
Chapter 4: Experimental Methods  118   
In the brain, the metabolism of [3-13C]pyruvate via the anaplerotic pathway (PC) results in the 
formation of [2-13C]glutamate, [2-13C]glutamine, and [4-13C]GABA after the first turn of 
TCA-cycle. Also [3-13C]glutamate is labelled via equilibration of oxaloacetate with the 
symmetrical fumarate. In the following turns of the TCA-cycle via PC, glutamate and 
glutamine are labelled at the C-1 position. This carbon is lost as labelled CO2 from α-
ketoglutarate. [3-13C]oxaloacetate, produced by [3-13C]pyruvate, is transaminated to [3-
13C]aspartate by aspartate aminotransfrase (AAT), and subsequently also to [2-13C]aspartate 
due to equilibration of oxaloacetate with fumarate (Fig. 4.5). 
 
 
4.2.8.6.2  Metabolic pathway of [3-13C]pyruvate via PDH 
 
A further pathway for [3-13C]pyruvate to enter the TCA-cycle is pyruvate dehydrogenase 
(PDH) which form [2-13C]acetyl-CoA. The condensation of unlabelled oxaloacetate with [2-
13C]acetyl-CoA produces citrate and subsequently [4-13C]glutamate, which can be converted 
into [4-13C]glutamine and [2-13C]GABA by glutamate dehydrogenase (GDH) and glutamate 
decarboxylase (GAD), respectively. During the second turn, [4-13C]α-ketoglutarate is 
transformed to [3-13C] and [2-13C]oxaloacetate passing the symmetrical succinate. 
Condensation of [3-13C]  or [2-13C] oxaloacetate with unlabelled acetyl-CoA leads to [2-13C] 
or [3-13C]glutamate. If labelled [2-13C]acetyl-CoA enters the TCA-cycle during the second 
turn, equal amounts of doubly labelled [3,4-13C] and [2,4-13C]glutamate are formed. The same 
isotopomer pattern as in glutamate is found in glutamine (Fig. 4.5). 
 
 
4.2.8.7 Metabolic pathways of [U-13C5]glutamine  
 
The use of glutamine, which is uniformly labelled ([U-13C5]) provides additional metabolic 
information and simplifies the analysis of spectra in the presence of natural abundance 13C 
due to carbon spin-spin coupling. The 13C-NMR spectra of cell extracts incubated with [U-
13C5]glutamine show a variety of isotopomers with complex coupling patterns. Figure 4.7 
represents schematically the metabolic fate of [U-13C5]glutamine. After entry of [U-
13C5]glutamine into the TCA-cycle by phosphate activated glutaminase (PAG) and 
subsequently glutamate dehydrogenase (GDH), uniformly labelled oxaloacetate and 
subsequently uniformly labelled aspartate are formed. The condensation of [U-
13C4]oxaloacetate with unlabelled acetyl-CoA leads to [3,4,5-13C3]glutamate (Fig. 4.7). On the 
other hand, uniformly labelled oxaloacetate or malate can leave the TCA-cycle through the 
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combined activities of phosphoenolpyruvate carboxy kinase (PEPCK) and pyruvate kinase 
(PK) or through NADP-linked malic enzyme (ME), respectively. Uniformly labelled pyruvate 
re-enters the TCA-cycle by PDH as acetyl-CoA. Since pyruvate is simultaneously being 
produced by ME and PEPCK enzymes and consumed by the TCA-cycle, the pathway was 
considered as a futile cycle of glycolysis/gluconeogenesis in the liver and termed “pyruvate 
recycling” (Hue et al., 1982). It was first described in the liver in the early 1970s (Friedman et 
al., 1971). The condensation of uniformly labelled acetyl-CoA with unlabelled oxaloacetate 
leads to citrate and subsequently [4,5-13C2]glutamate (Fig. 4.6 and 7 ). 
 
Figure 4.6: Isotopomers of glutamate and glutamine formed from [U-13C5]glutamine 
 
 
 
 
 
 
 
 
 
 
The 13C-NMR spectra were expanded to show the spitting pattern of Glu C3, Gln C3, and Gln C4 with their 
corresponding coupling constants. 
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Figure 4.5:  Metabolic pathways of [1-13C]glucose 
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Figure 4.7:   Metabolic fate of [U-13C5]glutamine (pyruvate recycling). 
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